Return toAuthors File Hompage

Peoria Authors Publications - A to Z List


AGARWAL,D.


     1.    Agarwal, S., Deshpande, G., Agarwal, D., Dave, A., & Shah, J. J. (2005). Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia. Pediatric cardiology.

AHEARN,M.A.


     1.    Ahearn, M. A. (1997). Consent form. Journal of Family Practice, 44, 432.

     2.    Ahearn, M. A. (1997). Using local anesthetics to expel foreign objects in the foot. American Family Physician, 55, 1073.

AIYER,M.K.


     1.    Aiyer, M. K., Crnkovich, D. J., & Carlson, R. W. (1995). Recognizing hyperthermia syndromes in critically ill patients : How to diagnose, treat, and prevent heat disorders. Journal of Critical Illness, 10, 630-640.

     2.    Aiyer, M. K., Burdick, J. S., & Sonnenberg, A. (1999). Outcome of surgical and endoscopic management of biliary pancreatitis. Dig.Dis.Sci., 44, 1684-1690.

     3.    Aiyer, M. K., Hemmer, P., Meyer, L. E., Albritton, T. A., Levine, S., & Reddy, S. (2002). Evidence-based medicine in internal medicine clerkships: a national survey. South.Med.J., 95, 1389-1395.

     4.    Dorsch, J. L., Aiyer, M. K., & Meyer, L. E. (2004). Impact of an evidence-based medicine curriculum on medical students' attitudes and skills. 92, 397-406.

     5.    Dorsch, J. L., Aiyer, M. K., Gumidyala, K., & Meyer, L. E. (2006). Retention of EBM Competencies. Med.Ref.Serv.Q., 25, 45-57.

ALDAG,J.C.


     1.    Chatterton, R. T., Hill, P. D., Aldag, J. C., Hodges, K. R., Belknap, S. M., & Zinaman, M. J. (2000). Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: Influence of stress. Journal of Clinical Endocrinology & Metabolism, 85, 3661-3668.

     2.    Choudhury, A. K., Yunus, M. B., Haq, S. A., Alam, M. N., Sebrina, F., & Aldag, J. C. (2001). Clinical features of fibromyalgia syndrome in a Bangladeshi population. Journal of Musculoskeletal Pain, 9, 25-33.

     3.    Clementz, G. L., Aldag, J. C., Gladfelter, T. T., Barclay, A. M., & Brooks, H. F. (1990). A randomized study of cancer screening in a family practice setting using a recall model. J.Fam.Pract., 30, 537-541.

     4.    Daniels, C. L., Lindborg, L. A., Rusch, S., Frederick, R., Aldag, J. C., & Novotny, N. (2000). Influence of Physician Training Level on Patients with Low-risk Pneumonia in the ED. Academic Emergency Medicine 7[5], 453.
Ref Type: Abstract

     5.    Duarte, C., Dunaway, F., Turner, L. M., Aldag, J. C., & Frederick, R. (1992). Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann.Emerg.Med., 21, 1116-1121.

     6.    Frasca, M. A., Dorsch, J. L., Aldag, J. C., & Christiansen, R. G. (1992). A multidisciplinary approach to information management and critical appraisal instruction: a controlled study. Bull.Med.Libr.Assoc., 80, 23-28.

     7.    Glover, C. L., III, Benink, E., Tudor, G., Aldag, J. C., & Smith, M. (2000). Outcome analysis of chest pain patients discharged from the ED--a pilot study. Am.J.Emerg.Med., 18, 779-783.

     8.    Graumlich, J. F., Habis, S., Avelino, R. R., Salverson, S. M., Gaddamanugu, M., Jamma, K. et al. (2005). Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy, 25, 1296-1302.

     9.    Hafner, J. W., Boston, W. S., & Aldag, J. C. (2004). Shift overtime among emergency medicine residents: Rresults of a national survey. Annals of Emergency Medicine, 44, S48.

   10.    Hafner, J. W., Gerdes, E., & Aldag, J. C. (2006). Letter to the Editor. J Emerg.Med., 30, 100-101.

   11.    Hanigan, W. C., Aldag, J. C., Sabo, R. A., Rose, J. A., & Aaland, M. O. (1996). Strangulation injuries in children. Part 2. Cerebrovascular hemodynamics. J.Trauma., 40, 73-77.

   12.    Hill, P. D. & Aldag, J. C. (1996). Smoking and breastfeeding status. Research in Nursing & Health, 19, 125-132.

   13.    Hill, P. D., Humenick, S. S., Argubright, T. M., & Aldag, J. C. (1997). Effects of parity and weaning practices on breastfeeding duration. Public Health Nursing, 14, 227-234.

   14.    Hill, P. D., Aldag, J. C., & Chatterton, R. T. (1999). Breastfeeding experience and milk weight in lactating mothers pumping for preterm infants. Birth, 26, 233-238.

   15.    Hill, P. D., Aldag, J. C., & Chatterton, R. T. (2002). Initiation of pumping and milk weight in mothers of nonnursing preterm infants. In M.Davis, C. E. Isaac, L. A. Hanson, & A. L. Wright (Eds.), Integrating population outcomes, biological mechanisms and research methods in the study of human milk and lactation (pp. 267). New York: Kluwer.

   16.    Hill, P. D., Wilhelm, P. A., Aldag, J. C., & Chatterton, R. T., Jr. (2004). Breast Augmentation & Lactation Outcome: A Case Report. MCN Am J Matern.Child Nurs., 29, 238-242.

   17.    Hill, P. D. & Aldag, J. C. (2005). Milk volume on day 4 and income predictive of lactation adequacy at 6 weeks of mothers of nonnursing preterm infants. The Journal of perinatal & neonatal nursing, 19, 273-282.

   18.    Hill, P. D., Aldag, J. C., Chatterton, R. T., & Zinaman, M. J. (2005). Comparison of milk output between mothers of preterm and term infants: The first 6 weeks after birth. Journal of Human Lactation, 21, 22-30.

   19.    Hill, P. D., Aldag, J. C., Chatterton, R. T., & Zinaman, M. J. (2005). Primary and secondary mediators' influence on milk output in lactating mothers of preterm and term infants. Journal of Human Lactation, 21, 138-150.

   20.    Hill, P. D., Aldag, J. C., Chatterton, R. T., & Zinaman, M. J. (2005). Psychological distress and milk volume in lactating mothers. Western journal of nursing research, 27, 676-693.

   21.    Hill, P. D., Aldag, J. C., Demirtas, H., Zinaman, M., & Chatterton, R. T. (2006). Mood states and milk output in lactating mothers of preterm and term infants. Journal of Human Lactation, 22, 305-314.

   22.    Inanici, F., Yunus, M. B., & Aldag, J. C. (1999). Clinical features and psychologic factors in regional soft tissue pain: Comparison with fibromyalgia syndrome. Journal of Musculoskeletal Pain, 7, 293-301.

   23.    Lindborg, L. A., Rusch, S., Daniels, C. L., Frederick, R. C., Novotny, N., & Aldag, J. C. (2000). Characteristics influencing discharge disposition for low risk community acquired pneumonia patients from the emergency department. Academic Emergency Medicine 7[5], 580.
Ref Type: Abstract

   24.    Masi, A. T., Fecht, T., Aldag, J. C., & Malamet, R. L. (1998). Smoking and rheumatoid arthritis - comment on the letter by McDonagh and Walker. Arthritis & Rheumatism, 41, 184-185.

   25.    Masi, A. T., Aldag, J. C., Chatterton, R. T., Kitabchi, A. E., & Adams, R. F. (1999). Adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis: A clue to it's physiopathogenesis? Zeitschrift fur Rheumatologie, 58, 300-301.

   26.    Masi, A. T., Chatterton, R. T., & Aldag, J. C. (1999). Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease. Ann.N.Y.Acad.Sci., 876, 53-62; discussion 62-3.

   27.    Masi, A. T. & Aldag, J. C. (1999). Significantly increased frequency of baseline IgA anti-type II collagen positivity in the placebo group in a study of oral type II collagen treatment of rheumatoid arthritis: comment. Arthritis & Rheumatism, 42, 585-587.

   28.    Masi, A. T., Aldag, J. C., Chatterton, R. T., Adams, R. F., & Kitabchi, A. E. (2000). Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset? Zeitschrift fur Rheumatologie, 59, 54-61.

   29.    Masi, A. T. & Aldag, J. C. (2001). Do antifilaggrin antibodies within the "normal" range predict rheumatoid arthritis? Journal of Rheumatology, 28, 1736-1737.

   30.    Masi, A. T., Aldag, J. C., & Malamet, R. L. (2001). Heavy cigarette smoking and RA. Annals of the Rheumatic Diseases., 60, 1154-1155.

   31.    Masi, A. T., Aldag, J. C., & Sipes, J. (2001). Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: Correlations with pre-RA status and baseline positive rheumatoid factors. Journal of Rheumatology, 28, 2359-2360.

   32.    Masi, A. T., Chatterton, R. T., Aldag, J. C., & Malamet, R. L. (2002). Neuroendocrine immune basis of the rheumatic diseases II: Perspectives on the relationship of adrenal steroids to rheumatoid arthritis. In (pp. 1-12). New York: New York Academy of Sciences.

   33.    Masi, A. T., Aldag, J. C., & Chatterton, R. T. (2003). Neuroendocrine Immune Perturbations in Rheumatoid Arthritis: Causes, Consequences, or Confounders in the Disease Process? The Journal of Rheumatology, 30, 2302-2305.

   34.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2004). Basal serum IL-1 beta correlations with glucocorticoid precursor and sex steroid levels differed significantly in men and women before onset of rheumatoid arthritis (pre-RA) versus their matched controls. Arthritis and Rheumatism, 50, S352-S353.

   35.    Masi, A. T., Kamat, S., Gajdosik, R., Ahmad, N., & Aldag, J. C. (2004). Does muscular hypertonicity (MHT) correlate with clinical features in ambulatory rheumatology patients?: A controlled study of fibromyalgia (FM) and osteoarthritis (OA) patients with and without MHT. Arthritis and Rheumatism, 50, S134.

   36.    Masi, A. T. & Aldag, J. C. (2005). Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase? Scandinavian Journal of Rheumatology, 34, 342-352.

   37.    Masi, A. T., Aldag, J. C., & Jacobs, J. W. (2005). Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy. Rheumatic Diseases Clinics of North America, 31, 131-160.

   38.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2005). Gender dimorphism in serum levels of soluble interleukin-2 receptor alpha subunit (sIL-2R alpha) observed in susceptibles to rheumatoid arthritis (RA) before clinical onset (pre-RA) and in matched cohort controls (CN). Arthritis and Rheumatism, 52, S653-S654.

   39.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2005). Gender dimorphism in serum levels of soluble tumor necrosis factor receptor type 1 (sTNF-RI) observed in susceptibles to rheumatoid arthritis (RA) before clinical onset (pre-RA) and in matched cohort 2 controls (CN). Arthritis and Rheumatism, 52, S654.

   40.    Masi, A. T., Aldag, J. C., & Chatterton, R. T. (2006). Sex hormones and risks of rheumatoid arthritis and developmental or environmental influences. Ann.N.Y.Acad.Sci., 1069:223-35., 223-235.

   41.    Medlock, M. D., Cruse, R. S., Winek, S. J., Geiss, D. M., Horndasch, R. L., Schultz, D. L. et al. (1993). A 10-year experience with postpump chorea. Ann.Neurol., 34, 820-826.

   42.    Morgan, A. M. & Aldag, J. C. (1996). Early identification of cerebral palsy using a profile of abnormal motor patterns [see comments]. Pediatrics, 98, 692-697.

   43.    Reddy, S. S., Yunus, M. B., Inanici, F., & Aldag, J. C. (2000). Tender point injections are beneficial in fibromyalgia syndrome: A descriptive, open study. Journal of Musculoskeletal Pain, 8, 7-18.

   44.    Sabo, R. A., Hanigan, W. C., & Aldag, J. C. (1995). Chronic subdural hematomas and seizures: the role of prophylactic anticonvulsive medication. Surg.Neurol., 43, 579-582.

   45.    Saving, K. L., Aldag, J. C., Jennings, D. E., Caughey, R. C., Regan, M., & Powers, W. (1991). Electron microscopic characterization of neonatal platelet ultrastructure: effects of sampling techniques. Thromb.Res., 61, 65-80.

   46.    Saving, K. L., Jennings, D. E., Aldag, J. C., & Caughey, R. C. (1994). Platelet ultrastructure of high-risk premature infants. Thromb.Res., 73, 371-384.

   47.    Torres, A., Skender, K. M., Wohrley, J. D., Aldag, J. C., Raff, G. W., Bysani, G. K. et al. (2004). Pulse oximetry in children with congenital heart disease: effects of cardiopulmonary bypass and cyanosis. Journal of intensive care medicine, 19, 229-234.

   48.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol.Suppl, 19:62-71., 62-71.

   49.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol., 16, 527-532.

   50.    Yunus, M. B., Kalyan-Raman, U. P., Masi, A. T., & Aldag, J. C. (1989). Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol., 16, 97-101.

   51.    Yunus, M. B., Ahles, T. A., Aldag, J. C., & Masi, A. T. (1991). Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum., 34, 15-21.

   52.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 95-97.

   53.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 90-94.

   54.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. The Journal of Rheumatology, 19, 95-97.

   55.    Yunus, M. B., Hussey, F. X., & Aldag, J. C. (1993). Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J.Rheumatol., 20, 1557-1560.

   56.    Yunus, M. B., Aldag, J. C., Dailey, J. W., & Jobe, P. C. (1995). Interrelationships of biochemical parameters in Classification of Fibromyalgia Syndrome and Health Normal Controls. Journal of Musculoskeletal Pain, 3, 15-24.

   57.    Yunus, M. B. & Aldag, J. C. (1996). Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ, 312, 1339.

   58.    Yunus, M. B., Inanici, F., Aldag, J. C., & Mangold, R. F. (2000). Fibromyalgia in men: Comparison of clinical features with women. Journal of Rheumatology, 27, 485-490.

   59.    Yunus, M. B., Arslan, S., & Aldag, J. C. (2002). Relationship between body mass index and fibromyalgia features. Scand.J.Rheumatol., 31, 27-31.

   60.    Yunus, M. B., Arslan, S., & Aldag, J. C. (2002). Relationship between fibromyalgia features and smoking. Scand.J.Rheumatol., 31, 301-305.

   61.    Yunus, M. B., Celiker, R., & Aldag, J. C. (2004). Fibromyalgia in men: Comparison of psychological features with women. Journal of Rheumatology, 31, 2464-2467.

   62.    Yunus, M. B., Young, C. S., Saeed, S. A., Mountz, J. M., & Aldag, J. C. (2004). Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis and Rheumatism, 51, 513-518.

ANDERSON,R.C.


     1.    Anderson, R. C. & DeBord, J. R. (1995). Tertiary vascular access surgery for chronic hemodialysis. Seminars in Dialysis, 8, 88-94.

     2.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     3.    Pyle, J. W., Ash, J. L., Hussain, S. M., Reid, N., & Anderson, R. C. (2005). Sternal resection and reconstruction after renal cell carcinoma metastatic to the sternum. The Journal of thoracic and cardiovascular surgery, 129, 1177-1178.

ASH,J.L.


     1.    Pyle, J. W., Ash, J. L., Hussain, S. M., Reid, N., & Anderson, R. C. (2005). Sternal resection and reconstruction after renal cell carcinoma metastatic to the sternum. The Journal of thoracic and cardiovascular surgery, 129, 1177-1178.

     2.    Whittaker, L. D., Jr., Estes, N. C., Ash, J. L., & Meyer, L. E. (2006). The value of resident teaching to improve student perceptions of surgery clerkships and surgical career choices. Am.J Surg., 191, 320-324.

ASSAF,B.A.


     1.    Assaf, B. A., Karkar, K. M., Laxer, K. D., Garcia, P. A., Austin, E. J., Barbaro, N. M. et al. (2003). Ictal magnetoencephalography in temporal and extratemporal lobe epilepsy. Epilepsia, 44, 1320-1327.

     2.    Assaf, B. A., Karkar, K. M., Laxer, K. D., Garcia, P. A., Austin, E. J., Barbaro, N. M. et al. (2004). Magnetoencephalography source localization and surgical outcome in temporal lobe epilepsy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 115, 2066-2076.

     3.    Kurth, S. M., Kurylo, M. F., Xu, M. Y., Patton, K. J., Mcvey, K. M., Rodde, M. et al. (2005). A paradigm for investigating memory localization using fMRI. Epilepsia, 46, 263.

     4.    Pflieger, M. E. & Assaf, B. A. (2004). A noninvasive method for analysis of epileptogenic brain connectivity. Epilepsia, 45, 70-71.

     5.    Xu, M. Y., Kurylo, M. F., Kurth, S. M., Mcvey, K. M., Patton, K. J., Rodde, M. et al. (2005). Functional MRI presugical memory function assessment in intractable epilepsy. Epilepsia, 46, 48.

BAILIE,M.D.


     1.    Bailie, M. D. (1992). Development of the endocrine function of the kidney. Clin.Perinatol., 19, 59-68.

     2.    Bailie, M. D. (1993). Diuretic treatment agents. Adv.Pediatr., 40, 273-285.

BALDWIN,K.A.


     1.    Baldwin, K. A. & Chen, S. C. (1996). Use of public health nursing services: relationship to adequacy of prenatal care and infant outcome. Public Health Nursing, 13, 13-20.

     2.    Baldwin, K. A., Sisk, R. J., Watts, P. R., McCubbin, J. E., Brockschmidt, B. A., & Marion, L. N. (1998). Acceptance of nurse practitioners and physician assistants in meeting the perceived needs of rural communities. Public Health Nursing, 15, 389-397.

     3.    Baldwin, K. A., Marvin, C. L., & Rodine, M. K. (1998). The development of a comprehensive interdisciplinary HIV/AIDS center: a community needs assessment. J.Public Health Manag.Pract., 4, 87-96.

     4.    Baldwin, K. A., Humbles, P., Armmer, F. A., & Cramer, M. (2001). Perceived Health Needs of Urban African American Church Congregants. Public Health Nursing, 18, 295-303.

     5.    Baldwin, K. A., Grinslade, M. S., Baer, L. C., Watts, P. R., Dinger, M. K., & McCubbin, J. E. (2005). Higher-order factor analysis of an instrument with dichotomous data. Research in Nursing & Health, 28, 431-440.

     6.    Issel, L. M., Baldwin, K. A., Lyons, R. L., & Madamala, K. (2006). Self-reported competency of public health nurses and faculty in Illinois. Public Health Nursing, 23, 168-177.

     7.    Watts, P. R., Dinger, M. K., Baldwin, K. A., Sisk, R. J., Brockschmidt, B. A., & McCubbin, J. E. (1999). Accessibility and perceived value of health services in five western Illinois rural communities. Journal of Community Health, 24, 147-157.

     8.    Wilson, S., Sisk, R. J., & Baldwin, K. A. (1997). Health beliefs of blue collar workers. Increasing self efficacy and removing barriers. AAOHN Journal, 45, 254-258.

BANNO,J.


     1.    Castaneda, F., Banno, J., Brady, T. M., Bertino, R. E., & Castaneda-Zuniga, W. R. (1991). Prostatic urethroplasy with Balloon Catheter as a Nonsurgical Alternative for Benign Prostatic Hyperplasia. Radiol.Clin.North Am., 29, 591-603.

     2.    Rajan, N., Allman, D., Scaglia, B., Banno, J., Stuart, R., Colombo, G. et al. (1995). Nonhodgkins lymphoma of the male urethra. Journal of Urology, 153, 1916-1917.

BARTLETT,G.L.


     1.    Bartlett, G. L. (1997). A bold statement. Scientist, 11, 10.

BASH,S.E.


     1.    Plunkett, M. D., Schneider, D. J., Shah, J. J., Bash, S. E., Bond, L. M., & Geiss, D. M. (1998). Homograft replacement of mitral valve in children. The Annals of Thoracic Surgery, 66, 849-852.

BERKMAN,W.A.


     1.    Wright, T. B., Bertino, R. E., Bishop, A. F., Brady, T. M., Castaneda, F., Berkman, W. A. et al. (1993). Complications of laparoscopic cholecystectomy and their interventional radiologic management. Radiographics, 13, 119-128.

BERTINO,R.E.


     1.    Castaneda, F., Banno, J., Brady, T. M., Bertino, R. E., & Castaneda-Zuniga, W. R. (1991). Prostatic urethroplasy with Balloon Catheter as a Nonsurgical Alternative for Benign Prostatic Hyperplasia. Radiol.Clin.North Am., 29, 591-603.

     2.    Swischuk, J. L., Castaneda, F., Patel, J. C., Li, R. Z., Brady, T. M., Fraser, K. et al. (1998). Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. Journal of Vascular & Interventional Radiology, 9, 347-352.

     3.    Wright, T. B., Bertino, R. E., Bishop, A. F., Brady, T. M., Castaneda, F., Berkman, W. A. et al. (1993). Complications of laparoscopic cholecystectomy and their interventional radiologic management. Radiographics, 13, 119-128.

BISHOP,A.F.


     1.    Rians, C. B., Bishop, A. F., Montgomery, C. E., & Cahill, B. R. (1990). False aneurysm of the perforating peroneal artery: a complication of lateral ankle sprain. A case report. J.Bone Joint Surg.[Am]., 72, 773-775.

     2.    Smith, S. M., Young, C. S., & Bishop, A. F. (1996). Adenocarcinoma of a foregut cyst: detection with positron emission tomography. Am.J.Roentgenol., 167, 1153-1154.

     3.    Wright, T. B., Bertino, R. E., Bishop, A. F., Brady, T. M., Castaneda, F., Berkman, W. A. et al. (1993). Complications of laparoscopic cholecystectomy and their interventional radiologic management. Radiographics, 13, 119-128.

BLAND,A.C.


     1.    Bland, A. C., Kreiter, C. D., & Gordon, J. A. (2005). The psychometric properties of five scoring methods applied to the script concordance test. Academic Medicine, 80, 395-399.

BOCHANTIN,T.


     1.    Kaufmann, R. C., Smith, T., Bochantin, T., Khardori, R., Evans, M. S., & Steahly, L. (1999). Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Obstetrics & Gynecology, 93, 734-737.

BONELLO,J.P.


     1.    Bonello, J. P. (2000). Civil War Medicine. The Surgical Technologist, 32, 10-18.

     2.    Bonello, J. P. (2003). Minimally invasive autopsy circa 1882 - Howard Kelly's innovative and imaginative series. Surgical Laparoscopy Endoscopy & Percutaneous Techniques, 13, 223-226.

BRADY,T.M.


     1.    Brady, T. M., Swischuk, J. L., Castaneda, F., Smouse, H. B., & Fox, P. F. (2000). Central venous thrombolysis/PTA/stenting. Seminars in Interventional Radiology, 17, 121-138.

     2.    Brady, T. M., Castaneda, F., Swischuk, J. L., & Smouse, H. B. (2001). Re: The Legs for Life (R) screening for peripheral vascular disease: Compliance with physician recommendations in moderate- and high-risk assessed patients. Journal of Vascular & Interventional Radiology, 12, 774.

     3.    Castaneda, F., Banno, J., Brady, T. M., Bertino, R. E., & Castaneda-Zuniga, W. R. (1991). Prostatic urethroplasy with Balloon Catheter as a Nonsurgical Alternative for Benign Prostatic Hyperplasia. Radiol.Clin.North Am., 29, 591-603.

     4.    Castaneda, F., Li, R. Z., Smouse, H. B., Fox, P. F., Brady, T. M., & Swischuk, J. L. (2000). Current status of endoluminal grafting of the thoracic aorta. Seminars in Interventional Radiology, 17, 193-200.

     5.    Castaneda, F., Li, R. Z., Young, K., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2002). Catheter-directed Thrombolysis in Deep Venous Thrombosis with Use of Reteplase: Immediate Results and Complications from a Pilot Study. J.Vasc.Interv.Radiol., 13, 577-580.

     6.    Castaneda, F., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2003). Gelatin Sponge Closure Device versus Manual Compression after Peripheral Arterial Catheterization Procedures. J Vasc.Interv.Radiol, 14, 1517-1523.

     7.    Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Smouse, H. B. (2000). Embolization techniques in trauma of the chest. Seminars in Interventional Radiology, 17, 161-169.

     8.    Hanigan, W. C., Brady, T. M., Medlock, M. D., & Smith, E. B. (1990). Spontaneous regression of giant arteriovenous fistulae during the perinatal period. Case report. J.Neurosurg., 73, 954-957.

     9.    Powell, F. C. & Brady, T. M. (1994). Reversal of insulin-dependent diabetes mellitus after percutaneous pancreatic pseudocyst drainage. Radiology, 191, 551-552.

   10.    Smouse, H. B., Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Pham, M. T. (2000). Intravascular foreign body removal. Seminars in Interventional Radiology, 17, 201-212.

   11.    Swischuk, J. L., Castaneda, F., Patel, J. C., Li, R. Z., Brady, T. M., Fraser, K. et al. (1998). Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. Journal of Vascular & Interventional Radiology, 9, 347-352.

   12.    Swischuk, J. L., Castaneda, F., Smouse, H. B., Fox, P. F., & Brady, T. M. (2000). Embolization of pulmonary arteriovenous malformations. Seminars in Interventional Radiology, 17, 171-183.

   13.    Swischuk, J. L., Fox, P. F., Young, K., Hussain, S. M., Smouse, H. B., Castaneda, F. et al. (2001). Transcatheter Intraarterial Infusion of rt-PA for Acute Lower Limb Ischemia: Results and Complications. J.Vasc.Interv.Radiol., 12, 423-430.

   14.    Wright, T. B., Bertino, R. E., Bishop, A. F., Brady, T. M., Castaneda, F., Berkman, W. A. et al. (1993). Complications of laparoscopic cholecystectomy and their interventional radiologic management. Radiographics, 13, 119-128.

BRUCE,T.J.


     1.    Bruce, T. J., Spiegel, D. A., Gregg, S. F., & Nuzzarello, A. (1995). Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder [see comments]. Am.J.Psychiatry, 152, 1156-1160.

     2.    Bruce, T. J. & Sanderson, W. C. (1998). Specific Phobias : Clinical Applications of Evidence-Based Psychotherapy. Jason Aronson Inc.

     3.    Bruce, T. J. & Saeed, S. A. (1999). Social anxiety disorder: a common, underrecognized mental disorder [see comments]. Am.Fam.Physician., 60, 2311-20, 2322.

     4.    Bruce, T. J., Spiegel, D. A., & Hegel, M. T. (1999). Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies. Journal of Consulting & Clinical Psychology, 67, 151-156.

     5.    Bruce, T. J. & Saeed, S. A. (2000). Social anxiety disorder - In reply. American Family Physician, 61, 3249-3250.

     6.    Saeed, S. A. & Bruce, T. J. (1998). Panic disorder: effective treatment options [see comments]. Am.Fam.Physician., 57, 2405-12, 2419-20.

     7.    Saeed, S. A. & Bruce, T. J. (1998). Seasonal affective disorders. Am.Fam.Physician., 57, 1340-6, 1351-2.

     8.    Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am.J.Psychiatry, 151, 876-881.

     9.    Spiegel, D. A., Saeed, S. A., & Bruce, T. J. (1996). An open trial of fluvoxamine therapy for panic disorder complicated by depression. J.Clin.Psychiatry, 57, 37-40; discussion 40-1.

   10.    Spiegel, D. A. & Bruce, T. J. (1997). Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder - conclusions from combined treatment trials. American Journal of Psychiatry, 154, 773-781.

BURGER,R.L.


     1.    Chen, S. Y., Burger, R. L., & Reith, M. E. (1996). Extracellular dopamine in the rat ventral tegmental area and nucleus accumbens following ventral tegmental infusion of cocaine. Brain Research, 729, 294-296.

     2.    Dailey, J. W., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Jobe, P. C. (1991). Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame. Epilepsy Res., 8, 122-133.

     3.    Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L., & Jobe, P. C. (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 260, 533-540.

     4.    Doretto, M. C., Burger, R. L., Mishra, P. K., Garcia-Cairasco, N., Dailey, J. W., & Jobe, P. C. (1994). A microdialysis study of amino acid concentrations in the extracellular fluid of the substantia nigr of freely behaving GEPR-9S - relationship to seizure predisposition. Epilepsy Research, 17, 157-165.

     5.    Jobe, P. C., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Dailey, J. W. (1992). Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats. Amino Acids, 3, 155-172.

     6.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The paradoxical effect of NMDA receptor stimulation on electrical activity of the sensorimotor cortex in freely behaving rats: analysis by combined EEG-intracerebral microdialysis. Synapse, 12, 87-98.

     7.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The combined EEG-intracerebral microdialysis technique: a new tool for neuropharmacological studies on freely behaving animals. J.Neurosci.Methods, 43, 129-137.

     8.    Mishra, P. K., Burger, R. L., Bettendorf, A. F., Browning, R. A., & Jobe, P. C. (1994). Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4. Exp.Neurol., 125, 58-64.

     9.    Mishra, P. K., Yan, Q. S., Burger, R. L., Dailey, J. W., & Jobe, P. C. (1994). Microdialysis for the Study of Seizure Regulation. In.

   10.    Yan, Q. S., Mishra, P. K., Burger, R. L., Bettendorf, A. F., Jobe, P. C., & Dailey, J. W. (1992). Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 261, 652-659.

BURNETTE,P.


     1.    Burnette, P. (2006). Using PDAs in libraries: A how-to-do-it manual. Reference & User Services Quarterly, 45, 268-269.

     2.    Peters, T., Dorsch, J. L., Bell, L., & Burnette, P. (2003). PDAs and health sciences libraries. Library Hi Tech, 21, 400-411.

CADY,C.


     1.    Dasari, V. R., Spomar, D. G., Li, L., Cady, C., Gujrati, M., Rao, J. S. et al. (2006). Human cord blood stem cells exhibit neural phenotypes and ameliorate caspase-3 pathway proteins after traumatic SCI in rats. Journal of Neurochemistry, 96, 52.

CAHILL,B.R.


     1.    Cahill, B. R. (1994). The anaerobic energy system in human performance. Instr.Course.Lect., 43, 5-9.

     2.    Cahill, B. R., Misner, J. E., & Boileau, R. A. (1997). The clinical importance of the anaerobic energy system and its assessment in human performance [see comments]. Am.J.Sports Med., 25, 863-872.

     3.    Cahill, B. R. & Ahten, S. M. (2001). The three critical components in the conservative treatment of juvenile osteochondritis dissecans (JOCD). Physician, parent, and child. Clin.Sports Med., 20, 287-98, vi.

     4.    Pitchford, K. R. & Cahill, B. R. (1997). Osteolysis of the distal clavicle in the overhead athlete. Operative Techniques in Sports Medicine, 5, 72-77.

     5.    Rians, C. B., Bishop, A. F., Montgomery, C. E., & Cahill, B. R. (1990). False aneurysm of the perforating peroneal artery: a complication of lateral ankle sprain. A case report. J.Bone Joint Surg.[Am]., 72, 773-775.

CAMPBELL,A.C.


     1.    Maguire, R. B., Stroncek, D. F., & Campbell, A. C. (1993). Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies [see comments]. Ann.Intern.Med., 119, 215-217.

CASTANEDA,F.


     1.    Brady, T. M., Swischuk, J. L., Castaneda, F., Smouse, H. B., & Fox, P. F. (2000). Central venous thrombolysis/PTA/stenting. Seminars in Interventional Radiology, 17, 121-138.

     2.    Brady, T. M., Castaneda, F., Swischuk, J. L., & Smouse, H. B. (2001). Re: The Legs for Life (R) screening for peripheral vascular disease: Compliance with physician recommendations in moderate- and high-risk assessed patients. Journal of Vascular & Interventional Radiology, 12, 774.

     3.    Castaneda, F. & Castaneda-Zuniga, W. R. (1990). Prostatic urethroplasty with balloon catheter as a nonsurgical alternative for prostatic hyperplasia. Urol.Radiol., 12, 138-141.

     4.    Castaneda, F., Hernandez-Graulau, J. M., & Castaneda-Zuniga, W. R. (1991). Interventional radiology of the lower urinary tract and its relationship to surgical treatment. Cardiovasc.Intervent.Radiol., 14, 205-221.

     5.    Castaneda, F., Banno, J., Brady, T. M., Bertino, R. E., & Castaneda-Zuniga, W. R. (1991). Prostatic urethroplasy with Balloon Catheter as a Nonsurgical Alternative for Benign Prostatic Hyperplasia. Radiol.Clin.North Am., 29, 591-603.

     6.    Castaneda, F., Wright, J. D., & Mendez, A. (1995). Angioplasty-induced pseudoaneurysm successfully treated with a Palmaz stent. A case report. Angiology., 46, 1021-1025.

     7.    Castaneda, F. & Hernandez-Graulau, J. M. (1996). Percutaneous endopyelotomy for the treatment of ureteropelvic juction obstruction. Seminars in Interventional Radiology, 13, 169-183.

     8.    Castaneda, F., Wyffels, P. L., Patel, J. C., Swischuk, J. L., Li, R. Z., Cole, B. A. et al. (1998). New thrombolytic brush catheter in thrombosed polytetrafluoroethylene dialysis grafts: preclinical animal study. J.Vasc.Interv.Radiol., 9, 793-798.

     9.    Castaneda, F., Smouse, H. B., Swischuk, J. L., Wyffels, P. L., Patel, J. C., & Li, R. Z. (2000). Pharmacomechanical thrombolysis with use of the brush catheter in canine thrombosed femoropopliteal arterial PTFE bypass grafts. J.Vasc.Interv.Radiol, 11, 503-508.

   10.    Castaneda, F., Ball, S. M., Wyffels, P. L., Young, K., & Li, R. Z. (2000). Assessment of a polyester-covered nitinol stent in an atherosclerotic swine model. J.Vasc.Interv.Radiol., 11, 483-491.

   11.    Castaneda, F., Li, R. Z., Smouse, H. B., Fox, P. F., Brady, T. M., & Swischuk, J. L. (2000). Current status of endoluminal grafting of the thoracic aorta. Seminars in Interventional Radiology, 17, 193-200.

   12.    Castaneda, F., Ball, S. M., Young, K., & Li, R. Z. (2000). Assessment of a Polyester-Covered Nitinol Stent in the Canine Aorta and Iliac Arteries. Cardiovasc.Intervent.Radiol., 23, 375-383.

   13.    Castaneda, F. & [Guest Editor]. (2000). Vascular Interventions in the Chest. Seminars in Interventional Radiology 17[2].
Ref Type: Journal (Full)

   14.    Castaneda, F., Li, R. Z., Patel, J. C., DeBord, J. R., & Swischuk, J. L. (2001). Comparison of three mechanical thrombus removal devices in thrombosed canine iliac arteries. Radiology, 219, 153-156.

   15.    Castaneda, F., Li, R. Z., Young, K., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2002). Catheter-directed Thrombolysis in Deep Venous Thrombosis with Use of Reteplase: Immediate Results and Complications from a Pilot Study. J.Vasc.Interv.Radiol., 13, 577-580.

   16.    Castaneda, F., Goodwin, S. C., Swischuk, J. L., Wong, G. C., Bonilla, S. M., Wang, M. J. et al. (2002). Treatment of pelvic arteriovenous malformations with ethylene vinyl alcohol copolymer (onyx). J.Vasc.Interv.Radiol., 13, 513-516.

   17.    Castaneda, F., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2003). Gelatin Sponge Closure Device versus Manual Compression after Peripheral Arterial Catheterization Procedures. J Vasc.Interv.Radiol, 14, 1517-1523.

   18.    Castaneda, F. (2004). Reasonable safety ranges. Cardiovascular and Interventional Radiology, 27, 164.

   19.    Cragg, A. H., Carl, A., Castaneda, F., Dickman, C., Guterman, L., & Oliveira, C. (2004). New percutaneous access method for minimally invasive anterior lumbosacral surgery. Journal of Spinal Disorders & Techniques, 17, 21-28.

   20.    Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Smouse, H. B. (2000). Embolization techniques in trauma of the chest. Seminars in Interventional Radiology, 17, 161-169.

   21.    Mendez, A., Mancera-Maldonado, J. L., & Castaneda, F. (1994). Complications of percutaneous cholecystostomy. Seminars in Interventional Radiology, 11, 283-286.

   22.    Mendez, A. & Castaneda, F. (1995). Anatomical principles of vascular access. Seminars in Interventional Radiology, 12, 111-118.

   23.    Ouriel, K., Castaneda, F., McNamara, T., Swischuk, J. L., Tepe, G., Smith, J. J. et al. (2004). Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: Results from the RELAX trial. Journal of Vascular and Interventional Radiology, 15, 229-238.

   24.    Smouse, H. B., Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Pham, M. T. (2000). Intravascular foreign body removal. Seminars in Interventional Radiology, 17, 201-212.

   25.    Swischuk, J. L., Castaneda, F., Patel, J. C., Li, R. Z., Brady, T. M., Fraser, K. et al. (1998). Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. Journal of Vascular & Interventional Radiology, 9, 347-352.

   26.    Swischuk, J. L., Castaneda, F., Smouse, H. B., Fox, P. F., & Brady, T. M. (2000). Embolization of pulmonary arteriovenous malformations. Seminars in Interventional Radiology, 17, 171-183.

   27.    Swischuk, J. L., Fox, P. F., Young, K., Hussain, S. M., Smouse, H. B., Castaneda, F. et al. (2001). Transcatheter Intraarterial Infusion of rt-PA for Acute Lower Limb Ischemia: Results and Complications. J.Vasc.Interv.Radiol., 12, 423-430.

   28.    Wright, T. B., Bertino, R. E., Bishop, A. F., Brady, T. M., Castaneda, F., Berkman, W. A. et al. (1993). Complications of laparoscopic cholecystectomy and their interventional radiologic management. Radiographics, 13, 119-128.

CAUGHEY,R.C.


     1.    Fukuchi, K. I., ccavitti-Loper, M. A., Kim, H. D., Tahara, K., Cao, Y., Lewis, T. L. et al. (2006). Amelioration of amyloid load by anti-A beta single-chain antibody in Alzheimer mouse model. Biochemical and biophysical research communications, 344, 79-86.

     2.    Hjelle, J. T., Waters, D. C., Golinska, B. T., Steidley, K. R., Burmeister, V., Caughey, R. C. et al. (1990). Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro. Am.J.Kidney Dis., 15, 123-136.

     3.    Hjelle, J. T., Miller-Hjelle, M. A., Poxton, I. R., Kajander, E. O., Ciftcioglu, N., Jones, M. L. et al. (2000). Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int., 57, 2360-2374.

     4.    Saving, K. L., Aldag, J. C., Jennings, D. E., Caughey, R. C., Regan, M., & Powers, W. (1991). Electron microscopic characterization of neonatal platelet ultrastructure: effects of sampling techniques. Thromb.Res., 61, 65-80.

     5.    Saving, K. L., Jennings, D. E., Aldag, J. C., & Caughey, R. C. (1994). Platelet ultrastructure of high-risk premature infants. Thromb.Res., 73, 371-384.

     6.    Saving, K. L., Mankin, P. E., Maragos, J., Adams, D., & Caughey, R. C. (2001). Association of whole blood aggregation response with immunogold-labeled glycoproteins in adult and neonatal platelets. Thrombosis Research, 101, 73-81.

CHAPA,A.R.


     1.    Mafee, M. F., Tran, B. H., & Chapa, A. R. (2006). Imaging of rhinosinusitis and its complications - Plain film, CT, and MRI. Clinical Reviews in Allergy & Immunology, 30, 165-185.

CHETTY,C.


     1.    Chetty, C., Bhoopathi, P., Joseph, P., Chittivelu, S., Rao, J. S., & Lakka, S. (2006). Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. mol.cancer ther., 5, 2289-2299.

     2.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

CHIOU,A.C.


     1.    Biggs, K. L., Chiou, A. C., Hagino, R. T., & Klucznik, R. P. (2004). Endovascular repair of a spontaneous carotid artery dissection with carotid stent and coils. Journal of Vascular Surgery, 40, 170-173.

     2.    Chiou, A. C., Biggs, K. L., & Matsumura, J. S. (2005). Vena cava filters: why, when, what, how? Perspect.Vasc.Surg.Endovasc.Ther., 17, 329-339.

     3.    Chiou, A. C. (2006). Intravascular ultrasound-guided bedside placement of inferior vena cava filters. Semin.Vasc.Surg., 19, 150-154.

CHITTIVELU,S.


     1.    Chetty, C., Bhoopathi, P., Joseph, P., Chittivelu, S., Rao, J. S., & Lakka, S. (2006). Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. mol.cancer ther., 5, 2289-2299.

     2.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

CLARK,S.E.


     1.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

CLEMENTZ,G.L.


     1.    Clementz, G. L., Aldag, J. C., Gladfelter, T. T., Barclay, A. M., & Brooks, H. F. (1990). A randomized study of cancer screening in a family practice setting using a recall model. J.Fam.Pract., 30, 537-541.

     2.    Clementz, G. L. & Schade, S. G. (1990). The spectrum of vitamin B12 deficiency [see comments]. Am.Fam.Physician., 41, 150-162.

CLEMSON,B.S.


     1.    Hoy, F. B. Y., Clemson, B. S., Geiss, D. M., Bond, L. M., Linett, C. E., & Gomez, R. C. (2001). Intracranial bleed during bridge to transplant may not preclude a successful result. J.Heart Lung Transplant., 20, 901-903.

     2.    Schoenhagen, P., Stone, G. W., Nissen, S. E., Grines, C. L., Griffin, J., Clemson, B. S. et al. (2003). Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions In Patients With Unstable and Stable Presentation. Arterioscler.Thromb.Vasc.Biol., 23, 1895-1900.

     3.    Tisol, W. B., Mueller, D. K., Hoy, F. B. Y., Gomez, R. C., Clemson, B. S., & Hussain, S. M. (2001). Ventricular assist device use with mechanical heart valves: an outcome series and literature review. The Annals of Thoracic Surgery, 72, 2051-2054.

CONLEE,L.S.


     1.    Estes, N. C., Conlee, L. S., bord-Smith, A., Smith, E., Whittaker, L. D., Jr., & Rossi, T. R. (2004). The value of using naive observers to assess resident ACGME competencies. Current surgery, 61, 629-635.

CRAWFORD,D.L.


     1.    Crawford, D. L. & Phillips, E. H. (1998). Laparoscopic repair and groin hernia surgery. Surgical Clinics of North America, 78, 1047-1062.

     2.    Crawford, D. L. (2000). Inexpensive retraction technique for advanced laparoscopic procedures. Surg.Laparosc.Endosc.Percutan.Tech., 10, 258-260.

     3.    Crawford, D. L. & Phillips, E. H. (2001). Left side first: A different approach for teaching laparoscopic Nissen fundoplication. Journal of the American College of Surgeons, 192, 539-544.

     4.    Rawlings, A. L., Woodland, J. H., & Crawford, D. L. (2006). Telerobotic surgery for right and sigmoid colectomies: 30 consecutive cases. Surg.Endosc., ..

     5.    Whitty, L. A., Crawford, D. L., Woodland, J. H., Patel, J. C., Nattier, B., & Thomas, C. R., Jr. (2005). Metastatic breast cancer presenting as linitis plastica of the stomach. Gastric Cancer, 8, 193-197.

CRNKOVICH,D.J.


     1.    Aiyer, M. K., Crnkovich, D. J., & Carlson, R. W. (1995). Recognizing hyperthermia syndromes in critically ill patients : How to diagnose, treat, and prevent heat disorders. Journal of Critical Illness, 10, 630-640.

     2.    Layson, R. T., Adelman, H. M., Wallach, P. M., Pfeifer, M. P., Johnston, S., Mcnutt, R. A. et al. (1994). Discussions about the use of life-sustaining treatments - a literature review of physicians and patients attitudes and practices. Journal of Clinical Ethics, 5, 195-203.

CRUSE,R.P.


     1.    Medlock, M. D., Hanigan, W. C., & Cruse, R. P. (1993). Dissociation of cerebral blood flow, glucose metabolism, and electrical activity in pediatric brain death. Case report [see comments]. J.Neurosurg., 79, 752-755.

CUMMINGS,A.J.


     1.    Cummings, A. J., Tisol, W. B., & Meyer, L. E. (2004). Modified transthecal digital block versus traditional digital block for anesthesia of the finger. J Hand Surg.[Am], 29, 44-48.

     2.    Cummings, A. J., Valentini, J., & Getz, M. A. (2005). Use of a novel animal prototype to teach advanced airway management skills. Teaching and learning in medicine, 17, 63-68.

     3.    Harbick, S., Frederick, R., Ward, M., & Cummings, A. J. (2000). Unusual cause of chest pain in a 60-year-old woman. Ann.Emerg.Med., 35, 382-390.

     4.    Joo, J. B. & Cummings, A. J. (2000). Acute thoracoabdominal aortic dissection presenting as painless, transient paralysis of the lower extremities: a case report. J.Emerg.Med., 19, 333-337.

CURTIS,B.A.


     1.    Curtis, B. A. (1992). Na/Ca exchange and first messenger Ca in skeletal muscle excitation-contraction coupling. Adv.Exp.Med.Biol., 311, 1-17.

     2.    Curtis, B. A. (1994). Effects of diltiazem upon a rapidly exchanging calcium compartment related to repriming in frog skeletal muscle. J.Muscle Res.Cell Motil., 15, 49-58.

     3.    Laver, D. R. & Curtis, B. A. (1996). Surface potentials measure ion concentrations near lipid bilayers during rapid solution changes. Biophysical Journal, 71, 722-731.

     4.    Laver, D. R. & Curtis, B. A. (1996). Response of ryanodine receptor channels to CA2+ steps produced by rapid solution. Biophysical Journal, 71, 732-741.

CUSACK,T.J.


     1.    Cusack, T. J. (1995). Chairperson's rounds for radiology residents. Academic Radiology, 2, 1021-1025.

     2.    Hanigan, W. C., Morgan, A. M., Anderson, R. J., Bradle, P., Cohen, H. S., Cusack, T. J. et al. (1991). Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infants. Neurosurgery, 29, 701-706.

     3.    McEachen, J. C., Cusack, T. J., & McEachen, J. C. (2003). A model for a PC-based, universal-format, multimedia digitization system: moving beyond the scanner. Acad.Radiol, 10, 914-918.

DAILEY,J.W.


     1.    Browning, R. A., Wood, A. V., Merrill, M. A., Dailey, J. W., & Jobe, P. C. (1997). Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur.J.Pharmacol., 336, 1-6.

     2.    Clough, R. W., Statnick, M. A., Maringsmith, M. L., Wang, C. D., Eells, J. B., Browning, R. A. et al. (1996). Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRS. Neuroreport, 8, 341-346.

     3.    Dailey, J. W. (1990). Sedative-Hypnotic and Anxiolytic Agents. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (3rd ed., pp. 440-451). Philidelphia: Lippincott Williams & Wilkins.

     4.    Dailey, J. W., Mishra, P. K., Ko, K. H., Penny, J. E., & Jobe, P. C. (1991). Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia, 32, 168-173.

     5.    Dailey, J. W., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Jobe, P. C. (1991). Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame. Epilepsy Res., 8, 122-133.

     6.    Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L., & Jobe, P. C. (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 260, 533-540.

     7.    Dailey, J. W., Mishra, P. K., Ko, K. H., Penny, J. E., & Jobe, P. C. (1992). Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci., 50, 319-326.

     8.    Dailey, J. W., Seo, D. O., Yan, Q. S., Ko, K. H., Jo, M., & Jobe, P. C. (1994). The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study [published erratum appears in Neurosci Lett 1994 Oct 24;180(2):294]. Neurosci.Lett., 178, 179-183.

     9.    Dailey, J. W., Cheong, J. H., Ko, K. H., Adams-Curtis, L. E., & Jobe, P. C. (1995). Anticonvulsant properties of D-20443 in genetically epilepsy- prone rats: prediction of clinical response. Neuroscience letters, 195, 77-80.

   10.    Dailey, J. W., Yan, Q. S., Adams-Curtis, L. E., Ryu, J. R., Ko, K. H., Mishra, P. K. et al. (1996). Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci., 58, 259-266.

   11.    Dailey, J. W. & Naritoku, D. K. (1996). Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem.Pharmacol., 52, 1323-1329.

   12.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+. Eur.J.Pharmacol., 328, 153-162.

   13.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. Neurosci.Lett., 227, 13-16.

   14.    Dailey, J. W. (1997). Sedative-Hypnotic and Anxiolytic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (5th ed., pp. 373-380). Philidelphia: Lippincott Williams & Wilkins.

   15.    Dailey, J. W., Reith, M. E., Steidley, K. R., Milbrandt, J. C., & Jobe, P. C. (1998). Carbamazepine-induced release of serotonin from rat hippocampus in vitro. Epilepsia, 39, 1054-1063.

   16.    Dailey, J. W. (2004). Sedative-Hypnotic and Anxiolytic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 355-363). Philidelphia: Lippincott Williams & Wilkins.

   17.    Doretto, M. C., Burger, R. L., Mishra, P. K., Garcia-Cairasco, N., Dailey, J. W., & Jobe, P. C. (1994). A microdialysis study of amino acid concentrations in the extracellular fluid of the substantia nigr of freely behaving GEPR-9S - relationship to seizure predisposition. Epilepsy Research, 17, 157-165.

   18.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (1999). Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur.J.Pharmacol., 369, 305-311.

   19.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (2000). Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain. Epilepsy Res., 40, 25-32.

   20.    Jobe, P. C., Lasley, S. M., & Dailey, J. W. (1988). Monoamines and seizures in genetically epilepsy-prone rats: inferences from precursor availablity. In G.Huether (Ed.), Amino acid availability and brain function in health and disease (pp. 207-214). New York, NY: Springer-Verlag.

   21.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1991). Scope and contribution of genetic models to an understanding of the epilepsies. Crit.Rev.Neurobiol., 6, 183-220.

   22.    Jobe, P. C. & Dailey, J. W. (1991). Neurobiology of seizure predisposition in the genetically epilepsy prone rat. Proc.West.Pharmacol.Soc., 34, 223-225.

   23.    Jobe, P. C., Mishra, P. K., & Dailey, J. W. (1991). Genetically Epilepsy-Prone Rats: Actions of Antiepileptic Drugs and Monoaminergic Neurotransmitters. In C.L.FainGold & G. H. Fromm (Eds.), Drugs for Control of Epilepsy (pp. 253-275). Boca Raton: CRC Press.

   24.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1991). Scope and contribution of genetic models to an understanding of the epilepsies. Critical reviews in neurobiology, 6, 183-220.

   25.    Jobe, P. C., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Dailey, J. W. (1992). Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats. Amino Acids, 3, 155-172.

   26.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1993). Genetic models of the Epilepsies. In P.A.Schwartzkroin (Ed.), Epilepsy: Models, Mechanisms, and Concepts (pp. 94-140). NY: Cambridge University Press.

   27.    Jobe, P. C. & Dailey, J. W. (1993). Aspartame and seizures. Amino Acids, 4, 197-235.

   28.    Jobe, P. C., Mishra, P. K., Browning, R. A., Wang, C. D., Adams-Curtis, L. E., Ko, K. H. et al. (1994). Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res.Bull., 35, 493-504.

   29.    Jobe, P. C., Mishra, P. K., Adams-Curtis, L. E., Ko, K. H., & Dailey, J. W. (1994). The GEPR model of the epilepsies. In A.Malafosse (Ed.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects (pp. 385-398). John Libbey & Company.

   30.    Jobe, P. C., Mishra, P. K., Adams-Curtis, L. E., Deoskar, V. U., Ko, K. H., Browning, R. A. et al. (1995). The genetically epilepsy-prone rat (GEPR). Italian Journal of Neurological Sciences, 16, 91-99.

   31.    Jobe, P. C., Mishra, P. K., Dailey, J. W., Ko, K. H., & Reith, M. E. (1999). Genetic predisposition to partial (focal) seizures and to generalized tonic/clonic seizures: interactions between seizure circuitry of the forebrain and brainstem. In S.F.Berkovic (Ed.), Genetics of Focal Epilepsies: Clinical Aspects and Molecular Biology (pp. 251-260). John Libbey & Company.

   32.    Jobe, P. C., Dailey, J. W., & Wernicke, J. F. (1999). A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev.Neurobiol., 13, 317-356.

   33.    Jobe, P. C. & Dailey, J. W. (2000). Genetically epilepsy-Prone Rats (GEPRs) in Drug Research. CNS Drug Reviews, 6, 241-260.

   34.    Kurtz, B. S., Lehman, J., Garlick, P., Amberg, J., Mishra, P. K., Dailey, J. W. et al. (2001). Penetrance and expressivity of genes involved in the development of epilepsy in the genetically epilepsy-prone rat (GEPR). Journal of Neurogenetics, 15, 233-244.

   35.    Mishra, P. K., Kahle, E. H., Bettendorf, A. F., Dailey, J. W., & Jobe, P. C. (1993). Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s). Life Sci., 52, 1435-1441.

   36.    Mishra, P. K., Yan, Q. S., Burger, R. L., Dailey, J. W., & Jobe, P. C. (1994). Microdialysis for the Study of Seizure Regulation. In.

   37.    Montpied, P., Winsky, L., Dailey, J. W., Jobe, P. C., & Jacobowitz, D. M. (1995). Alteration in levels of expression of brain calbindin D-28K and calretinin MRNA in genetically epilepsy-prone rats. Epilepsia, 36, 911-921.

   38.    Ryu, J. R., Jobe, P. C., Milbrandt, J. C., Mishra, P. K., Clough, R. W., Browning, R. A. et al. (1999). Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues. Experimental Neurology, 156, 84-91.

   39.    Ryu, J. R., Shin, C. Y., Park, K. H., Jeon, G. S., Kim, H. C., Kim, W. K. et al. (2000). Effect of repeated seizure experiences on tyrosine hydroxylase immunoreactivities in the brain of genetically epilepsy-prone rats. Brain Research Bulletin, 53, 777-782.

   40.    Seo, D. O., Shin, C. Y., Lee, C. J., Dailey, J. W., Reith, M. E., Jobe, P. C. et al. (1999). Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats. Eur.J.Pharmacol., 365, 39-46.

   41.    Seo, D. O., Shin, C. Y., Ryu, J. R., Cheong, J. H., Choi, C. R., Dailey, J. W. et al. (2000). Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats. Eur.J.Pharmacol., 396, 53-58.

   42.    Statnick, M. A., Maringsmith, M. L., Clough, R. W., Wang, C. D., Dailey, J. W., Jobe, P. C. et al. (1996). Effect of 5,7-Dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci., 59, 1763-1771.

   43.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Neither intranigral fluoxetine nor 5,7-Dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats. Eur.J.Pharmacol., 299, 93-102.

   44.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Abnormalities in brain serotonin concentration, high-affinity uptake, and hydroxlyse activity in severe-seizure genetically epilepsy-prone rats. Epilepsia, 37, 311-321.

   45.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9S). Neuropharmacology, 35, 111-118.

   46.    Wang, C. D., Mishra, P. K., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1994). Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3S - A neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine. Epilepsy Research, 18, 1-9.

   47.    Yan, Q. S., Mishra, P. K., Burger, R. L., Bettendorf, A. F., Jobe, P. C., & Dailey, J. W. (1992). Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 261, 652-659.

   48.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Research, 610, 24-31.

   49.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res., 14, 229-236.

   50.    Yan, Q. S., Jobe, P. C., Cheong, J. H., Ko, K. H., & Dailey, J. W. (1994). Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch.Pharmacol., 350, 149-152.

   51.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1994). Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur.J.Pharmacol., 252, 105-112.

   52.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1995). Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br.J.Pharmacol., 115, 1314-1318.

   53.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1996). Focal ethanol elevates extracellular dopamine and serotonin concentrations in the rat ventral tegmental area. Eur.J.Pharmacol., 301, 49-57.

   54.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1997). Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research, 765, 149-158.

   55.    Yan, Q. S., Dailey, J. W., Steenbergen, J. L., & Jobe, P. C. (1998). Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study. Brain Research, 780, 199-209.

   56.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 95-97.

   57.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 90-94.

   58.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. The Journal of Rheumatology, 19, 95-97.

   59.    Yunus, M. B., Aldag, J. C., Dailey, J. W., & Jobe, P. C. (1995). Interrelationships of biochemical parameters in Classification of Fibromyalgia Syndrome and Health Normal Controls. Journal of Musculoskeletal Pain, 3, 15-24.

DASARI,V.R.


     1.    Dasari, V. R., Spomar, D. G., Li, L., Cady, C., Gujrati, M., Rao, J. S. et al. (2006). Human cord blood stem cells exhibit neural phenotypes and ameliorate caspase-3 pathway proteins after traumatic SCI in rats. Journal of Neurochemistry, 96, 52.

DE GROOTE,S.L.


     1.    De Groote, S. L. (2000). PubMed, Internet Grateful Med, and Ovid: A comparison of three MEDLINE internet interfaces. Medical Reference Services Quarterly, 19, 1-13.

     2.    De Groote, S. L. & Dorsch, J. L. (2001). Online journals: impact on print journal usage. Bull.Med.Libr.Assoc., 89, 372-378.

     3.    De Groote, S. L. & Dorsch, J. L. (2003). Measuring use patterns of online journals and databases. Journal of the Medical Library Association, 91, 231-240.

     4.    De Groote, S. L. & Doranski, M. (2004). The use of personal digital assistants in the health sciences: results of a survey. J.Med.Libr.Assoc., 92, 341-348.

     5.    De Groote, S. L., Shultz, M., & Doranski, M. (2005). Online journals' impact on the citation patterns of medical faculty. J.Med.Libr.Assoc., 93, 223-228.

     6.    De Groote, S. L. (2005). Questions asked at the virtual and physical health sciences reference desk: how do they compare and what do they tell us? Med.Ref.Serv.Q., 24, 11-23.

     7.    De Groote, S. L., Dorsch, J. L., Collard, S., & Scherrer, C. (2005). Quantifying cooperation: Collaborative digital reference service in the large academic library. College & Research Libraries, 66, 436-454.

     8.    Shultz, M. & De Groote, S. L. (2003). MEDLINE SDI services: how do they compare? J.Med.Libr.Assoc., 91, 460-467.

DEBORD,J.R.


     1.    Anderson, R. C. & DeBord, J. R. (1995). Tertiary vascular access surgery for chronic hemodialysis. Seminars in Dialysis, 8, 88-94.

     2.    Castaneda, F., Li, R. Z., Patel, J. C., DeBord, J. R., & Swischuk, J. L. (2001). Comparison of three mechanical thrombus removal devices in thrombosed canine iliac arteries. Radiology, 219, 153-156.

     3.    DeBord, J. R., Marshall, W. H., Wyffels, P. L., Marshall, J. S., & Humphrey, P. (1991). Carotid endarterectomy in a community hospital surgical practice. The American Surgeon, 57, 627-32; discussion 632-3.

     4.    DeBord, J. R., Debord, R. A., & Marshall, W. H. (1994). The history of the midwest-surgical-association. American Surgeon, 60, 484-489.

     5.    DeBord, J. R. (1998). The historical development of prosthetics in hernia surgery. Surgical Clinics of North America, 78, 973-1006.

     6.    DeBord, J. R. & Gupta, S. K. (2004). Prosthetic Materials and Their Interactions with Host Tissue. In M.Deysine (Ed.), Hernia Infections: Pathophysiology, Diagnosis, Treatment, Prevention ( Marcel Dekker.

     7.    DeBord, J. R. (2004). Importance of statistical significance. Hernia., 8, 15.

     8.    DeBord, J. R. (2006). Invited commentary. Hernia, 1.

     9.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

   10.    Kraus, R. R., Bergstein, J. M., & DeBord, J. R. (1999). Diagnosis, treatment, and outcome of blunt carotid arterial injuries. Am.J.Surg., 178, 190-193.

   11.    Marshall, J. S., Srivastava, A., Gupta, S. K., Rossi, T. R., & DeBord, J. R. (2003). Roux-en-Y gastric bypass leak complications. Archives of Surgery, 138, 520-523.

   12.    Patel, G. N., Braastad, F. E., & DeBord, J. R. (2000). Cystic adventitial disease of the popliteal artery: An illustrative case and literature review. Vascular Surgery, 34, 259-263.

   13.    Reitter, D. R., Paulsen, J. K., DeBord, J. R., & Estes, N. C. (2000). Five-year experience with the "four-before" laparoscopic ventral hernia repair. The American Surgeon, 66, 465-468; discussion 468-9.

   14.    Smith, E. B., DeBord, J. R., & Hanigan, W. C. (1991). Intestinal injury after lumbar discectomy. Surg.Gynecol.Obstet., 173, 22-24.

   15.    Wyffels, P. L. & DeBord, J. R. (1990). Increased limb salvage. Distal tibial/peroneal artery thrombectomy/embolectomy in acute lower extremity ischemia. The American Surgeon, 56, 468-475.

   16.    Wyffels, P. L., DeBord, J. R., Marshall, J. S., Thors, G., & Marshall, W. H. (1992). Increased limb salvage with intraoperative and postoperative ankle level urokinase infusion in acute lower extremity ischemia. J.Vasc.Surg., 15, 771-8; discussion 778-9.

DESHMUKH,P.


     1.    Deshmukh, P., Glick, R. P., Lichtor, T., Moser, R., & Cohen, E. P. (2001). Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice. J.Neurosurg., 94, 287-292.

     2.    Glick, R. P., Lichtor, T., de Zoeten, E., Deshmukh, P., & Cohen, E. P. (1999). Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2. Neurosurgery, 45, 867-874.

     3.    Olivero, W. C., Deshmukh, P., & Gujrati, M. (1999). Bilateral enhancing thalamic lesions in a 10 year old boy: case report. J Neurol Neurosurg Psychiatry, 66, 633-635.

     4.    Olivero, W. C., Deshmukh, P., & Gujrati, M. (2000). Radiation-induced cavernous angioma mimicking metastatic disease. British Journal of Neurosurgery, 14, 575-578.

DESHPANDE,G.


     1.    Agarwal, S., Deshpande, G., Agarwal, D., Dave, A., & Shah, J. J. (2005). Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia. Pediatric cardiology.

     2.    Deshpande, G., Gharpure, V., Sarnaik, A. P., & Valentini, R. P. (2006). Acute hypermagnesemia in a child. Am.J.Health Syst.Pharm., 63, 262-265.

DINH,D.H.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Adachi, Y., Chandrasekar, N., Kin, Y., Lakka, S. S., Mohanam, S., Yanamandra, N. et al. (2002). Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene, 21, 87-95.

     3.    Chandrasekar, N., Jasti, S. L., Alfred-Yung, W. K., Ali-Osman, F., Dinh, D. H., Olivero, W. C. et al. (2000). Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin.Exp.Metastasis, 18, 337-342.

     4.    Chandrasekar, N., Mohanam, S., Gujrati, M., Olivero, W. C., Dinh, D. H., & Rao, J. S. (2003). Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene, 22, 392-400.

     5.    Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Glial Cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin.Cancer Res., 9, 2342-2349.

     6.    Dasari, V. R., Spomar, D. G., Li, L., Cady, C., Gujrati, M., Rao, J. S. et al. (2006). Human cord blood stem cells exhibit neural phenotypes and ameliorate caspase-3 pathway proteins after traumatic SCI in rats. Journal of Neurochemistry, 96, 52.

     7.    Dinh, D. H., Tompkins, J., & Clark, S. B. (2001). Transcostovertebral approach for thoracic disc herniations. J.Neurosurg., 94, 38-44.

     8.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C. et al. (2003). Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene, 22, 5967-5975.

     9.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res., 64, 4069-4077.

   10.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23, 8486-8496.

   11.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). Inhibition of glioma cell invasion, angiogenesis, and tumor growth in both in vivo and in vitro models by downregulation of uPAR, uPA, and MMP-9 by using small interfering hairpin RNA (siRNA) driven by a CMV promoter. Neuro-oncology, 6, 309-310.

   12.    Gondi, C. S., Kandhukuri, N., Kondraganti, S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2006). Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int.J Oncol., 28, 633-639.

   13.    Kondraganti, S., Gondi, C. S., McCutcheon, I., Dinh, D. H., Gujrati, M., Rao, J. S. et al. (2006). RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int.J.Oncol., 28, 1353-1360.

   14.    Kondraganti, S., Gondi, C. S., Gujrati, M., McCutcheon, I., Dinh, D. H., Rao, J. S. et al. (2006). Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int.J.Oncol., 29, 25-32.

   15.    Konduri, S. D., Lakka, S. S., Tasiou, A., Yanamandra, N., Gondi, C. S., Dinh, D. H. et al. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology, 19, 519-524.

   16.    Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20, 6938-6945.

   17.    Konduri, S. D., Osman, F. A., Rao, C. N., Srinivas, H., Yanamandra, N., Tasiou, A. et al. (2002). Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas. Oncogene, 21, 921-928.

   18.    Konduri, S. D., Yanamandra, N., Siddique, K., Joseph, A., Dinh, D. H., Olivero, W. C. et al. (2002). Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 21, 8705-8712.

   19.    Konduri, S. D., Srivenugopal, K. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells. Oncogene, 22 , 4509-4516.

   20.    Krishnamoorthy, B., Darnay, B., Aggarwal, B., Dinh, D. H., Kouraklis, G., Olivero, W. C. et al. (2001). Glioma cells deficient in urokinase plasminogen activator receptor expression are susceptible to tumor necrosis factor-a-related apoptosis-inducing ligand-induced apoptosis. Clin.Cancer Res., 7, 4195-4201.

   21.    Lakka, S. S., Rajagopal, R., Rajan, M. K., Mohan, P. M., Adachi, Y., Dinh, D. H. et al. (2001). Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research, 7, 1087-1093.

   22.    Lakka, S. S., Rajan, M. K., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L. et al. (2002). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene, 21, 8011-8019.

   23.    Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23, 4681-4689.

   24.    Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H. et al. (2005). Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. Journal of Biological Chemistry.

   25.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Kin, Y., Fuller, G. N. et al. (2001). Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin.Cancer Res., 7, 2519-2526.

   26.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Lakka, S. S., Kin, Y. et al. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 20, 3665-3673.

   27.    Mohanam, S., Chandrasekar, N., Yanamandra, N., Siddique, K., Mirza, F., Dinh, D. H. et al. (2002). Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene, 21, 7824-7829.

   28.    Olivero, W. C. & Dinh, D. H. (1992). Chiari I malformation with traumatic syringomyelia and spontaneous resolution: case report and literature review. Neurosurgery, 30, 758-760.

   29.    Rao, J. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., & Gujrati, M. (2006). RNAi-mediated downregulation of proteases and uPAR in xenograft glioma cells inhibits invasion angiogenesis and tumor growth. Journal of Neurochemistry, 96, 72.

   30.    Siddique, K., Yanamandra, N., Gujrati, M., Dinh, D. H., Rao, J. S., & Olivero, W. C. (2003). Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. Int.J.Oncol., 22, 289-294.

   31.    Tasiou, A., Konduri, S. D., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2001). A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Int.J.Oncol., 19, 591-597.

   32.    Yanamandra, N., Konduri, S. D., Mohanam, S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2000). Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clin.Exp.Metastasis, 18, 611-615.

   33.    Yanamandra, N., Berhow, M. A., Konduri, S. D., Dinh, D. H., Olivero, W. C., Nicolson, G. L. et al. (2003). Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells. Clinical & Experimental Metastasis, 20, 375-383.

   34.    Yanamandra, N., Kondraganti, S., Srinivasula, S. M., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells. Oncogene, ..

   35.    Yanamandra, N., Gumidyala, K. V., Waldron, K. G., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene, 23, 2224-2230.

   36.    Yanamandra, N., Kondraganti, S., Gondi, C. S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2005). Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer, 115, 998-1005.

DORSCH,J.L.


     1.    Blecic, D. D., Dorsch, J. L., & Koenig, M. H. (1999). A longitudinal study of the effects of OPAC screen changes on searching behavior and searcher success (at the University of Illinois at Chicago). College and Research Libraries, 60, 515-530.

     2.    De Groote, S. L. & Dorsch, J. L. (2001). Online journals: impact on print journal usage. Bull.Med.Libr.Assoc., 89, 372-378.

     3.    De Groote, S. L. & Dorsch, J. L. (2003). Measuring use patterns of online journals and databases. Journal of the Medical Library Association, 91, 231-240.

     4.    De Groote, S. L., Dorsch, J. L., Collard, S., & Scherrer, C. (2005). Quantifying cooperation: Collaborative digital reference service in the large academic library. College & Research Libraries, 66, 436-454.

     5.    Dorsch, J. L., Landwirth, T. K., & Wilson, M. L. (1988). Reference activity and the external user: confluence of community needs at a medical school branch library (University of Illinois at Chicago Library of the Health Sciences: paper presented at the 87th annual meeting of the Medical Library Association, Portland, Oregon, 1987). Bull.Med.Libr.Assoc., 76, 205-212.

     6.    Dorsch, J. L., Frasca, M. A., & Wilson, M. L. (1990). A multidisciplinary approach to information and critical appraisal instruction. Bull.Med.Libr.Assoc., 78, 38-44.

     7.    Dorsch, J. L. & Landwirth, T. K. (1993). Rural GRATEFUL MED outreach; project results, impact, and future needs (Library of the Health Sciences-Peoria end-user training project; presented at the 1992 MLA Conference). Bull.Med.Libr.Assoc., 81, 377-382.

     8.    Dorsch, J. L. & Landwirth, T. K. (1994). Document needs in a rural GRATEFUL MED outreach project (at the Library of the Health Sciences--Peoria; presented at the 1993 MLA Conference). Bull.Med.Libr.Assoc., 82, 357-362.

     9.    Dorsch, J. L. & Pifalo, V. (1995). Rural Health Professioanls and Information Access: a Follow-Up Study. In (pp. 6-10).

   10.    Dorsch, J. L. & Pifalo, V. (1997). Information needs of rural health professionals: a retrospective use study. Bull.Med.Libr.Assoc., 85, 341-347.

   11.    Dorsch, J. L. (1997). BIOETHICSLINE use by medical students: curriculum-integrated instruction and collection development implications. Bull.Med.Libr.Assoc., 85, 147-153.

   12.    Dorsch, J. L. (1997). Equalizing rural health professionals' information access: lessons from a follow-up outreach project. Bull.Med.Libr.Assoc., 85, 39-47.

   13.    Dorsch, J. L., Blecic, D. D., & Bangalore, N. S. (1998). Using transaction log analysis to improve OPAC retrieval results. College and Research Libraries, 59, 39-50.

   14.    Dorsch, J. L. (2000). Information needs of rural health professionals: a review of the literature. Bull.Med.Libr.Assoc., 88, 346-354.

   15.    Dorsch, J. L., Jacobson, S., & Scherrer, C. S. (2003). Teaching EBM teachers: a team approach. Med.Ref.Serv.Q., 22, 107-114.

   16.    Dorsch, J. L. (2004). Users' Guide Interactive: Electronic Resources Review. Journal of the Medical Library Association, 91, 501.

   17.    Dorsch, J. L., Aiyer, M. K., & Meyer, L. E. (2004). Impact of an evidence-based medicine curriculum on medical students' attitudes and skills. 92, 397-406.

   18.    Dorsch, J. L., Aiyer, M. K., Gumidyala, K., & Meyer, L. E. (2006). Retention of EBM Competencies. Med.Ref.Serv.Q., 25, 45-57.

   19.    Frasca, M. A., Dorsch, J. L., Aldag, J. C., & Christiansen, R. G. (1992). A multidisciplinary approach to information management and critical appraisal instruction: a controlled study. Bull.Med.Libr.Assoc., 80, 23-28.

   20.    Masi, A. T., Dorsch, J. L., & Cholewicki, J. (2003). Are adolescent idiopathic scoliosis and ankylosing spondylitis counter-opposing conditions? A hypothesis on biomechanical contributions predisposing to these spinal disorders. Clinical & Experimental Rheumatology, 21, 573-580.

   21.    Peters, T., Dorsch, J. L., Bell, L., & Burnette, P. (2003). PDAs and health sciences libraries. Library Hi Tech, 21, 400-411.

   22.    Scherrer, C. S. & Dorsch, J. L. (1999). The evolving role of the librarian in evidence-based medicine. Bull.Med.Libr.Assoc., 87, 322-328.

DORSCH,T.R.


     1.    Dorsch, T. R. (1991). Evaluation of thyroid nodules. Semin.Surg.Oncol., 7, 64-66.

DUNNIWAY,D.


     1.    Kim, Y. & Dunniway, D. (2001). Women's services without walls. Nurs.Manage., 32, 25-27.

DZURISIN,M.J.


     1.    Dzurisin, M. J. (2002). Making a Point. The Artist's Magazine, 16-20.

EKLUND,G.W.


     1.    Cardenosa, G., Doudna, C., & Eklund, G. W. (1994). Mucinous (colloid) breast cancer - clinical mammographic findings in 10 patients. American Journal of Roentgenology, 162, 1077-1079.

     2.    Cardenosa, G., Doudna, C., & Eklund, G. W. (1994). Ductography of the breast - technique and findings. American Journal of Roentgenology, 162, 1081-1087.

     3.    Cardenosa, G. & Eklund, G. W. (1995). Screening mammography in women 40-49 years old. American Journal of Roentgenology, 164, 1104-1106.

     4.    Cupples, T. E., Eklund, G. W., & Cardenosa, G. (1996). Mammographic halo sign revisited. Radiology, 199, 105-108.

     5.    Eklund, G. W. & Cardenosa, G. (1992). The art of mammographic positioning. Radiol.Clin.North Am., 30, 21-53.

     6.    Eklund, G. W., Cardenosa, G., & Parsons, W. (1994). Assessing adequacy of mammographic image quality. Radiology, 190, 297-307.

     7.    Eklund, G. W. (1995). Re: Problems with the American College of Radiology standard for diagnostic mammography. American Journal of Roentgenology, 165, 1370-1371.

     8.    Eklund, G. W. (1995). A surgeon wishes to schedule a woman for wire localization of a nonpalpable breast lesion. American Journal of Roentgenology, 164, 1293-1294.

     9.    Eklund, G. W. (2000). Shortage of qualified breast imagers could lead to crisis. Diagn.Imaging, 22, 31-3, 69.

ELWOOD,E.T.


     1.    Elwood, E. T. & Hultman, C. S. (2002). Reconstruction of Congenital and Traumatic Breast Defects. Breast Disease, 16, 129-139.

     2.    Elwood, E. T., Burstein, F. D., Graham, L., Williams, J. K., & Paschal, M. (2003). Midface Distraction to Alleviate Upper Airway Obstruction in Achondroplastic Dwarfs. The Cleft Palate-Craniofacial Journal, 40, 100-103.

     3.    Elwood, E. T., Petronio, J., & Wood, R. J. (2005). Parental Satisfaction With the CranioCap: A New Cranial Orthosis for Deformational Plagiocephaly. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 42, 340-343.

     4.    Elwood, E. T., Shahwan, T. G., Dajani, N., & Murray, J. D. (2005). Isolated Xanthoma of the Frontal Bone. The Journal of craniofacial surgery, 16, 391-394.

ESTES,N.C.


     1.    Estes, N. C. (2000). Crisis in surgical quality. The American Surgeon, 66, 317-325.

     2.    Estes, N. C., Conlee, L. S., bord-Smith, A., Smith, E., Whittaker, L. D., Jr., & Rossi, T. R. (2004). The value of using naive observers to assess resident ACGME competencies. Current surgery, 61, 629-635.

     3.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     4.    Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N. et al. (2001). Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New England Journal of Medicine., 345, 725-730.

     5.    Muralikrishna, P. S., Gondi, C. S., Lakka, S. S., Julta, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival and tumorigenicity in vivo. Journal of Biological Chemistry.

     6.    Poplin, E. A., Benedetti, J., Estes, N. C., Haller, D. G., Mayer, R. J., Goldberg, R. M. et al. (2005). Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. Journal of Clinical Oncology, 23, 1819-1825.

     7.    Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol.Chem., 280, 36529-36540.

     8.    Reitter, D. R., Paulsen, J. K., DeBord, J. R., & Estes, N. C. (2000). Five-year experience with the "four-before" laparoscopic ventral hernia repair. The American Surgeon, 66, 465-468; discussion 468-9.

     9.    Rossi, T. R., Dynda, D. I., Estes, N. C., & Marshall, J. S. (2005). Stricture dilation 1820after laparoscopic Roux-en-Y gastric bypass. American Journal of Surgery, 189, 357-360.

   10.    Smalley, S. R., Benedetti, J., Williamson, S., Robertson, J., Fisher, B., Martenson, J. A. et al. (2004). Intergroup 0144 a phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI plus XRT vs PVT before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): Mature outcome results and pelvic failure analysis. International Journal of Radiation Oncology Biology Physics, 60, S137-S138.

   11.    Smalley, S. R., Benedetti, J. K., Williamson, S. K., Robertson, J. M., Estes, N. C., Maher, T. et al. (2006). Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. Journal of Clinical Oncology, 24, 3542-3547.

   12.    Whittaker, L. D., Jr., Estes, N. C., Ash, J. L., & Meyer, L. E. (2006). The value of resident teaching to improve student perceptions of surgery clerkships and surgical career choices. Am.J Surg., 191, 320-324.

FELDMAN,A.


     1.    Feldman, A., Cox, R., & Rosser, J. (1997). Measurement of the effective size of the input phosphor of an x- ray image intensifier. Medical Physics, 24, 1641-1642.

FISCHER,J.L.


     1.    Fischer, J. L. & Cation, L. J. (2005). DEVELOPMENTS: Impact of a Residency Research Program on Research Activity, Faculty Involvement, and Institutional Cost. Teaching and learning in medicine, 17, 159-165.

FRASCA,M.A.


     1.    Dorsch, J. L., Frasca, M. A., & Wilson, M. L. (1990). A multidisciplinary approach to information and critical appraisal instruction. Bull.Med.Libr.Assoc., 78, 38-44.

     2.    Frasca, M. A., Dorsch, J. L., Aldag, J. C., & Christiansen, R. G. (1992). A multidisciplinary approach to information management and critical appraisal instruction: a controlled study. Bull.Med.Libr.Assoc., 80, 23-28.

FRASER,K.


     1.    Alvernia, J., Fraser, K., & Lanzino, G. (2006). The occipital artery: a microanatomical study. Neurosurgery., 58, ONS114-ONS122.

     2.    Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2004). Subacute spinal subdural hematoma after spontaneous resolution of cranial subdural hematoma: causal relationship or coincidence? Case report. J Neurosurg., 100, 372-374.

     3.    Hanigan, W. C., Fraser, K., Tarantino, M. D., & Wang, H. (2005). Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report. Journal of neurosurgery, 102, 426-430.

     4.    Kanaan, Y., Kaneshiro, D., Fraser, K., Wang, D., & Lanzino, G. (2005). Evolution of endovascular therapy for aneurysm treatment. Historical overview. Neurosurg.Focus., 18, E2.

     5.    Lanzino, G., Kanaan, Y., Perrini, P., Dayoub, H., & Fraser, K. (2005). Emerging concepts in the treatment of intracranial aneurysms: stents, coated coils, and liquid embolic agents. Neurosurgery., 57, 449-459.

     6.    Lanzino, G., Fraser, K., Kanaan, Y., & Wagenbach, A. (2006). Treatment of ruptured intracranial aneurysms since the International Subarachnoid Aneurysm Trial: practice utilizing clip ligation and coil embolization as individual or complementary therapies. J Neurosurg., 104, 344-349.

     7.    Lin, J., Elwood, P. W., & Fraser, K. (2003). Venous ligation of dural arteriovenous fistulae. British Journal of Neurosurgery, 17, 239-243.

     8.    Paolini, S., Kanaan, Y., Wagenbach, A., Fraser, K., & Lanzino, G. (2005). Illustrative Review Cerebral Vasospasm in patients with unruptured intracranial aneurysms. Acta Neurochir.(Wien.)., 147, 1181-1188.

     9.    Perrini, P., Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2005). Thrombosed giant intracavernous aneurysm with subsequent spontaneous ipsilateral carotid artery occlusion. Acta Neurochirurgica, 147, 215-216.

   10.    Siddique, K., Alvernia, J., Fraser, K., & Lanzino, G. (2003). Treatment of aneurysms with wires and electricity: a historical overview. J Neurosurg., 99, 1102-1107.

   11.    Swischuk, J. L., Castaneda, F., Patel, J. C., Li, R. Z., Brady, T. M., Fraser, K. et al. (1998). Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. Journal of Vascular & Interventional Radiology, 9, 347-352.

   12.    Wang, D. Z., Wang, H., Fraser, K., & Lanzino, G. (2004). Treatment Options for Unruptured Cerebral Aneurysm. Curr Treat Options Neuro, 6, 451-458.

   13.    Wang, H., Lanzino, G., Kraus, R. R., & Fraser, K. (2003). Provocative test occlusion or the Matas test: who was Rudolph Matas? J.Neurosurg., 98, 926-928.

   14.    Wang, H., Lanzino, G., Fraser, K., Tracy, P. T., & Wang, D. (2003). Urgent endovascular treatment of acute symptomatic occlusion of the cervical internal carotid artery. J Neurosurg., 99, 972-977.

   15.    Wang, H., Fraser, K., Bortolotti, C., & Lanzino, G. (2005). Emergent endovascular treatment with direct carotid puncture for exsanguinating Carotid Blowout Syndrome. Neurocritical Care, 2, 176-178.

   16.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery, 57, E398.

   17.    Wang, H., Fraser, K., Wang, D., & Lanzino, G. (2005). The evolution of endovascular therapy for neurosurgical disease. Neurosurgery clinics of North America, 16, 223-229.

   18.    Wang, H., Swischuk, J. L., Fraser, K., Alvernia, J., & Lanzino, G. (2005). Transaxillary carotid stenting: technical case report. Neurosurgery, 56, E441.

   19.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery., 57, E398.

FREDERICK,R.


     1.    Daniels, C. L., Lindborg, L. A., Rusch, S., Frederick, R., Aldag, J. C., & Novotny, N. (2000). Influence of Physician Training Level on Patients with Low-risk Pneumonia in the ED. Academic Emergency Medicine 7[5], 453.
Ref Type: Abstract

     2.    Duarte, C., Dunaway, F., Turner, L. M., Aldag, J. C., & Frederick, R. (1992). Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann.Emerg.Med., 21, 1116-1121.

     3.    Frederick, R., Brown, C., Renusch, J., & Turner, L. M. (1991). Addisonian crisis: emergency presentation of primary adrenal insufficiency. Ann.Emerg.Med., 20, 802-806.

     4.    Frederick, R. (1997). Parenteral NSAIDs in the Treatment of Migraine Cephalalgia. Headache Quarterly, 8, 219-223.

     5.    Harbick, S., Frederick, R., Ward, M., & Cummings, A. J. (2000). Unusual cause of chest pain in a 60-year-old woman. Ann.Emerg.Med., 35, 382-390.

     6.    Hendricksen, D. K., Eshelman, B., Dill, L., & Frederick, R. (1993). Unusual etiology for left flank pain in a 29-year-old man. Ann.Emerg.Med., 22, 1455-1462.

     7.    Lindborg, L. A., Rusch, S., Daniels, C. L., Frederick, R. C., Novotny, N., & Aldag, J. C. (2000). Characteristics influencing discharge disposition for low risk community acquired pneumonia patients from the emergency department. Academic Emergency Medicine 7[5], 580.
Ref Type: Abstract

FUKUCHI,K.I.


     1.    Fukuchi, K. I., ccavitti-Loper, M. A., Kim, H. D., Tahara, K., Cao, Y., Lewis, T. L. et al. (2006). Amelioration of amyloid load by anti-A beta single-chain antibody in Alzheimer mouse model. Biochemical and biophysical research communications, 344, 79-86.

     2.    Fukuchi, K. I., Tahara, K., Kim, H. D., Maxwell, J. A., Lewis, T. L., ccavitti-Loper, M. A. et al. (2006). Anti-A beta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Neurobiology of Disease, 23, 502-511.

     3.    Kim, H. D., Maxwell, J. A., Kong, F. K., Tang, D. C., & Fukuchi, K. I. (2005). Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: Toward safer and effective vaccines against Alzheimer's disease. Biochemical and biophysical research communications.

     4.    Lalonde, R., Kim, H. D., Maxwell, J. A., & Fukuchi, K. I. (2005). Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/Delta E9 mice with amyloid plaques. Neuroscience letters, 390, 87-92.

     5.    Tahara, K., Kim, H. D., Jin, J. J., Maxwell, J. A., Li, L., & Fukuchi, K. I. (2006). Role of toll-like receptor signalling in A{beta} uptake and clearance. Brain., 19;..

GARWACKI,D.J.


     1.    Wang, D. Z., Rose, J. A., Honings, D., Garwacki, D. J., & Milbrandt, J. C. (2000). Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke, 31, 77-81.

GEISS,D.M.


     1.    Dickes, M. S., Buckley, K. W., Glogowski, K. R., Raff, G. W., & Geiss, D. M. (2003). Conversion from extracorporeal membrane oxygenation to total cardiopulmonary bypass: a simplified method. J Extra.Corpor.Technol., 35, 196-199.

     2.    Hoy, F. B. Y., Mueller, D. K., Geiss, D. M., Munns, J. R., Bond, L. M., Linett, C. E. et al. (2000). Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? The Annals of Thoracic Surgery, 70, 1259-1263.

     3.    Hoy, F. B. Y., Clemson, B. S., Geiss, D. M., Bond, L. M., Linett, C. E., & Gomez, R. C. (2001). Intracranial bleed during bridge to transplant may not preclude a successful result. J.Heart Lung Transplant., 20, 901-903.

     4.    Medlock, M. D., Cruse, R. S., Winek, S. J., Geiss, D. M., Horndasch, R. L., Schultz, D. L. et al. (1993). A 10-year experience with postpump chorea. Ann.Neurol., 34, 820-826.

     5.    Plunkett, M. D., Bond, L. M., & Geiss, D. M. (1998). Use of the "chimney patch" technique for Norwood stage I procedures. The Annals of Thoracic Surgery, 66, 1438-1439.

     6.    Plunkett, M. D., Schneider, D. J., Shah, J. J., Bash, S. E., Bond, L. M., & Geiss, D. M. (1998). Homograft replacement of mitral valve in children. The Annals of Thoracic Surgery, 66, 849-852.

     7.    Plunkett, M. D., Bond, L. M., & Geiss, D. M. (1999). Allograft mitral valve replacement. Semin.Thorac.Cardiovasc.Surg.Pediatr.Card Surg.Annu., 2, 95-110.

     8.    Plunkett, M. D., Bond, L. M., & Geiss, D. M. (2000). Staged repair of acute type I aortic dissection and coarctation in pregnancy. The Annals of Thoracic Surgery, 69, 1945-1947.

     9.    Raff, G. W., Geiss, D. M., Shah, J. J., & Bond, L. M. (2002). Repair of transposition of the great arteries with total anomalous pulmonary venous return. The Annals of Thoracic Surgery, 73, 655-657.

   10.    Sedaghat-Yazdi, F., Torres, A., Fortuna, R., & Geiss, D. M. (2005). Pulse oximeter performance affected by probe position in cyanotic critically ill infants. Critical Care Medicine, 33, A62.

   11.    Torres, A., DiLiberti, J. H., Pearl, R. H., Wohrley, J. D., Raff, G. W., Bysani, G. K. et al. (2002). Noncardiac surgery in children with hypoplastic left heart syndrome. J Pediatr.Surg., 37, 1399-1403.

   12.    Torres, A., Skender, K. M., Wohrley, J. D., Aldag, J. C., Raff, G. W., Bysani, G. K. et al. (2004). Pulse oximetry in children with congenital heart disease: effects of cardiopulmonary bypass and cyanosis. Journal of intensive care medicine, 19, 229-234.

GENSEL,K.


     1.    Misra, S., Lee, A., & Gensel, K. (2006). Chronic constipation in overweight children. JPEN J Parenter.Enteral Nutr., 30, 81-84.

GETZ,M.A.


     1.    Cummings, A. J., Valentini, J., & Getz, M. A. (2005). Use of a novel animal prototype to teach advanced airway management skills. Teaching and learning in medicine, 17, 63-68.

     2.    Woodland, J. H., Tudor, G., & Getz, M. A. (2003). Investigation of the Use of Core Practical Objectives for Standardizing the Experiences of Fourth Year Medical Students during an Emergency Medicine Clerkship. Academic Emergency Medicine, 10, 503.

GOLEMON,T.B.


     1.    Griebel, C. P., Halvorsen, J. G., Golemon, T. B., & Day, A. A. (2005). Management of spontaneous abortion. Am.Fam.Physician, 72, 1243-1250.

     2.    Trachtenbarg, D. E. & Golemon, T. B. (1998). Office care of the premature infant: Part II. Common medical and surgical problems. Am.Fam.Physician., 57, 2383-90, 2400-2.

     3.    Trachtenbarg, D. E. & Golemon, T. B. (1998). Care of the premature infant: Part I. Monitoring growth and development. Am.Fam.Physician., 57, 2123-2130.

GONDI,C.S.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C. et al. (2003). Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene, 22, 5967-5975.

     3.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res., 64, 4069-4077.

     4.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23, 8486-8496.

     5.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). Inhibition of glioma cell invasion, angiogenesis, and tumor growth in both in vivo and in vitro models by downregulation of uPAR, uPA, and MMP-9 by using small interfering hairpin RNA (siRNA) driven by a CMV promoter. Neuro-oncology, 6, 309-310.

     6.    Gondi, C. S., Kandhukuri, N., Kondraganti, S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2006). Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int.J Oncol., 28, 633-639.

     7.    Kondraganti, S., Gondi, C. S., McCutcheon, I., Dinh, D. H., Gujrati, M., Rao, J. S. et al. (2006). RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int.J.Oncol., 28, 1353-1360.

     8.    Kondraganti, S., Gondi, C. S., Gujrati, M., McCutcheon, I., Dinh, D. H., Rao, J. S. et al. (2006). Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int.J.Oncol., 29, 25-32.

     9.    Konduri, S. D., Lakka, S. S., Tasiou, A., Yanamandra, N., Gondi, C. S., Dinh, D. H. et al. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology, 19, 519-524.

   10.    Lakka, S. S., Rajan, M. K., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L. et al. (2002). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene, 21, 8011-8019.

   11.    Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23, 4681-4689.

   12.    Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H. et al. (2005). Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. Journal of Biological Chemistry.

   13.    Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005). Proteases and glioma angiogenesis. Brain Pathology, 15, 327-341.

   14.    Muralikrishna, P. S., Gondi, C. S., Lakka, S. S., Julta, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival and tumorigenicity in vivo. Journal of Biological Chemistry.

   15.    Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol.Chem., 280, 36529-36540.

   16.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

   17.    Rao, J. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., & Gujrati, M. (2006). RNAi-mediated downregulation of proteases and uPAR in xenograft glioma cells inhibits invasion angiogenesis and tumor growth. Journal of Neurochemistry, 96, 72.

   18.    Subramanian, R., Gondi, C. S., Lakka, S. S., Jutla, A., & Rao, J. S. (2006). siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int.J Oncol., 28, 831-839.

   19.    Yanamandra, N., Kondraganti, S., Gondi, C. S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2005). Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer, 115, 998-1005.

GORMAN,M.J.


     1.    Saving, K. L., Mankin, P. E., & Gorman, M. J. (2002). Differences in adhesion receptor expression between immature and older platelets and red blood cells of neonates and adults. J.Pediatr.Hematol.Oncol., 24, 120-124.

GRAUMLICH,J.F.


     1.    Cutler, J., Piller, L., Pressel, S., Graumlich, J. F., Hamilton, B., Parish, D. et al. (2004). Results of monotherapy in ALLHAT: On-treatment analyses. Journal of hypertension, 22, S248.

     2.    D'Agostino, R. B., Weintraub, M., Russell, H. K., Stepanians, M., Cantilena, L. R., Graumlich, J. F. et al. (1998). The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis. Clinical Pharmacology & Therapeutics, 64, 579-596.

     3.    Graumlich, J. F., Ludden, T. M., Conry-Cantilena, C., Cantilena, L. R., Wang, Y. L., & Levine, M. (1997). Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm.Res., 14, 1133-1139.

     4.    Graumlich, J. F. & Sidhu, D. S. (1997). B-Lactam Antiobiotics. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (5th ed., pp. 561-572). Philidelphia: Lippincott Williams & Wilkins.

     5.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (1999). Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur.J.Pharmacol., 369, 305-311.

     6.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (2000). Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain. Epilepsy Res., 40, 25-32.

     7.    Graumlich, J. F., Belknap, S. M., Bullard, S. A., Storm, B. S., Brunsman, K. S., & Howerton, J. A. (2000). Pharmaceutical Care of Postoperative Nausea and Vomiting: Balanced Scorecard for Outcomes. Pharmacotherapy, 20, 1365-1374.

     8.    Graumlich, J. F. (2001). Safety of bolus vs infusion thrombolytic therapy. Jama: Journal of the American Medical Association, 285, 2075.

     9.    Graumlich, J. F. (2001). Preventing gastrointestinal complications of NSAIDs - Risk factors, recent advances, and latest strategies. Postgrad.Med., 109, 117-+.

   10.    Graumlich, J. F., Blough, L. S., McLaughlin, R. G., Milbrandt, J. C., Calderon, C. L., Agha, S. Y. et al. (2003). Healing Pressure Ulcers with Collagen or Hydrocolloid: A Randomized, Controlled Trial. Journal of the American Geriatrics Society, 51, 147-153.

   11.    Graumlich, J. F. (2004). b-Lactam Antiobiotics. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 526-537). Philidelphia: Lippincott Williams & Wilkins.

   12.    Graumlich, J. F., Craig, C. R., & Stitzel, R. E. (2004). ÃÅ̧-Lactam Antiobiotics. In Modern Pharmacology with Clinical Applications (6th ed., pp. 526-537). Philidelphia: Lippincott Williams & Wilkins.

   13.    Graumlich, J. F., Habis, S., Avelino, R. R., Salverson, S. M., Gaddamanugu, M., Jamma, K. et al. (2005). Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy, 25, 1296-1302.

   14.    Grimm, R., Davis, B., Piller, L., Margolis, K., Barzilay, J., Dart, R. et al. (2004). Did type of prior antihypertensive therapy influence the heart failure results in ALLHAT? Journal of hypertension, 22, S151.

   15.    Levine, M., Conry-Cantilena, C., Wang, Y. L., Welch, R. W., Washko, P. W., Dhariwal, K. R. et al. (1996). Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc.Natl.Acad.Sci.U.S.A, 93, 3704-3709.

   16.    Roth, S. K., Graumlich, J. F., Maynard, J. C., & Nelson, R. A. (1995). Research in progress at member institutions of the Central Society for Clinical Research. Journal of Laboratory & Clinical Medicine, 125, 417-418.

GRAY,B.M.


     1.    Raff, G. W., Gray, B. M., Torres, A., & Hasselman, T. (2004). Aortitis in a Child with Abiotrophia defectiva Endocarditis. The Pediatric Infectious Disease Journal, 23, 574-576.

GREGG,S.F.


     1.    Bruce, T. J., Spiegel, D. A., Gregg, S. F., & Nuzzarello, A. (1995). Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder [see comments]. Am.J.Psychiatry, 152, 1156-1160.

     2.    Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am.J.Psychiatry, 151, 876-881.

GROSS,T.L.


     1.    Kim, E. S. & Gross, T. L. (1999). Prenatal ultrasound detection of a congenital epulis in a triple X female fetus: a case report. Prenat.Diagn., 19, 774-776.

     2.    McLaren, R. A., Chauhan, S. P., & Gross, T. L. (1996). Intrapartum factors in early-onset group B streptococcal sepsis in term neonates: a case-control study. Am.J.Obstet.Gynecol., 174, 1934-1937; discussion 1937-40.

     3.    Osborn, P., Gross, T. L., Shah, J. J., & Ma, L. (2000). Prenatal diagnosis of fetal heart failure in twin reversed arterial perfusion syndrome. Prenat.Diagn., 20, 615-617.

     4.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

     5.    Wolfe, H. M. & Gross, T. L. (1994). Obesity in pregnancy. Clinical Obstetrics & Gynecology, 37, 596-604.

GRUNDBACHER,F.J.


     1.    Grundbacher, F. J. (1992). Behring's discovery of diphtheria and tetanus antitoxins [see comments]. Immunol.Today, 13, 188-190.

HAFNER,J.W.


     1.    Hafner, J. W., Belknap, S. M., Squillante, M. D., & Bucheit, K. A. (2002). Adverse drug events in emergency department patients. Annals of Emergency Medicine, 39, 258-267.

     2.    Hafner, J. W., Boston, W. S., & Aldag, J. C. (2004). Shift overtime among emergency medicine residents: Rresults of a national survey. Annals of Emergency Medicine, 44, S48.

     3.    Hafner, J. W. (2005). The clinical diagnosis of streptococcal pharyngitis. Annals of Emergency Medicine, 46, 87-89.

     4.    Hafner, J. W., Gerdes, E., & Aldag, J. C. (2006). Letter to the Editor. J Emerg.Med., 30, 100-101.

     5.    Nelson, T. A. & Hafner, J. W. (2005). Emergency department pediatric all-terrain vehicle injuries in West Central Illinois. Pediatric Emergency Care, 21, 719-724.

     6.    Walsh, W. P., Hafner, J. W., & Kattah, J. C. (2003). Bilateral internuclear ophthalmoplegia following minor head trauma. J.Emerg.Med., 24, 19-22.

HALL,D.M.


     1.    Brinkman, W. J., Hall, D. M., Suo, J. L., & Weber, R. J. (1998). Centrally-mediated opioid-induced immunosuppression. Elucidation of sympathetic nervous system involvement. Adv.Exp.Med.Biol., 437, 43-49.

     2.    Hall, D. M., Suo, J. L., & Weber, R. J. (1998). Opioid mediated effects on the immune system: sympathetic nervous system involvement. J.Neuroimmunol., 83, 29-35.

HALVORSEN,J.G.


     1.    Griebel, C. P., Halvorsen, J. G., Golemon, T. B., & Day, A. A. (2005). Management of spontaneous abortion. Am.Fam.Physician, 72, 1243-1250.

     2.    Halvorsen, J. G. (1999). Who am I, professionally speaking? The Journal of the American Board of Family Pracatice, 12, 173-177.

     3.    Halvorsen, J. G. (1999). Professionalism reconsidered. Priorities for physicians. Arch.Fam.Med., 8, 173-176.

     4.    Halvorsen, J. G. (2001). Family medicine's failures: Reflections on Keystone III. Family Medicine, 33, 390-392.

     5.    Halvorsen, J. G. (2003). The Clinical Evaluation of Common Sexual Concerns. CNS Spectrums, 8, 217-224.

HANIGAN,W.C.


     1.    Crawford, T. S., Olivero, W. C., & Hanigan, W. C. (2000). The Prognosis of Children with Hydrocephalus and Congenital Heart Disease. Pediatr.Neurosurg., 33, 12-15.

     2.    Hanigan, W. C., Brady, T. M., Medlock, M. D., & Smith, E. B. (1990). Spontaneous regression of giant arteriovenous fistulae during the perinatal period. Case report. J.Neurosurg., 73, 954-957.

     3.    Hanigan, W. C., Asner, N. G., & Elwood, P. W. (1990). Magnetic resonance imaging and the nonoperative treatment of spinal epidural abscess. Surg.Neurol., 34, 408-413.

     4.    Hanigan, W. C., Morgan, A. M., Stahlberg, L. K., & Hiller, J. L. (1990). Tentorial hemorrhage associated with vacuum extraction. Pediatrics, 85, 534-539.

     5.    Hanigan, W. C., Ragen, W., & Foster, R. (1990). Dryander of Marburg and the first textbook of neuroanatomy. Neurosurgery, 26, 489-498.

     6.    Hanigan, W. C., Morgan, A. M., Anderson, R. J., Bradle, P., Cohen, H. S., Cusack, T. J. et al. (1991). Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infants. Neurosurgery, 29, 701-706.

     7.    Hanigan, W. C., Morgan, A. M., Shaaban, A., & Bradle, P. (1991). Surgical treatment and long-term neurodevelopmental outcome for infants with idiopathic aqueductal stenosis. Childs.Nerv.Syst., 7, 386-390.

     8.    Hanigan, W. C., Ragen, W., & Ludgera, M. (1992). Neurological surgery in the nineteenth century: the principles and techniques of Ernst von Bergmann. Neurosurgery, 30, 750-757.

     9.    Hanigan, W. C. & Anderson, R. J. (1992). Commentary on NASCIS-2. J.Spinal.Disord., 5, 125-31; discussion 132-3.

   10.    Hanigan, W. C., Powell, F. C., Elwood, P. W., & Henderson, J. P. (1993). Odontoid fractures in elderly patients. J.Neurosurg., 78, 32-35.

   11.    Hanigan, W. C. (1994). Obstinate valour: the military service and death of Sir Victor Horsley. Br.J.Neurosurg., 8, 279-288.

   12.    Hanigan, W. C., Powell, F. C., Miller, T. C., & Wright, R. M. (1995). Symptomatic intracranial hemorrhage in full-term infants. Childs.Nerv.Syst., 11, 698-707.

   13.    Hanigan, W. C., Powell, F. C., Palagallo, G. L., & Miller, T. C. (1995). Lobar hemorrhages in full-term neonates. Childs.Nerv.Syst., 11, 276-280.

   14.    Hanigan, W. C. & King, S. C. (1996). Cold blood and clinical research during World War I. Military Medicine, 161, 392-400.

   15.    Hanigan, W. C., Aldag, J. C., Sabo, R. A., Rose, J. A., & Aaland, M. O. (1996). Strangulation injuries in children. Part 2. Cerebrovascular hemodynamics. J.Trauma., 40, 73-77.

   16.    Hanigan, W. C. (2003). Surgery of the head and 70-day brain surgeons. Neurosurgery, 53, 713-721.

   17.    Hanigan, W. C. & Zallek, S. N. (2004). Headaches, shunts, and obstructive sleep apnea: report of two cases. Neurosurgery, 54, 764-768.

   18.    Hanigan, W. C. & Sloffer, C. A. (2004). Nelson's wound: treatment of spinal cord injury in 19th and early 20th century military conflicts. Neurosurg.Focus., 16, E4.

   19.    Hanigan, W. C., Fraser, K., Tarantino, M. D., & Wang, H. (2005). Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report. Journal of neurosurgery, 102, 426-430.

   20.    Kraus, R. R., Hanigan, W. C., Kattah, J. C., & Olivero, W. C. (2003). Changes in visual acuity associated with shunt failure. Childs.Nerv.Syst., 19, 226-231.

   21.    Kraus, R. R., Tracy, P. T., & Hanigan, W. C. (2003). Intracranial hemorrhage following blunt injury to a shunt valve. Childs Nerv.Syst., 20, 68-70.

   22.    Lin, J., Hanigan, W. C., Tarantino, M. D., & Wang, J. (2003). The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J.Neurosurg., 98, 737-740.

   23.    Medlock, M. D., Olivero, W. C., Hanigan, W. C., Wright, R. M., & Winek, S. J. (1992). Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery, 31, 870-6; discussion 876.

   24.    Medlock, M. D., Hanigan, W. C., & Cruse, R. P. (1993). Dissociation of cerebral blood flow, glucose metabolism, and electrical activity in pediatric brain death. Case report [see comments]. J.Neurosurg., 79, 752-755.

   25.    Medlock, M. D. & Hanigan, W. C. (1994). Blood flow and glucose metabolism - response. J.Neurosurg., 81, 645.

   26.    Medlock, M. D. & Hanigan, W. C. (1997). Neurologic birth trauma - intracranial, spinal cord, and brachial plexus injury. Clinics in Perinatology, 24, 845.

   27.    Olivero, W. C., Hanigan, W. C., & McCluney, K. W. (1993). Angiographic demonstration of a spinal epidural arteriovenous malformation. Case report. J.Neurosurg., 79, 119-120.

   28.    Powell, F. C., Hanigan, W. C., & Olivero, W. C. (1993). A risk/benefit analysis of spinal manipulation therapy for relief of lumbar or cervical pain [see comments]. Neurosurgery, 33, 73-8; discussion 78-9.

   29.    Powell, F. C., Hanigan, W. C., & McCluney, K. W. (1994). Subcortical infarction in children. Stroke, 25, 117-121.

   30.    Sabo, R. A., Hanigan, W. C., & Aldag, J. C. (1995). Chronic subdural hematomas and seizures: the role of prophylactic anticonvulsive medication. Surg.Neurol., 43, 579-582.

   31.    Sabo, R. A., Hanigan, W. C., Flessner, K., Rose, J. A., & Aaland, M. O. (1996). Strangulation injuries in children. Part 1. Clinical analysis [see comments]. J.Trauma., 40, 68-72.

   32.    Smith, E. B., DeBord, J. R., & Hanigan, W. C. (1991). Intestinal injury after lumbar discectomy. Surg.Gynecol.Obstet., 173, 22-24.

   33.    Smith, E. B. & Hanigan, W. C. (1992). Surgical results and complications in elderly patients with benign lesions of the spinal canal. J.Am.Geriatr.Soc., 40, 867-870.

   34.    Tracy, P. T. & Hanigan, W. C. (1990). Spinal dysraphism: use of magnetic resonance imaging in evaluation. Clin.Pediatr.(Phila)., 29, 228-233.

HASSELMAN,T.


     1.    Hasselman, T., Schneider, D. J., Madan, N., & Jacobs, M. (2005). Reversal of fenestration flow during ventricular systole in Fontan patients in junctional or ventricular paced rhythm. Pediatr Cardiol., 26, 638-641.

     2.    Raff, G. W., Gray, B. M., Torres, A., & Hasselman, T. (2004). Aortitis in a Child with Abiotrophia defectiva Endocarditis. The Pediatric Infectious Disease Journal, 23, 574-576.

HEVESY,G.Z.


     1.    Rood, L. K. & Hevesy, G. Z. (1991). An unusual complication of radial head fractures. Am.J.Emerg.Med., 9, 553-554.

HJELLE,J.T.


     1.    Ciftcioglu, N., Miller-Hjelle, M. A., Hjelle, J. T., & Kajander, E. O. (2002). Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrobial Agents and Chemotherapy, 46, 2077-2086.

     2.    Hjelle, J. T., Guenthner, T. M., Bell, K., Whalen, R., Flouret, G., & Carone, F. A. (1990). Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites. Toxicology, 60, 211-222.

     3.    Hjelle, J. T., Waters, D. C., Golinska, B. T., Steidley, K. R., Burmeister, V., Caughey, R. C. et al. (1990). Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro. Am.J.Kidney Dis., 15, 123-136.

     4.    Hjelle, J. T., Christensen, E. I., Carone, F. A., & Selhub, J. (1991). Cell fractionation and electron microscope studies of kidney folate-binding protein. Am.J.Physiol., 260, C338-46.

     5.    Hjelle, J. T., Golinska, B. T., Waters, D. C., Steidley, K. R., Miller, M. A., McCarroll, D. R. et al. (1991). Lectin staining of peritoneal mesothelial cells in vitro. Perit.Dial.Int., 11, 307-316.

     6.    Hjelle, J. T., Steidley, K. R., Welch, M. H., Miller, M. A., & Dobbie, J. W. (1991). Lectins as probes of membrane carbohydrates in mesothelial cells in vitro. Adv.Perit.Dial., 7, 30-34.

     7.    Hjelle, J. T., Golinska, B. T., Waters, D. C., Steidley, K. R., McCarroll, D. R., Pavlina, T. M. et al. (1991). In vivo and in vitro characterization of mesothelial lipid inclusions. Perit.Dial.Int., 11, 207-212.

     8.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1992). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 8, 30-32.

     9.    Hjelle, J. T., Steidley, K. R., Pavlina, T. M., & Dobbie, J. W. (1993). Choline incorporation into phospholipids in mesothelial cells in vitro. Perit.Dial.Int., 13, 289-295.

   10.    Hjelle, J. T., Ho, A. K., Dobbie, J. W., Steidley, K. R., & Duffield, R. (1993). Evidence of muscarinic acetylcholine receptors and GTP-binding proteins in peritoneal mesothelial cells in vitro. Adv.Perit.Dial., 9, 303-306.

   11.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1993). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 9, 299-302.

   12.    Hjelle, J. T., Miller-Hjelle, M. A., & Dobbie, J. W. (1995). The biology of the mesothelium during peritoneal dialysis. Perit.Dial.Int., 15, S13-22; discussion S22-3.

   13.    Hjelle, J. T., Ho, A. K., Miller-Hjelle, M. A., Reith, M. E., Steidley, K. R., Duffield, R. et al. (1995). Multiple drug classes and hyperosmolarity alter binding of muscarinic drugs to mesothelial cells in vitro. Adv.Perit.Dial., 11, 3-6.

   14.    Hjelle, J. T., Miller-Hjelle, M. A., Nowak, D. M., Dombrink-Kurtzman, M. A., & Peterson, S. W. (2000). Polycystic kidney disease, fungi, and bacterial endotoxin: shifting paradigms involving infection and diet. Reviews in Medical Microbiology, 11, 23-35.

   15.    Hjelle, J. T., Miller-Hjelle, M. A., Poxton, I. R., Kajander, E. O., Ciftcioglu, N., Jones, M. L. et al. (2000). Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int., 57, 2360-2374.

   16.    Kajander, E. O., Ciftcioglu, N., Miller-Hjelle, M. A., & Hjelle, J. T. (2001). Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr.Opin.Nephrol.Hypertens., 10, 445-452.

   17.    Miller-Hjelle, M. A., Hjelle, J. T., Jones, M. L., Mayberry, W. R., Dombrink-Kurtzman, M. A., Peterson, S. W. et al. (1997). Polycystic kidney disease: an unrecognized emerging infectious disease? Emerging Infectious Diseases, 3, 113-127.

   18.    Miller-Hjelle, M. A. & Hjelle, J. T. (2003). Nanobacteria: Methods for Growth and Identification of this Recently Discovered Calciferous Agent. In W.P.Olson (Ed.), Rapid Analytical Microbiology: the Chemistry and Physics of Microbial Identification (pp. 297-312). Godalming, Surrey, UK: Horwood International Publishing, Ltd.

   19.    Miller-Hjelle, M. A., Somaraju, V., & Hjelle, J. T. (2004). Synthetic Organic Antimicrobials: Sulfonamides, Trimethoprim,Nitrofurans, Quinolones, Methenamine. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 515-525). Philidelphia: Lippincott Williams & Wilkins.

   20.    Miller, M. A., Prior, R. B., Horvath, F. J., & Hjelle, J. T. (1990). Detection of endotoxiuria in polycystic kidney disease patients by the use of the Limulus amebocyte lysate assay. Am.J.Kidney Dis., 15, 117-122.

   21.    Nowak, D. M., Ansell, I., Hjelle, J. T., Ross, J. A., Miller-Hjelle, M. A., Dobbie, J. D. et al. (1998). Sphingosine and sphinganine levels in human mesothelial cells in vitro as a potential index of signal transduction pathways impacted by microbes and osmolality. Adv.Perit.Dial., 14, 158-163.

   22.    Peterson, S. W., Corneli, S., Hjelle, J. T., Miller-Hjelle, M. A., Nowak, D. M., & Bonneau, P. A. (1999). Penicillium pimiteouiense: a new species isolated from polycystic kidney cell cultures. Mycologia, 91, 269-277.

HOCKER,J.R.


     1.    Drenckpohl, D., Hocker, J. R., Shareef, M., Vegunta, R. K., & Colgan, C. (2005). Adding dietary green beans resolves the diarrhea associated with bowel surgery in neonates: a case study. Nutr.Clin.Pract., 20, 674-677.

     2.    Hocker, J. R. & Saving, K. L. (1995). Fatal aortic thrombosis in a neonate during infusion of epsilon- aminocaproic acid. J.Pediatr.Surg., 30, 1490-1492.

     3.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

HOLLY,W.M.


     1.    Holly, W. M. (2000). Strategic Decision Support System(SDSS) in the New Millennium. NAEB Journal, Summer, 15-18.

HORNDASCH,R.L.


     1.    Horndasch, R. L. (1999). Health issues for minority adolescents. Journal of Cross-Cultural Psychology, 30, 547-548.

     2.    Medlock, M. D., Cruse, R. S., Winek, S. J., Geiss, D. M., Horndasch, R. L., Schultz, D. L. et al. (1993). A 10-year experience with postpump chorea. Ann.Neurol., 34, 820-826.

HORVATH,F.J.


     1.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1992). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 8, 30-32.

     2.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1993). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 9, 299-302.

     3.    Horvath, F. J. (2000). Renal Diseases. In H.M.Winn & J. C. Hobbins (Eds.), Clinical Maternal-fetal Medicine (pp. 505-513). New York: Parthenon Publishing Group.

     4.    Miller, M. A., Prior, R. B., Horvath, F. J., & Hjelle, J. T. (1990). Detection of endotoxiuria in polycystic kidney disease patients by the use of the Limulus amebocyte lysate assay. Am.J.Kidney Dis., 15, 117-122.

HOY,F.B.Y.


     1.    Hoy, F. B. Y., Mueller, D. K., Geiss, D. M., Munns, J. R., Bond, L. M., Linett, C. E. et al. (2000). Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? The Annals of Thoracic Surgery, 70, 1259-1263.

     2.    Hoy, F. B. Y., Clemson, B. S., Geiss, D. M., Bond, L. M., Linett, C. E., & Gomez, R. C. (2001). Intracranial bleed during bridge to transplant may not preclude a successful result. J.Heart Lung Transplant., 20, 901-903.

     3.    Tisol, W. B., Mueller, D. K., Hoy, F. B. Y., Gomez, R. C., Clemson, B. S., & Hussain, S. M. (2001). Ventricular assist device use with mechanical heart valves: an outcome series and literature review. The Annals of Thoracic Surgery, 72, 2051-2054.

JENNINGS,M.T.


     1.    Jennings, M. T., Cmelak, A., Johnson, M. D., Moots, P. L., Pais, R., & Shyr, Y. (2004). Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Pediatric Blood & Cancer, 43, 46-54.

JOBE,P.C.


     1.    Browning, R. A., Wang, C. D., Lanker, M. L., & Jobe, P. C. (1990). Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern. Epilepsy Res., 6, 1-11.

     2.    Browning, R. A., Wood, A. V., Merrill, M. A., Dailey, J. W., & Jobe, P. C. (1997). Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur.J.Pharmacol., 336, 1-6.

     3.    Browning, R. A., Wang, C. D., Nelson, D. K., & Jobe, P. C. (1999). Effect of precollicular transection on audiogenic seizures in genetically epilepsy-prone rats. Experimental Neurology, 155, 295-301.

     4.    Burmeister, V., Ludvig, N., & Jobe, P. C. (2000). Artifact-free Electron Microscopic Immunocytochemistry on Rat Brain Tissue. Proceeding of the 49th Annual Meeting of the Electron Microscopy Society of America, 272-273.

     5.    Chen, N. H., Wang, C. D., Jobe, P. C., & Reith, M. E. (1994). Facilitation of amygdala kindling development and kindled seizures by metaphit. Epilepsia, 35, 927-932.

     6.    Clough, R. W., Browning, R. A., Maring, M. L., & Jobe, P. C. (1991). Intracerebral grafting of fetal dorsal pons in genetically epilepsy-prone rats: effects on audiogenic-induced seizures. Exp.Neurol., 112, 195-199.

     7.    Clough, R. W., Browning, R. A., Maring, M. L., Statnick, M. A., Wang, C. D., & Jobe, P. C. (1994). Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine. Journal of Neural Transplantation & Plasticity, 5, 65-79.

     8.    Clough, R. W., Statnick, M. A., Maringsmith, M. L., Wang, C. D., Eells, J. B., Browning, R. A. et al. (1996). Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRS. Neuroreport, 8, 341-346.

     9.    Clough, R. W., Eells, J. B., Browning, R. A., & Jobe, P. C. (1997). Seizures and proto-oncogene expression of FOS in the brain of adult Genetically Epilepsy-Prone Rats. Experimental Neurology, 146, 341-353.

   10.    Clough, R. W., Peterson, B. R., Steenbergen, J. L., Jobe, P. C., Eells, J. B., Browning, R. A. et al. (1998). Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3S) - An in vitro study on the locus coeruleus. Epilepsy Research, 29, 135-146.

   11.    Coffey, L. L., Reith, M. E., Chen, N. H., Mishra, P. K., & Jobe, P. C. (1996). Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats. Epilepsia, 37, 188-197.

   12.    Dailey, J. W., Mishra, P. K., Ko, K. H., Penny, J. E., & Jobe, P. C. (1991). Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia, 32, 168-173.

   13.    Dailey, J. W., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Jobe, P. C. (1991). Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame. Epilepsy Res., 8, 122-133.

   14.    Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L., & Jobe, P. C. (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 260, 533-540.

   15.    Dailey, J. W., Mishra, P. K., Ko, K. H., Penny, J. E., & Jobe, P. C. (1992). Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci., 50, 319-326.

   16.    Dailey, J. W., Seo, D. O., Yan, Q. S., Ko, K. H., Jo, M., & Jobe, P. C. (1994). The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study [published erratum appears in Neurosci Lett 1994 Oct 24;180(2):294]. Neurosci.Lett., 178, 179-183.

   17.    Dailey, J. W., Cheong, J. H., Ko, K. H., Adams-Curtis, L. E., & Jobe, P. C. (1995). Anticonvulsant properties of D-20443 in genetically epilepsy- prone rats: prediction of clinical response. Neuroscience letters, 195, 77-80.

   18.    Dailey, J. W., Yan, Q. S., Adams-Curtis, L. E., Ryu, J. R., Ko, K. H., Mishra, P. K. et al. (1996). Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci., 58, 259-266.

   19.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+. Eur.J.Pharmacol., 328, 153-162.

   20.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. Neurosci.Lett., 227, 13-16.

   21.    Dailey, J. W., Reith, M. E., Steidley, K. R., Milbrandt, J. C., & Jobe, P. C. (1998). Carbamazepine-induced release of serotonin from rat hippocampus in vitro. Epilepsia, 39, 1054-1063.

   22.    Delbel, E. A., Oliveira, P. R., Oliveira, J. A. C., Mishra, P. K., Jobe, P. C., & Garcia-Cairasco, N. (1997). Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Brazilian Journal of Medical & Biological Research, 30, 971-979.

   23.    Doretto, M. C., Burger, R. L., Mishra, P. K., Garcia-Cairasco, N., Dailey, J. W., & Jobe, P. C. (1994). A microdialysis study of amino acid concentrations in the extracellular fluid of the substantia nigr of freely behaving GEPR-9S - relationship to seizure predisposition. Epilepsy Research, 17, 157-165.

   24.    Eells, J. B., Clough, R. W., Browning, R. A., & Jobe, P. C. (1997). FOS in locus coeruleus neurons following audiogenic seizure in the genetically epilepsy-prone rat - comparison to electroshock and pentylenetrazol seizure models. Neurosci.Lett., 233, 21-24.

   25.    Eells, J. B., Clough, R. W., Miller, J. W., Jobe, P. C., & Browning, R. A. (2000). Fos expression and 2-deoxyglucose uptake following seizures in developing genetically epilepsy-prone rats. Brain Res.Bull., 52, 379-389.

   26.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (1999). Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur.J.Pharmacol., 369, 305-311.

   27.    Graumlich, J. F., McLaughlin, R. G., Birkhahn, D., Shah, N., Burk, A., Jobe, P. C. et al. (2000). Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain. Epilepsy Res., 40, 25-32.

   28.    Jobe, P. C., Lasley, S. M., & Dailey, J. W. (1988). Monoamines and seizures in genetically epilepsy-prone rats: inferences from precursor availablity. In G.Huether (Ed.), Amino acid availability and brain function in health and disease (pp. 207-214). New York, NY: Springer-Verlag.

   29.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1991). Scope and contribution of genetic models to an understanding of the epilepsies. Crit.Rev.Neurobiol., 6, 183-220.

   30.    Jobe, P. C. & Dailey, J. W. (1991). Neurobiology of seizure predisposition in the genetically epilepsy prone rat. Proc.West.Pharmacol.Soc., 34, 223-225.

   31.    Jobe, P. C., Mishra, P. K., & Dailey, J. W. (1991). Genetically Epilepsy-Prone Rats: Actions of Antiepileptic Drugs and Monoaminergic Neurotransmitters. In C.L.FainGold & G. H. Fromm (Eds.), Drugs for Control of Epilepsy (pp. 253-275). Boca Raton: CRC Press.

   32.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1991). Scope and contribution of genetic models to an understanding of the epilepsies. Critical reviews in neurobiology, 6, 183-220.

   33.    Jobe, P. C., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Dailey, J. W. (1992). Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats. Amino Acids, 3, 155-172.

   34.    Jobe, P. C., Mishra, P. K., Ludvig, N., & Dailey, J. W. (1993). Genetic models of the Epilepsies. In P.A.Schwartzkroin (Ed.), Epilepsy: Models, Mechanisms, and Concepts (pp. 94-140). NY: Cambridge University Press.

   35.    Jobe, P. C. & Dailey, J. W. (1993). Aspartame and seizures. Amino Acids, 4, 197-235.

   36.    Jobe, P. C., Adams-Curtis, L. E., Burks, T. F., Fuller, R. W., Peck, C. C., Ruffolo, R. R. et al. (1994). The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation. Physiologist, 37, 79-86.

   37.    Jobe, P. C., Mishra, P. K., Browning, R. A., Wang, C. D., Adams-Curtis, L. E., Ko, K. H. et al. (1994). Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res.Bull., 35, 493-504.

   38.    Jobe, P. C., Mishra, P. K., Adams-Curtis, L. E., Ko, K. H., & Dailey, J. W. (1994). The GEPR model of the epilepsies. In A.Malafosse (Ed.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects (pp. 385-398). John Libbey & Company.

   39.    Jobe, P. C., Mishra, P. K., Adams-Curtis, L. E., Deoskar, V. U., Ko, K. H., Browning, R. A. et al. (1995). The genetically epilepsy-prone rat (GEPR). Italian Journal of Neurological Sciences, 16, 91-99.

   40.    Jobe, P. C., Mishra, P. K., Dailey, J. W., Ko, K. H., & Reith, M. E. (1999). Genetic predisposition to partial (focal) seizures and to generalized tonic/clonic seizures: interactions between seizure circuitry of the forebrain and brainstem. In S.F.Berkovic (Ed.), Genetics of Focal Epilepsies: Clinical Aspects and Molecular Biology (pp. 251-260). John Libbey & Company.

   41.    Jobe, P. C., Dailey, J. W., & Wernicke, J. F. (1999). A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev.Neurobiol., 13, 317-356.

   42.    Jobe, P. C. & Dailey, J. W. (2000). Genetically epilepsy-Prone Rats (GEPRs) in Drug Research. CNS Drug Reviews, 6, 241-260.

   43.    Jobe, P. C. (2002). Are there specific anatomical and/or transmitter systems (cortical or subcortical) that should be targeted? Int.Rev.Neurobiol., 49, 221-252.

   44.    Jobe, P. C. (2003). Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav., 4, 14-24.

   45.    Jobe, P. C. (2004). Current and Future Therapeutic Opportunities in the Comorbidity Between the Epilepsies and Affective Disorders. Clinical EEG and Neuroscience, 35, 1-3.

   46.    Jobe, P. C. (2004). Shared Mechanisms of Antidepressant and Antiepileptic Treatments: Drugs and Devices. Clinical EEG and Neuroscience, 35, 25-37.

   47.    Jobe, P. C. (2004). Affective Disorder and Epilepsy Comorbidity: Implications for Development of Treatments, Preventions, and Diagnostic Approaches. Clinical EEG and Neuroscience, 35, 53-68.

   48.    Jobe, P. C. & Browning, R. A. (2005). The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy & Behavior, 7, 602-619.

   49.    Kurtz, B. S., Lehman, J., Garlick, P., Amberg, J., Mishra, P. K., Dailey, J. W. et al. (2001). Penetrance and expressivity of genes involved in the development of epilepsy in the genetically epilepsy-prone rat (GEPR). Journal of Neurogenetics, 15, 233-244.

   50.    Ludvig, N., Burmeister, V., Jobe, P. C., & Kincaid, R. L. (1991). Electron microscopic immunocytochemical evidence that the calmodulin-dependent cyclic nucleotide phosphodiesterase is localized predominantly at postsynaptic sites in the rat brain. Neuroscience, 44, 491-500.

   51.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The paradoxical effect of NMDA receptor stimulation on electrical activity of the sensorimotor cortex in freely behaving rats: analysis by combined EEG-intracerebral microdialysis. Synapse, 12, 87-98.

   52.    Ludvig, N., Mishra, P. K., & Jobe, P. C. (1992). Dibutyryl cyclic AMP has epileptogenic potential in the hippocampus of freely behaving rats: a combined EEG-intracerebral microdialysis study. Neurosci.Lett., 141, 187-191.

   53.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The combined EEG-intracerebral microdialysis technique: a new tool for neuropharmacological studies on freely behaving animals. J.Neurosci.Methods, 43, 129-137.

   54.    Merrill, M. A., Clough, R. W., Jobe, P. C., & Browning, R. A. (2003). Role of the Superior Colliculus and the Intercollicular Nucleus in the Brainstem Seizure Circuitry of the Genetically Epilepsy-prone Rat. Epilepsia, 44, 305-314.

   55.    Merrill, M. A., Clough, R. W., Jobe, P. C., & Browning, R. A. (2005). Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model. Epilepsia, 46, 1380-1388.

   56.    Mills, S. A., Razani-Boroujerdi, S., Reigel, C. E., Jobe, P. C., & Savage, D. D. (1990). Decrease in hippocampal [3H]vinylidene kainic acid binding in genetically epilepsy-prone rats. Neuroscience, 35, 519-524.

   57.    Mishra, P. K., Kahle, E. H., Bettendorf, A. F., Dailey, J. W., & Jobe, P. C. (1993). Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s). Life Sci., 52, 1435-1441.

   58.    Mishra, P. K., Burger, R. L., Bettendorf, A. F., Browning, R. A., & Jobe, P. C. (1994). Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4. Exp.Neurol., 125, 58-64.

   59.    Mishra, P. K., Yan, Q. S., Burger, R. L., Dailey, J. W., & Jobe, P. C. (1994). Microdialysis for the Study of Seizure Regulation. In.

   60.    Montpied, P., Winsky, L., Dailey, J. W., Jobe, P. C., & Jacobowitz, D. M. (1995). Alteration in levels of expression of brain calbindin D-28K and calretinin MRNA in genetically epilepsy-prone rats. Epilepsia, 36, 911-921.

   61.    Moraes, M. F., Chavali, M., Mishra, P. K., Jobe, P. C., & Garcia-Cairasco, N. (2005). A comprehensive electrographic and behavioral analysis of generalized tonic-clonic seizures of GEPR-9s. Brain Research, 1033, 1-12.

   62.    Moraes, M. F., Mishra, P. K., Jobe, P. C., & Garcia-Cairasco, N. (2005). An electrographic analysis of the synchronous discharge patterns of GEPR-9s generalized seizures. Brain Research.

   63.    Noebels, J. L., Fariello, R. G., Jobe, P. C., Lasley, S. M., & Marescaux, C. (1997). Genetic Models of Generalized Epilepsy. In J.J.Engel (Ed.), Epilepsy: A Comprehensice Textbook (pp. 457-465). Philadelphia: Lippincott-Raven Publishers.

   64.    Ryu, J. R., Jobe, P. C., Milbrandt, J. C., Mishra, P. K., Clough, R. W., Browning, R. A. et al. (1999). Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues. Experimental Neurology, 156, 84-91.

   65.    Ryu, J. R., Shin, C. Y., Park, K. H., Jeon, G. S., Kim, H. C., Kim, W. K. et al. (2000). Effect of repeated seizure experiences on tyrosine hydroxylase immunoreactivities in the brain of genetically epilepsy-prone rats. Brain Research Bulletin, 53, 777-782.

   66.    Seo, D. O., Shin, C. Y., Lee, C. J., Dailey, J. W., Reith, M. E., Jobe, P. C. et al. (1999). Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats. Eur.J.Pharmacol., 365, 39-46.

   67.    Seo, D. O., Shin, C. Y., Ryu, J. R., Cheong, J. H., Choi, C. R., Dailey, J. W. et al. (2000). Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats. Eur.J.Pharmacol., 396, 53-58.

   68.    Statnick, M. A., Maringsmith, M. L., Clough, R. W., Wang, C. D., Dailey, J. W., Jobe, P. C. et al. (1996). Effect of 5,7-Dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci., 59, 1763-1771.

   69.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Neither intranigral fluoxetine nor 5,7-Dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats. Eur.J.Pharmacol., 299, 93-102.

   70.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Abnormalities in brain serotonin concentration, high-affinity uptake, and hydroxlyse activity in severe-seizure genetically epilepsy-prone rats. Epilepsia, 37, 311-321.

   71.    Statnick, M. A., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996). Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9S). Neuropharmacology, 35, 111-118.

   72.    Wang, C. D., Mishra, P. K., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1994). Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3S - A neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine. Epilepsy Research, 18, 1-9.

   73.    Yan, Q. S., Mishra, P. K., Burger, R. L., Bettendorf, A. F., Jobe, P. C., & Dailey, J. W. (1992). Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 261, 652-659.

   74.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Research, 610, 24-31.

   75.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res., 14, 229-236.

   76.    Yan, Q. S., Jobe, P. C., Cheong, J. H., Ko, K. H., & Dailey, J. W. (1994). Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch.Pharmacol., 350, 149-152.

   77.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1994). Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur.J.Pharmacol., 252, 105-112.

   78.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1995). Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br.J.Pharmacol., 115, 1314-1318.

   79.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1996). Focal ethanol elevates extracellular dopamine and serotonin concentrations in the rat ventral tegmental area. Eur.J.Pharmacol., 301, 49-57.

   80.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1997). Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research, 765, 149-158.

   81.    Yan, Q. S., Reith, M. E., Yan, S. G., & Jobe, P. C. (1998). Effect of systemic ethanol on basal and stimulated glutamate releases in the nucleus accumbens of freely moving Sprague-Dawley rats: a microdialysis study. Neurosci.Lett., 258, 29-32.

   82.    Yan, Q. S., Dailey, J. W., Steenbergen, J. L., & Jobe, P. C. (1998). Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study. Brain Research, 780, 199-209.

   83.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 95-97.

   84.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 90-94.

   85.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. The Journal of Rheumatology, 19, 95-97.

   86.    Yunus, M. B., Aldag, J. C., Dailey, J. W., & Jobe, P. C. (1995). Interrelationships of biochemical parameters in Classification of Fibromyalgia Syndrome and Health Normal Controls. Journal of Musculoskeletal Pain, 3, 15-24.

JOHNSON,B.A.


     1.    Slawson, S. H. & Johnson, B. A. (2001). Ductography: how to and what if? Radiographics, 21, 133-150.

JOSEPH,P.


     1.    Chetty, C., Bhoopathi, P., Joseph, P., Chittivelu, S., Rao, J. S., & Lakka, S. (2006). Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. mol.cancer ther., 5, 2289-2299.

JOSEPH,P.A.


     1.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

KANAAN,Y.


     1.    Kanaan, Y., Kaneshiro, D., Fraser, K., Wang, D., & Lanzino, G. (2005). Evolution of endovascular therapy for aneurysm treatment. Historical overview. Neurosurg.Focus., 18, E2.

     2.    Lanzino, G., Kanaan, Y., Perrini, P., Dayoub, H., & Fraser, K. (2005). Emerging concepts in the treatment of intracranial aneurysms: stents, coated coils, and liquid embolic agents. Neurosurgery., 57, 449-459.

     3.    Lanzino, G., Fraser, K., Kanaan, Y., & Wagenbach, A. (2006). Treatment of ruptured intracranial aneurysms since the International Subarachnoid Aneurysm Trial: practice utilizing clip ligation and coil embolization as individual or complementary therapies. J Neurosurg., 104, 344-349.

     4.    Paolini, S., Kanaan, Y., Wagenbach, A., Fraser, K., & Lanzino, G. (2005). Illustrative Review Cerebral Vasospasm in patients with unruptured intracranial aneurysms. Acta Neurochir.(Wien.)., 147, 1181-1188.

KANDHUKURI,N.


     1.    Gondi, C. S., Kandhukuri, N., Kondraganti, S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2006). Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int.J Oncol., 28, 633-639.

KANESHIRO,D.


     1.    Kanaan, Y., Kaneshiro, D., Fraser, K., Wang, D., & Lanzino, G. (2005). Evolution of endovascular therapy for aneurysm treatment. Historical overview. Neurosurg.Focus., 18, E2.

KATTAH,J.C.


     1.    Al Kawi, A., Wang, D. Z., Kishore, K., & Kattah, J. C. (2004). A Case of Ischemic Cerebral Infarction Associated with Acute Posterior Multifocal Placoid Pigment Epitheliopathy, CNS Vasculitis, Vitamin B(12) Deficiency and Homocysteinemia. Cerebrovascular diseases (Basel, Switzerland), 18, 338-339.

     2.    Alkawi, A., Kattah, J. C., & Wyman, K. (2005). Downbeat nystagmus as a result of lamotrigine toxicity. Epilepsy Research.

     3.    Kattah, J. C., Mejico, L., Chrousos, G. A., Zimmerman, L. E., & Manz, H. J. (1999). Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis. Neurology, 53, 177-180.

     4.    Kattah, J. C. & FitzGibbon, E. J. (2003). Superior oblique myokymia. Curr.Neurol.Neurosci.Rep., 3, 395-400.

     5.    Kattah, J. C., Gujrati, M., Hui, E. T., & Chen, C. C. (2004). Bilateral occipital lobe hyperperfusion demonstrated by single photon emission computed tomography during seizure-related cortical blindness. J Neuroophthalmol., 24, 24-26.

     6.    Kattah, J. C. (2005). Optic neuritis and multiple sclerosis: Long-term prognostic considerations. Archives of Neurology, 62, 506.

     7.    Kattah, J. C. & Gujrati, M. (2005). Familial positional downbeat nystagmus and cerebellar ataxia: clinical and pathologic findings. Annals of the New York Academy of Sciences, 1039, 540-543.

     8.    Kraus, R. R., Hanigan, W. C., Kattah, J. C., & Olivero, W. C. (2003). Changes in visual acuity associated with shunt failure. Childs.Nerv.Syst., 19, 226-231.

     9.    Kraus, R. R., Kattah, J. C., Bortolotti, C., & Lanzino, G. (2004). Oculomotor palsy from an unruptured posterior communicating artery aneurysm presenting with cerebrospinal fluid pleocytosis and enhancement of the third cranial nerve. Case report. Journal of neurosurgery, 101, 352-353.

   10.    Talkad, A. V., Kattah, J. C., Xu, M. Y., Orth, E. H., & Chang, J. Y. (2004). Prolactinoma presenting as painful postganglionic Horner syndrome. Neurology, 62, 1440-1441.

   11.    Walsh, W. P., Hafner, J. W., & Kattah, J. C. (2003). Bilateral internuclear ophthalmoplegia following minor head trauma. J.Emerg.Med., 24, 19-22.

KELLY,N.R.


     1.    Kelly, N. R., Shoemaker, M., & Steele, T. (1996). The experience of being a male student nurse. J.Nurs.Educ., 35, 170-174.

     2.    Kelly, N. R. & Swisher, L. (1998). The transitional process of retirement for nurses. J.Prof.Nurs., 14, 53-61.

     3.    Kelly, N. R. & Mathews, M. (2001). The transition to first position as nurse practitioner. J.Nurs.Educ., 40, 156-162.

KHOKHAR,O.S.


     1.    Khokhar, O. S. & Lewis, J. H. (2005). Expectant management of chronic hepatitis C infection - The patient perspective. Hepatology, 42, 682A-683A.

KIM,J.M.


     1.    Masi, A. T., Sierakowski, S., & Kim, J. M. (2005). Jacques Forestier's vanished bowstring sign in ankylosing spondylitis: a call to test its validity and possible relation to spinal myofascial hypertonicity. Clin.Exp.Rheumatol., 23, 760-766.

KUMAR,J.


     1.    Carlo, J. R., Nelson, K. R., Kumar, J., & Rivner, M. (1996). EMGBASE. Journal of Clinical Neurophysiology, 13, 93-95.

     2.    Kumar, J. & Kimm, J. A. (1994). MR in Toxocara canis myelopathy. Am.J.Neuroradiol., 15, 1918-1920.

LAGOUROS,P.A.


     1.    Peyman, G. A., Cheema, R. A., & Lagouros, P. A. (2001). Endoresection of a ciliochoroidal melanoma. Canadian Journal of Ophthalmology, 36, 411-415.

LAKKA,S.S.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Adachi, Y., Chandrasekar, N., Kin, Y., Lakka, S. S., Mohanam, S., Yanamandra, N. et al. (2002). Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene, 21, 87-95.

     3.    Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Glial Cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin.Cancer Res., 9, 2342-2349.

     4.    Chetty, C., Bhoopathi, P., Joseph, P., Chittivelu, S., Rao, J. S., & Lakka, S. (2006). Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. mol.cancer ther., 5, 2289-2299.

     5.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C. et al. (2003). Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene, 22, 5967-5975.

     6.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res., 64, 4069-4077.

     7.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23, 8486-8496.

     8.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). Inhibition of glioma cell invasion, angiogenesis, and tumor growth in both in vivo and in vitro models by downregulation of uPAR, uPA, and MMP-9 by using small interfering hairpin RNA (siRNA) driven by a CMV promoter. Neuro-oncology, 6, 309-310.

     9.    Jadhav, U., Chigurupati, S., Lakka, S. S., & Mohanam, S. (2004). Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. International Journal of Oncology, 25, 1407-1414.

     10.    Konduri, S. D., Lakka, S. S., Tasiou, A., Yanamandra, N., Gondi, C. S., Dinh, D. H. et al. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology, 19, 519-524.

   11.    Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20, 6938-6945.

   12.    Konduri, S. D., Srivenugopal, K. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells. Oncogene, 22 , 4509-4516.

   13.    Lakka, S. S., Konduri, S. D., Mohanam, S., Nicolson, G. L., & Rao, J. S. (2000). In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clinical & Experimental Metastasis, 18, 239-244.

   14.    Lakka, S. S., Jasti, S. L., Kyritsis, A. P., Yung, W. K. A., Ali-Osman, F., Nicolson, G. L. et al. (2000). Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clinical & Experimental Metastasis, 18, 245-252.

   15.    Lakka, S. S., Rajagopal, R., Rajan, M. K., Mohan, P. M., Adachi, Y., Dinh, D. H. et al. (2001). Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research, 7, 1087-1093.

   16.    Lakka, S. S., Rajan, M. K., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L. et al. (2002). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene, 21, 8011-8019.

   17.    Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23, 4681-4689.

   18.    Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H. et al. (2005). Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. Journal of Biological Chemistry.

   19.    Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005). Proteases and glioma angiogenesis. Brain Pathology, 15, 327-341.

   20.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Kin, Y., Fuller, G. N. et al. (2001). Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin.Cancer Res., 7, 2519-2526.

   21.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Lakka, S. S., Kin, Y. et al. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 20, 3665-3673.

   22.    Muralikrishna, P. S., Gondi, C. S., Lakka, S. S., Julta, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival and tumorigenicity in vivo. Journal of Biological Chemistry.

   23.    Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol.Chem., 280, 36529-36540.

   24.    Rao, C. N., Lakka, S. S., Kin, Y., Konduri, S. D., Fuller, G. N., Mohanam, S. et al. (2001). Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clinical Cancer Research, 7, 570-576.

   25.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

   26.    Subramanian, R., Gondi, C. S., Lakka, S. S., Jutla, A., & Rao, J. S. (2006). siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int.J Oncol., 28, 831-839.

LANDWIRTH,T.K.


     1.    Dorsch, J. L., Landwirth, T. K., & Wilson, M. L. (1988). Reference activity and the external user: confluence of community needs at a medical school branch library (University of Illinois at Chicago Library of the Health Sciences: paper presented at the 87th annual meeting of the Medical Library Association, Portland, Oregon, 1987). Bull.Med.Libr.Assoc., 76, 205-212.

     2.    Dorsch, J. L. & Landwirth, T. K. (1993). Rural GRATEFUL MED outreach; project results, impact, and future needs (Library of the Health Sciences-Peoria end-user training project; presented at the 1992 MLA Conference). Bull.Med.Libr.Assoc., 81, 377-382.

     3.    Dorsch, J. L. & Landwirth, T. K. (1994). Document needs in a rural GRATEFUL MED outreach project (at the Library of the Health Sciences--Peoria; presented at the 1993 MLA Conference). Bull.Med.Libr.Assoc., 82, 357-362.

     4.    Landwirth, T. K. (1987). The women's health movement: an information based phenomenon. Serials Librarian, 12, 89-105.

     5.    Landwirth, T. K. (1991). Why authors fail (MLA Bulletin rejections). Bull.Med.Libr.Assoc., 79, 337-338.

LANZINO,G.


     1.    Alvernia, J., Fraser, K., & Lanzino, G. (2006). The occipital artery: a microanatomical study. Neurosurgery., 58, ONS114-ONS122.

     2.    Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2004). Subacute spinal subdural hematoma after spontaneous resolution of cranial subdural hematoma: causal relationship or coincidence? Case report. J Neurosurg., 100, 372-374.

     3.    Cardia, A., Caroli, M., Pluderi, M., Arienta, C., Gaini, S. M., Lanzino, G. et al. (2006). Endoscope-assisted infratentorial-supracerebellar approach to the third ventricle: an anatomical study. Journal of neurosurgery, 104, 409-414.

     4.    Catapano, D., Sloffer, C. A., Frank, G., Pasquini, E., D'Angelo, V. A., & Lanzino, G. (2006). Comparison between the microscope and endoscope in the direct endonasal extended transsphenoidal approach: anatomical study. J Neurosurg., 104, 419-425.

     5.    Horn, E. M., Zabramski, J. M., Feiz-Erfan, I., Lanzino, G., & McDougall, C. G. (2004). Distal lenticulostriate artery aneurysm rupture presenting as intraparenchymal hemorrhage: Case report. Neurosurgery, 55, 708.

     6.    Kanaan, Y., Kaneshiro, D., Fraser, K., Wang, D., & Lanzino, G. (2005). Evolution of endovascular therapy for aneurysm treatment. Historical overview. Neurosurg.Focus., 18, E2.

     7.    Kraus, R. R., Kattah, J. C., Bortolotti, C., & Lanzino, G. (2004). Oculomotor palsy from an unruptured posterior communicating artery aneurysm presenting with cerebrospinal fluid pleocytosis and enhancement of the third cranial nerve. Case report. Journal of neurosurgery, 101, 352-353.

     8.    Lanzino, G. & Laws, E. R., Jr. (2003). Key personalities in the development and popularization of the transsphenoidal approach to pituitary tumors: an historical overview. Neurosurg.Clin.N.Am., 14, 1-10.

     9.    Lanzino, G. & Spetzler, R. F. (2003). Clip wrapping for partial avulsion of the aneurysm neck. Technical note. J Neurosurg., 99, 931-932.

   10.    Lanzino, G. (2005). Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. Journal of neurosurgery, 102, 974-975.

   11.    Lanzino, G., Paolini, S., & Spetzler, R. F. (2005). Far-lateral approach to the craniocervical junction. Neurosurgery, 57, 367-371.

   12.    Lanzino, G., Kanaan, Y., Perrini, P., Dayoub, H., & Fraser, K. (2005). Emerging concepts in the treatment of intracranial aneurysms: stents, coated coils, and liquid embolic agents. Neurosurgery., 57, 449-459.

   13.    Lanzino, G., Fraser, K., Kanaan, Y., & Wagenbach, A. (2006). Treatment of ruptured intracranial aneurysms since the International Subarachnoid Aneurysm Trial: practice utilizing clip ligation and coil embolization as individual or complementary therapies. J Neurosurg., 104, 344-349.

   14.    Lanzino, G. (2006). Clip ligation or coil occlusion? - Response. Journal of neurosurgery, 104, 343.

   15.    Paolini, S., Kanaan, Y., Wagenbach, A., Fraser, K., & Lanzino, G. (2005). Illustrative Review Cerebral Vasospasm in patients with unruptured intracranial aneurysms. Acta Neurochir.(Wien.)., 147, 1181-1188.

   16.    Perrini, P., Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2005). Thrombosed giant intracavernous aneurysm with subsequent spontaneous ipsilateral carotid artery occlusion. Acta Neurochirurgica, 147, 215-216.

   17.    Perrini, P. & Lanzino, G. (2006). The association of venous developmental anomalies and cavernous malformations: pathophysiological, diagnostic, and surgical considerations. Neurosurg.Focus., 21, e5.

   18.    Siddique, K., Alvernia, J., Fraser, K., & Lanzino, G. (2003). Treatment of aneurysms with wires and electricity: a historical overview. J Neurosurg., 99, 1102-1107.

   19.    Sloffer, C. A., Augspurger, L., Wagenbach, A., & Lanzino, G. (2005). Antimicrobial-impregnated external ventricular catheters: does the very low infection rate observed in clinical trials apply to daily clinical practice? Neurosurgery, 56, 1041-1044.

   20.    Sloffer, C. A. & Lanzino, G. (2006). Historical vignette. Dominique Anel: father of the Hunterian ligation? J Neurosurg., 104, 626-629.

   21.    Wang, D. Z., Wang, H., Fraser, K., & Lanzino, G. (2004). Treatment Options for Unruptured Cerebral Aneurysm. Curr Treat Options Neuro, 6, 451-458.

   22.    Wang, H., Lanzino, G., Kraus, R. R., & Fraser, K. (2003). Provocative test occlusion or the Matas test: who was Rudolph Matas? J.Neurosurg., 98, 926-928.

   23.    Wang, H., Lanzino, G., Fraser, K., Tracy, P. T., & Wang, D. (2003). Urgent endovascular treatment of acute symptomatic occlusion of the cervical internal carotid artery. J Neurosurg., 99, 972-977.

   24.    Wang, H., Olivero, W. C., Lanzino, G., Elkins, W., Rose, J. A., Honings, D. et al. (2004). Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg., 100, 272-277.

   25.    Wang, H., Fraser, K., Bortolotti, C., & Lanzino, G. (2005). Emergent endovascular treatment with direct carotid puncture for exsanguinating Carotid Blowout Syndrome. Neurocritical Care, 2, 176-178.

   26.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery, 57, E398.

   27.    Wang, H., Fraser, K., Wang, D., & Lanzino, G. (2005). The evolution of endovascular therapy for neurosurgical disease. Neurosurgery clinics of North America, 16, 223-229.

   28.    Wang, H., Swischuk, J. L., Fraser, K., Alvernia, J., & Lanzino, G. (2005). Transaxillary carotid stenting: technical case report. Neurosurgery, 56, E441.

   29.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery., 57, E398.

   30.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent: a brief historical overview. Acta Neurochir.(Wien.)., ..

   31.    Wang, H., Wang, D., Lanzino, G., Elkins, W., & Olivero, W. C. (2006). Differential interhemispheric cooling and ICP compartmentalization in a patient with left ICA occlusion. Acta Neurochir.(Wien.)., ..

   32.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent. Acta Neurochirurgica, 148, 565-570.

LASLEY,S.M.


     1.    Dailey, J. W., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Jobe, P. C. (1991). Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame. Epilepsy Res., 8, 122-133.

     2.    Gilbert, M. E., Mack, C. M., & Lasley, S. M. (1999). The influence of developmental period of lead exposure on long- term potentiation in the adult rat dentate gyrus in vivo. Neurotoxicology, 20, 57-69.

     3.    Gilbert, M. E., Mack, C. M., & Lasley, S. M. (1999). Chronic developmental lead exposure and hippocampal long-term potentiation: Biphasic dose-response relationship. Neurotoxicology, 20, 71-82.

     4.    Jobe, P. C., Lasley, S. M., & Dailey, J. W. (1988). Monoamines and seizures in genetically epilepsy-prone rats: inferences from precursor availablity. In G.Huether (Ed.), Amino acid availability and brain function in health and disease (pp. 207-214). New York, NY: Springer-Verlag.

     5.    Jobe, P. C., Lasley, S. M., Burger, R. L., Bettendorf, A. F., Mishra, P. K., & Dailey, J. W. (1992). Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats. Amino Acids, 3, 155-172.

     6.    Lasley, S. M. (1991). Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat. Brain Research, 560, 63-70.

     7.    Lasley, S. M. (1992). Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure. Neurotoxicology, 13, 625-635.

     8.    Lasley, S. M., Polan-Curtain, J., & Armstrong, D. L. (1993). Chronic exposure to environmental levels of lead impairs in vivo induction of long-term potentiation in rat hippocampal dentate. Brain Research, 614, 347-351.

     9.    Lasley, S. M. & Yan, Q. S. (1994). Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats. Neurosci.Lett., 175, 145-148.

   10.    Lasley, S. M. & Gilbert, M. E. (1996). Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Research, 736, 125-134.

   11.    Lasley, S. M. (1997). Antipsychotic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (5th ed., pp. 421-428). Philidelphia: Lippincott Williams & Wilkins.

   12.    Lasley, S. M., Green, M. C., & Gilbert, M. E. (1999). Influence of exposure period on in vivo hippocampal glutamate and GABA release in rats chronically exposed to lead. Neurotoxicology, 20, 619-629.

   13.    Lasley, S. M. & Gilbert, M. E. (1999). Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site. Toxicol.Appl.Pharmacol., 159, 224-233.

   14.    Lasley, S. M. & Gilbert, M. E. (2000). Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology, 21, 1057-1068.

   15.    Lasley, S. M., Green, M. C., & Gilbert, M. E. (2001). Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicology & Teratology, 23, 185-189.

   16.    Lasley, S. M. & Gilbert, M. E. (2002). Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicological Sciences, 66, 139-147.

   17.    Lasley, S. M. (2003). Chronic lead neurotoxicity: current status of research and therapy. Therapeutics & Toxins News, 18.

   18.    Lasley, S. M. (2004). Antipsychotic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 397-405). Philidelphia: Lippincott Williams & Wilkins.

   19.    Lasley, S. M. & Gilbert, M. E. (2004). Impairment of Synaptic Function by Exposure to lead. In E.Tiffany-Castiglioni (Ed.), In Vitro Neurotoxicology: Principles and Challenges, ( Totowa, N.J. : Humana Press.

   20.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The paradoxical effect of NMDA receptor stimulation on electrical activity of the sensorimotor cortex in freely behaving rats: analysis by combined EEG-intracerebral microdialysis. Synapse, 12, 87-98.

   21.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The combined EEG-intracerebral microdialysis technique: a new tool for neuropharmacological studies on freely behaving animals. J.Neurosci.Methods, 43, 129-137.

   22.    Noebels, J. L., Fariello, R. G., Jobe, P. C., Lasley, S. M., & Marescaux, C. (1997). Genetic Models of Generalized Epilepsy. In J.J.Engel (Ed.), Epilepsy: A Comprehensice Textbook (pp. 457-465). Philadelphia: Lippincott-Raven Publishers.

   23.    Tiffany-Castiglioni, E., Ehrich, M., Dees, L., Costa, L. G., Kodavanti, P. R. S., Lasley, S. M. et al. (1999). Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicological Sciences, 51, 178-183.

   24.    Yokel, R. A., Lasley, S. M., & Dorman, D. C. (2006). The speciation of metals in mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment. Journal of Toxicology and Environmental Health-Part B-Critical Reviews, 9, 63-85.

LEE,A.


     1.    Misra, S., Lee, A., & Ginsel, K. (2004). P1061 Overweight and Obestiy Risk Factors for Functional Constipation in Children. Journal of Pedicatric Gastroenterology and Nutrition, 39, 460-461.

     2.    Misra, S., Lee, A., & Gensel, K. (2006). Chronic constipation in overweight children. JPEN J Parenter.Enteral Nutr., 30, 81-84.

LEONARDI,M.R.


     1.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

LIN,J.


     1.    Lin, J., Olivero, W. C., & McCluney, K. W. (1999). Acute hydrocephalus following lateral C1-2 puncture - Case illustration. J.Neurosurg., 90, S277.

     2.    Lin, J., Nauta, H. J. W., & Olivero, W. C. (2001). Anatomical relationships between Sylvian fissure and the sphenoid ridge. Neurological Research, 23, 645-646.

     3.    Lin, J., Hanigan, W. C., Tarantino, M. D., & Wang, J. (2003). The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J.Neurosurg., 98, 737-740.

     4.    Lin, J., Morris, M., Olivero, W. C., Boop, F., & Sanford, R. A. (2003). Computational and experimental study of proximal flow in ventricular catheters. Technical note. J Neurosurg., 99, 426-431.

     5.    Lin, J., Elwood, P. W., & Fraser, K. (2003). Venous ligation of dural arteriovenous fistulae. British Journal of Neurosurgery, 17, 239-243.

LORENZ,R.A.


     1.    Clark, C. M., Fradkin, J. E., Hiss, R. G., Lorenz, R. A., Vinicor, F., & Warren-Boulton, E. (2000). Promoting early diagnosis and treatment of type 2 diabetes - The National Diabetes Education Program. Jama: Journal of the American Medical Association, 284, 363-365.

     2.    Clark, C. M., Fradkin, J. E., Hiss, R. G., Lorenz, R. A., Vinicor, F., & Warren-Boulton, E. (2001). The National Diabetes Education Program, changing the way diabetes is treated - Comprehensive diabetes care. Diabetes Care, 24, 617-618.

     3.    DiLiberti, J. H. & Lorenz, R. A. (2001). Long-term trends in childhood diabetes mortality: 1968-1998. Diabetes Care, 24, 1348-1352.

     4.    Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., Peterson, C. M. et al. (2004). Tests of glycemia in diabetes. Diabetes Care, 27, 1761-1773.

     5.    Lorenz, R. A. (1999). Modern insulin therapy for type 1 diabetes mellitus. Prim.Care, 26, 917-929.

     6.    Lorenz, R. A., Gregory, R. P., Davis, D. L., Schlundt, D. G., & Wermanger, J. (2000). Diabetes training for dietitians: Needs assessment, program description, and effects on knowledge and problem solving. Journal of the American Dietetic Association, 100, 225-228.

     7.    Lorenz, R. A., Gregory, R. P., & Davis, D. L. (2000). Utility of a brief self-efficacy scale in clinical training program evaluation. Eval.Health Prof., 23, 182-193.

     8.    Lorenz, R. A. (2003). Medical management needs of children with diabetes at school. School Nurse News, 20, 36-37.

     9.    Lorenz, R. A. & Silverstein, J. (2005). Managing insulin requirements at school. School Nurse News, 22, 10-14.

LYONS,R.L.


     1.    Issel, L. M., Baldwin, K. A., Lyons, R. L., & Madamala, K. (2006). Self-reported competency of public health nurses and faculty in Illinois. Public Health Nursing, 23, 168-177.

MA,L.


     1.    Osborn, P., Gross, T. L., Shah, J. J., & Ma, L. (2000). Prenatal diagnosis of fetal heart failure in twin reversed arterial perfusion syndrome. Prenat.Diagn., 20, 615-617.

MACWAN,K.


     1.    Macwan, K., Shareef, M., Albert, V. L., & Drenckpohl, D. (2004). Initiation of oral feedings in infants less than 34 weeks to facilitate early discharge from NICU. Pediatric research, 56, 672.

     2.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

MAGUIRE,R.B.


     1.    Maguire, R. B., Stroncek, D. F., & Campbell, A. C. (1993). Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies [see comments]. Ann.Intern.Med., 119, 215-217.

     2.    Maguire, R. B., Stroncek, D. F., Gale, E., & Yearlsey, M. (1994). Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am.J.Hematol., 46, 363-366.

MANKIN,P.E.


     1.    Mankin, P. E., Maragos, J., Akhand, M., & Saving, K. L. (2000). Impaired platelet--dense granule release in neonates. J.Pediatr.Hematol.Oncol., 22, 143-147.

     2.    Saving, K. L., Mankin, P. E., Maragos, J., Adams, D., & Caughey, R. C. (2001). Association of whole blood aggregation response with immunogold-labeled glycoproteins in adult and neonatal platelets. Thrombosis Research, 101, 73-81.

     3.    Saving, K. L., Mankin, P. E., & Gorman, M. J. (2002). Differences in adhesion receptor expression between immature and older platelets and red blood cells of neonates and adults. J.Pediatr.Hematol.Oncol., 24, 120-124.

     4.    Saving, K. L. & Mankin, P. E. (2003). CD62 expression during thrombus formation. Journal of Pediatric Hematology/Oncology, 25, 266-269.

MARSHALL,J.S.


     1.    DeBord, J. R., Marshall, W. H., Wyffels, P. L., Marshall, J. S., & Humphrey, P. (1991). Carotid endarterectomy in a community hospital surgical practice. The American Surgeon, 57, 627-32; discussion 632-3.

     2.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     3.    Marshall, J. S. (2000). Small Left Colon Syndrome. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secretes (pp. 151).

     4.    Marshall, J. S., Srivastava, A., Gupta, S. K., Rossi, T. R., & DeBord, J. R. (2003). Roux-en-Y gastric bypass leak complications. Archives of Surgery, 138, 520-523.

     5.    Rossi, T. R., Dynda, D. I., Estes, N. C., & Marshall, J. S. (2005). Stricture dilation 1820after laparoscopic Roux-en-Y gastric bypass. American Journal of Surgery, 189, 357-360.

     6.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

     7.    Wyffels, P. L., DeBord, J. R., Marshall, J. S., Thors, G., & Marshall, W. H. (1992). Increased limb salvage with intraoperative and postoperative ankle level urokinase infusion in acute lower extremity ischemia. J.Vasc.Surg., 15, 771-8; discussion 778-9.

MASI,A.T.


     1.    Bijlsma, J. W., Cutolo, M., Masi, A. T., & Chikanza, I. C. (1999). The neuroendocrine immune basis of rheumatic diseases. Immunology Today, 20, 298-301.

     2.    Bijlsma, J. W., Cutolo, M., Straub, R. H., & Masi, A. T. (2005). Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases. Rheumatic Disease Clinics of North America, 31, XIII-XXVI.

     3.    Comstock, G. W., Burke, A. E., Hoffman, S. C., Helzlsouer, K. J., Bendich, A., Masi, A. T. et al. (1997). Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Annals of the Rheumatic Diseases, 56, 323-325.

     4.    Cutolo, M., Sulli, A., Seriolo, B., Accardo, S., & Masi, A. T. (1995). Estrogens, the immune response and autoimmunity. Clinical & Experimental Rheumatology, 13, 217-226.

     5.    Cutolo, M. & Masi, A. T. (1998). Do androgens influence the pathophysiology of rheumatois arthritis - facts and hypotheses. Journal of Rheumatology, 25, 1041-1047.

     6.    Cutolo, M., Masi, A. T., Bijlsma, J. W., Chikanza, I. C., Bradlow, H. L., & Castagnetta, L. (1999). Neuroendocrine immune basis of the rheumatic diseases. Annals of the New York Academy of Sciences, 876, xi-xv.

     7.    Cutolo, M., Bijlsma, J. W., Lahita, R. G., Masi, A. T., Straub, R. H., & Bradlow, H. L. (2002). Neuroendocrine immune basis of the rheumatic diseases II: Altered Neuroendocrine Immune (NEI) Networks in Rheumatology. In (pp. xiii-xviii). New York, New York: New York Academy of Sciences.

     8.    Cutolo, M. & Masi, A. T. (2005). Circadian rhythms and arthritis. Rheumatic Disease Clinics of North America, 31, 115.

     9.    Furst, D. E., Clements, P. J., Steen, V. D., Medsger, T. A., Masi, A. T., Dangelo, W. A. et al. (1998). The modified rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. Journal of Rheumatology, 25, 84-88.

   10.    Hanissian, A. S., Masi, A. T., Pitner, S. E., Cape, C. C., & Medsger, T. A. (1982). Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol., 9, 390-394.

   11.    Kalyan-Raman, U. P., Kalyan-Raman, K., Yunus, M. B., & Masi, A. T. (1984). Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol., 11, 808-813.

   12.    Masi, A. T. (1980). Infectious agent arthritis (IAA): a continuing diagnostic and therapeutic problem. J Rheumatol., 7, 433-436.

   13.    Masi, A. T. (1983). Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy? J Rheumatol., 10, 675-678.

   14.    Masi, A. T. (1988). Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol., 15, 894-898.

   15.    Masi, A. T. (1988). Rheumatoid factor negative (seronegative) rheumatoid arthritis: evolving clinical classification and immunogenetic associations. J Rheumatol., 15, 4-6.

   16.    Masi, A. T. (1992). Do sex hormones play a role in ankylosing spondylitis? Rheum.Dis.Clin.North Am., 18, 153-176.

   17.    Masi, A. T. (1994). An intuitive person-centred perspective on fibromyalgia syndrome and its management. Baillieres.Clin.Rheumatol., 8, 957-993.

   18.    Masi, A. T. (1994). Fibromyalgia and myofascial pain syndromes - preface. Baillieres Clinical Rheumatology, 8, R 11-R 12.

   19.    Masi, A. T. (1994). Incidence of rheumatoid arthritis - do the observed age sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis. British Journal of Rheumatology, 33, 697-699.

   20.    Masi, A. T., Feigenbaum, S. L., & Chatterton, R. T. (1995). Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. Semin.Arthritis Rheum., 25, 1-27.

   21.    Masi, A. T. (1995). Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clinical & Experimental Rheumatology, 13, 227-240.

   22.    Masi, A. T., Feigenbaum, S. L., Chatterton, R. T., & Cutolo, M. (1995). Integrated hormonal-immunological-vascular (H-I-V triad) systems interactions in the rheumatic diseases. Clinical & Experimental Rheumatology, 13, 203-216.

   23.    Masi, A. T. & Cutolo, M. (1995). Conclusions from the special articles and recent related research. Clin.Exp.Rheumatol., 13, 241-242.

   24.    Masi, A. T. & Cutolo, M. (1995). Perspectives on sex hormones and the systemic rheumatic diseases. Clin.Exp.Rheumatol., 13, 201-202.

   25.    Masi, A. T., Da Silva, J. A., & Cutolo, M. (1996). Pertubations of hypothalamic-pituitary-gonadal (HPG) axis and adrernal androgen (AA) functions in rheumatoid arthritis. Baillieres Clinical Rheumatology, 10, 295-332.

   26.    Masi, A. T. & Wilkins, W. R. (1996). Does male/female sex ration in ankylosing spondylitis change with age. Journal of Rheumatology, 23, 947-948.

   27.    Masi, A. T. & Chrousos, G. P. (1996). Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. Journal of Rheumatology, 23, 577-581.

   28.    Masi, A. T. & Chrousos, G. P. (1997). Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. Ann.Rheum.Dis., 56, 1-4.

   29.    Masi, A. T. & Chang, H. J. (1998). Cigarette smoking and other acquired risk factors for rheumatoid arthritis. In L.D.Kaufman & J. Varga (Eds.), Rheumatic diseases and the environment (pp. 111). New York: Oxford University Press.

   30.    Masi, A. T. (1998). Concepts of illness in populations as applied to fibromyalgia syndromes: a biopsychosocial perspective. Zeitschrift fur Rheumatologie, 57, 31-35.

   31.    Masi, A. T., Fecht, T., Aldag, J. C., & Malamet, R. L. (1998). Smoking and rheumatoid arthritis - comment on the letter by McDonagh and Walker. Arthritis & Rheumatism, 41, 184-185.

   32.    Masi, A. T., Aldag, J. C., Chatterton, R. T., Kitabchi, A. E., & Adams, R. F. (1999). Adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis: A clue to it's physiopathogenesis? Zeitschrift fur Rheumatologie, 58, 300-301.

   33.    Masi, A. T., Bijlsma, J. W., Chikanza, I. C., Pitzalis, C., & Cutolo, M. (1999). Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin.Arthritis Rheum., 29, 65-81.

   34.    Masi, A. T., Chatterton, R. T., & Aldag, J. C. (1999). Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease. Ann.N.Y.Acad.Sci., 876, 53-62; discussion 62-3.

   35.    Masi, A. T. & Aldag, J. C. (1999). Significantly increased frequency of baseline IgA anti-type II collagen positivity in the placebo group in a study of oral type II collagen treatment of rheumatoid arthritis: comment. Arthritis & Rheumatism, 42, 585-587.

   36.    Masi, A. T., Chrousos, G. P., & Bornstein, S. R. (1999). Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. Journal of Rheumatology, 26, 247-250.

   37.    Masi, A. T. (1999). Nonarticular Rheumatism. In The Merck Manual (17th ed., pp. 474-482).

   38.    Masi, A. T. & Chang, H. J. (1999). Cigarette smoking and other acquired risk factors for Rheumatoid Arthritis. In L.D.Kaufman & J. Varga (Eds.), Rheumatic Diseases and the Environment (1 ed., pp. 111-127). New York: Oxford.

   39.    Masi, A. T. & Chatterton, R. T. (2000). Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients. Scandinavian Journal of Rheumatology, 29, 85-88.

   40.    Masi, A. T., Feigenbaum, S. L., & Lockshin, M. D. (2000). Rheumatological diseases and antiphospholipid syndrome. In H.M.Winn & J. C. Hobbins (Eds.), Clinical Maternal-Fetal Medicine (pp. 515-533). Pearl River: Parthenon Publishing Group.

   41.    Masi, A. T. (2000). Neuroendocrine immune mechanisms in rheumatic diseases. An overview and future implications. Rheum.Dis.Clin.North Am., 26, 1003-1017.

   42.    Masi, A. T. (2000). Hormonal and immunologic risk factors for the development of rheumatoid arthritis: an integrative physiopathogenetic perspective. Rheum.Dis.Clin.North Am., 26, 775-803.

   43.    Masi, A. T., Aldag, J. C., Chatterton, R. T., Adams, R. F., & Kitabchi, A. E. (2000). Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset? Zeitschrift fur Rheumatologie, 59, 54-61.

   44.    Masi, A. T., Bijlsma, J. W., Chikanza, I. C., & Cutolo, M. (2000). Neuroendocrine mechanisms in rheumatic diseases - Preface. Rheumatic Diseases Clinics of North America, 26, XIII-XIXV.

   45.    Masi, A. T. & Aldag, J. C. (2001). Do antifilaggrin antibodies within the "normal" range predict rheumatoid arthritis? Journal of Rheumatology, 28, 1736-1737.

   46.    Masi, A. T., Aldag, J. C., & Malamet, R. L. (2001). Heavy cigarette smoking and RA. Annals of the Rheumatic Diseases., 60, 1154-1155.

   47.    Masi, A. T., King, J. R., & Burgos-Vargas, R. (2001). Novel concepts of severity mechanisms in ankylosing spondylitis. Journal of Rheumatology, 28, 2151-2154.

   48.    Masi, A. T., Aldag, J. C., & Sipes, J. (2001). Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: Correlations with pre-RA status and baseline positive rheumatoid factors. Journal of Rheumatology, 28, 2359-2360.

   49.    Masi, A. T. & Hamilos, D. L. (2002). Leukotriene antagonists: Bystanders or causes of Churg-Strauss syndrome? Seminars.in Arthritis & Rheumatism., 31, 211-217.

   50.    Masi, A. T., Chatterton, R. T., Aldag, J. C., & Malamet, R. L. (2002). Neuroendocrine immune basis of the rheumatic diseases II: Perspectives on the relationship of adrenal steroids to rheumatoid arthritis. In (pp. 1-12). New York: New York Academy of Sciences.

   51.    Masi, A. T. & Walsh, E. G. (2003). Ankylosing spondylitis: integrated clinical and physiological perspectives. Clin.Exp.Rheumatol., 21, 1-8.

   52.    Masi, A. T., Dorsch, J. L., & Cholewicki, J. (2003). Are adolescent idiopathic scoliosis and ankylosing spondylitis counter-opposing conditions? A hypothesis on biomechanical contributions predisposing to these spinal disorders. Clinical & Experimental Rheumatology, 21, 573-580.

   53.    Masi, A. T. & Chrousos, G. P. (2003). Polycystic ovarian syndrome and rheumatoid arthritis: possible physiopathogenetic clues to hormonal influences on chronic inflammation. Semin.Arthritis Rheum., 33, 67-71.

   54.    Masi, A. T., Aldag, J. C., & Chatterton, R. T. (2003). Neuroendocrine Immune Perturbations in Rheumatoid Arthritis: Causes, Consequences, or Confounders in the Disease Process? The Journal of Rheumatology, 30, 2302-2305.

   55.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2004). Basal serum IL-1 beta correlations with glucocorticoid precursor and sex steroid levels differed significantly in men and women before onset of rheumatoid arthritis (pre-RA) versus their matched controls. Arthritis and Rheumatism, 50, S352-S353.

   56.    Masi, A. T., Kamat, S., Gajdosik, R., Ahmad, N., & Aldag, J. C. (2004). Does muscular hypertonicity (MHT) correlate with clinical features in ambulatory rheumatology patients?: A controlled study of fibromyalgia (FM) and osteoarthritis (OA) patients with and without MHT. Arthritis and Rheumatism, 50, S134.

   57.    Masi, A. T. & Aldag, J. C. (2005). Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase? Scandinavian Journal of Rheumatology, 34, 342-352.

   58.    Masi, A. T., Aldag, J. C., & Jacobs, J. W. (2005). Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy. Rheumatic Diseases Clinics of North America, 31, 131-160.

   59.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2005). Gender dimorphism in serum levels of soluble interleukin-2 receptor alpha subunit (sIL-2R alpha) observed in susceptibles to rheumatoid arthritis (RA) before clinical onset (pre-RA) and in matched cohort controls (CN). Arthritis and Rheumatism, 52, S653-S654.

   60.    Masi, A. T., Aldag, J. C., Chatterton, R. T., & Malamet, R. L. (2005). Gender dimorphism in serum levels of soluble tumor necrosis factor receptor type 1 (sTNF-RI) observed in susceptibles to rheumatoid arthritis (RA) before clinical onset (pre-RA) and in matched cohort 2 controls (CN). Arthritis and Rheumatism, 52, S654.

   61.    Masi, A. T., Sierakowski, S., & Kim, J. M. (2005). Jacques Forestier's vanished bowstring sign in ankylosing spondylitis: a call to test its validity and possible relation to spinal myofascial hypertonicity. Clin.Exp.Rheumatol., 23, 760-766.

   62.    Masi, A. T., Aldag, J. C., & Chatterton, R. T. (2006). Sex hormones and risks of rheumatoid arthritis and developmental or environmental influences. Ann.N.Y.Acad.Sci., 1069:223-35., 223-235.

   63.    Yunus, M., Plattner, P. F., Masi, A. T., Shah, I. K., Lindahl, L. S., & Conner, D. E. (1982). Ulnar deviation of the fingers in gout simulating rheumatoid arthritis. J Rheumatol., 9, 619-623.

   64.    Yunus, M. B., Radford, C. M., Masi, A. T., Zimmerman, T. J., Calabro, J. J., & Miller, K. A. (1984). Aortic regurgitation in scleroderma. J Rheumatol., 11, 384-386.

   65.    Yunus, M. B., Morgan, R. J., Barclay, A. M., Shah, I. K., & Masi, A. T. (1985). Organic brain syndrome in rheumatoid arthritis after corticosteroid withdrawal. J Rheumatol., 12, 636-637.

   66.    Yunus, M. B., Denko, C. W., & Masi, A. T. (1986). Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. J Rheumatol., 13, 183-186.

   67.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol.Suppl, 19:62-71., 62-71.

   68.    Yunus, M. B., Berg, B. C., & Masi, A. T. (1989). Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: a blinded study. J Rheumatol., 16, 1466-1468.

   69.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol., 16, 527-532.

   70.    Yunus, M. B., Kalyan-Raman, U. P., Masi, A. T., & Aldag, J. C. (1989). Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol., 16, 97-101.

   71.    Yunus, M. B., Ahles, T. A., Aldag, J. C., & Masi, A. T. (1991). Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum., 34, 15-21.

   72.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 95-97.

   73.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 90-94.

   74.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. The Journal of Rheumatology, 19, 95-97.

MCGEE,J.L.


     1.    Smoron, G. L., Lennox, A. J., & McGee, J. L. (1999). Osteogenic sarcoma of the maxilla: neutron therapy for unresectable disease. Sarcoma, 3, 141-144.

MCLEAN,J.M.


     1.    Armon, C., Swanson, J. W., Mclean, J. M., Westbrook, P. R., Okazaki, H., Kurtin, P. J. et al. (1996). Subacute Encephalomyelitis presenting as stiff-person syndrome - clincal, polygrapic, and pathologic correlations. Movement Disorders, 11, 701-709.

     2.    Mclean, J. M., Palagallo, G. L., Henderson, J. P., & Kimm, J. A. (1995). Myelopathy associated with fibrocartilaginous emboli (FE): review and two suspected cases. Surg.Neurol., 44, 228-235.

MERIDEN,T.


     1.    Meriden, T. (1995). Lessons for the American Diabetes Association from the health care debate. Diabetes Care, 18, 1396.

     2.    Meriden, T. (2004). Progress with thiazolidinediones in the management of type 2 diabetes mellitus. Clin.Ther., 26, 177-190.

MEYER,L.E.


     1.    Aiyer, M. K., Hemmer, P., Meyer, L. E., Albritton, T. A., Levine, S., & Reddy, S. (2002). Evidence-based medicine in internal medicine clerkships: a national survey. South.Med.J., 95, 1389-1395.

     2.    Cummings, A. J., Tisol, W. B., & Meyer, L. E. (2004). Modified transthecal digital block versus traditional digital block for anesthesia of the finger. J Hand Surg.[Am], 29, 44-48.

     3.    Dorsch, J. L., Aiyer, M. K., & Meyer, L. E. (2004). Impact of an evidence-based medicine curriculum on medical students' attitudes and skills. 92, 397-406.

     4.    Dorsch, J. L., Aiyer, M. K., Gumidyala, K., & Meyer, L. E. (2006). Retention of EBM Competencies. Med.Ref.Serv.Q., 25, 45-57.

     5.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     6.    Meyer, L. E. (1998). Evaluation: Programs, Residents, Faculty. In Guide to Graduate Medical Education (2 ed., pp. 47-59,305-326). Washington,DC: Association for Hospital Medical Education.

     7.    Whittaker, L. D., Jr., Estes, N. C., Ash, J. L., & Meyer, L. E. (2006). The value of resident teaching to improve student perceptions of surgery clerkships and surgical career choices. Am.J Surg., 191, 320-324.

MILBRANDT,J.C.


     1.    Caspary, D. M., Holder, T. M., Hughes, L. F., Milbrandt, J. C., McKernan, R. M., & Naritoku, D. K. (1999). Age-Related Changes in GABAa Receptor Subunit Composition and Function in Rat Auditory System. Neuroscience, 93, 307-312.

     2.    Dailey, J. W., Reith, M. E., Steidley, K. R., Milbrandt, J. C., & Jobe, P. C. (1998). Carbamazepine-induced release of serotonin from rat hippocampus in vitro. Epilepsia, 39, 1054-1063.

     3.    Graumlich, J. F., Blough, L. S., McLaughlin, R. G., Milbrandt, J. C., Calderon, C. L., Agha, S. Y. et al. (2003). Healing Pressure Ulcers with Collagen or Hydrocolloid: A Randomized, Controlled Trial. Journal of the American Geriatrics Society, 51, 147-153.

     4.    Nakayama, M., Caspary, D. M., Konrad, H. R., Milbrandt, J. C., & Helfert, R. H. (1999). Age-related changes in [3H]strychnine binding in the vestibular nuclei of rats. Hearing Research, 127, 103-107.

     5.    Ryu, J. R., Jobe, P. C., Milbrandt, J. C., Mishra, P. K., Clough, R. W., Browning, R. A. et al. (1999). Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues. Experimental Neurology, 156, 84-91.

     6.    Wang, D. Z., Rose, J. A., & Milbrandt, J. C. (1998). OSF Stroke Network: Exploring the Way of Community Stroke Care. Stroke Interventionist, I, 11-13.

     7.    Wang, D. Z., Rose, J. A., Honings, D., & Milbrandt, J. C. (2000). tPA: A rural network experience - Response. Stroke, 31, 1457-1458.

     8.    Wang, D. Z., Rose, J. A., Honings, D., Garwacki, D. J., & Milbrandt, J. C. (2000). Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke, 31, 77-81.

MILLER,B.


     1.    Miller, B., Montgomery, C. E., Watne, A. L., Johnson, D., Bailey, T. S., & Kowalski, R. (1991). Lymphoepithelioma-like carcinoma of the lung. J.Surg.Oncol., 48, 62-68.

MILLER,G.D.


     1.    Miller, G. D. (1999). Just another house call. J.Am.Board.Fam.Pract., 12, 495-496.

MILLER,M.A.


     1.    Hjelle, J. T., Waters, D. C., Golinska, B. T., Steidley, K. R., Burmeister, V., Caughey, R. C. et al. (1990). Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro. Am.J.Kidney Dis., 15, 123-136.

     2.    Hjelle, J. T., Golinska, B. T., Waters, D. C., Steidley, K. R., Miller, M. A., McCarroll, D. R. et al. (1991). Lectin staining of peritoneal mesothelial cells in vitro. Perit.Dial.Int., 11, 307-316.

     3.    Hjelle, J. T., Steidley, K. R., Welch, M. H., Miller, M. A., & Dobbie, J. W. (1991). Lectins as probes of membrane carbohydrates in mesothelial cells in vitro. Adv.Perit.Dial., 7, 30-34.

     4.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1992). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 8, 30-32.

     5.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1993). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 9, 299-302.

     6.    Miller, M. A., Prior, R. B., Horvath, F. J., & Hjelle, J. T. (1990). Detection of endotoxiuria in polycystic kidney disease patients by the use of the Limulus amebocyte lysate assay. Am.J.Kidney Dis., 15, 117-122.

MILLER,T.C.


     1.    Hanigan, W. C., Morgan, A. M., Anderson, R. J., Bradle, P., Cohen, H. S., Cusack, T. J. et al. (1991). Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infants. Neurosurgery, 29, 701-706.

     2.    Hanigan, W. C., Powell, F. C., Miller, T. C., & Wright, R. M. (1995). Symptomatic intracranial hemorrhage in full-term infants. Childs.Nerv.Syst., 11, 698-707.

     3.    Hanigan, W. C., Powell, F. C., Palagallo, G. L., & Miller, T. C. (1995). Lobar hemorrhages in full-term neonates. Childs.Nerv.Syst., 11, 276-280.

     4.    Saving, K. L., McLaren, R. A., & Miller, T. C. (1990). Responsibility expands to extended family members. American Journal of Obstetrics & Gynecology, 163, 1369-1370.

     5.    Trachtenbarg, D. E. & Miller, T. C. (1995). Office care of the small, premature infant. Prim.Care, 22, 1-21.

MILLER-HJELLE,M.A.


     1.    Ciftcioglu, N., Miller-Hjelle, M. A., Hjelle, J. T., & Kajander, E. O. (2002). Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrobial Agents and Chemotherapy, 46, 2077-2086.

     2.    Hjelle, J. T., Miller-Hjelle, M. A., & Dobbie, J. W. (1995). The biology of the mesothelium during peritoneal dialysis. Perit.Dial.Int., 15, S13-22; discussion S22-3.

     3.    Hjelle, J. T., Ho, A. K., Miller-Hjelle, M. A., Reith, M. E., Steidley, K. R., Duffield, R. et al. (1995). Multiple drug classes and hyperosmolarity alter binding of muscarinic drugs to mesothelial cells in vitro. Adv.Perit.Dial., 11, 3-6.

     4.    Hjelle, J. T., Miller-Hjelle, M. A., Nowak, D. M., Dombrink-Kurtzman, M. A., & Peterson, S. W. (2000). Polycystic kidney disease, fungi, and bacterial endotoxin: shifting paradigms involving infection and diet. Reviews in Medical Microbiology, 11, 23-35.

     5.    Hjelle, J. T., Miller-Hjelle, M. A., Poxton, I. R., Kajander, E. O., Ciftcioglu, N., Jones, M. L. et al. (2000). Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int., 57, 2360-2374.

     6.    Kajander, E. O., Ciftcioglu, N., Miller-Hjelle, M. A., & Hjelle, J. T. (2001). Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr.Opin.Nephrol.Hypertens., 10, 445-452.

     7.    Miller-Hjelle, M. A., Hjelle, J. T., Jones, M. L., Mayberry, W. R., Dombrink-Kurtzman, M. A., Peterson, S. W. et al. (1997). Polycystic kidney disease: an unrecognized emerging infectious disease? Emerging Infectious Diseases, 3, 113-127.

     8.    Miller-Hjelle, M. A. & Hjelle, J. T. (2003). Nanobacteria: Methods for Growth and Identification of this Recently Discovered Calciferous Agent. In W.P.Olson (Ed.), Rapid Analytical Microbiology: the Chemistry and Physics of Microbial Identification (pp. 297-312). Godalming, Surrey, UK: Horwood International Publishing, Ltd.

     9.    Miller-Hjelle, M. A., Somaraju, V., & Hjelle, J. T. (2004). Synthetic Organic Antimicrobials: Sulfonamides, Trimethoprim,Nitrofurans, Quinolones, Methenamine. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 515-525). Philidelphia: Lippincott Williams & Wilkins.

   10.    Nowak, D. M., Ansell, I., Hjelle, J. T., Ross, J. A., Miller-Hjelle, M. A., Dobbie, J. D. et al. (1998). Sphingosine and sphinganine levels in human mesothelial cells in vitro as a potential index of signal transduction pathways impacted by microbes and osmolality. Adv.Perit.Dial., 14, 158-163.

   11.    Peterson, S. W., Corneli, S., Hjelle, J. T., Miller-Hjelle, M. A., Nowak, D. M., & Bonneau, P. A. (1999). Penicillium pimiteouiense: a new species isolated from polycystic kidney cell cultures. Mycologia, 91, 269-277.

MISRA,S.


     1.    Misra, S. (2004). Esophagitis. In R.D.Feigin (Ed.), Textbook of Pediatric Infectious Diseases (5th ed., pp. 605-609). Philadelphia: Saunders.

     2.    Misra, S., Lee, A., & Ginsel, K. (2004). P1061 Overweight and Obestiy Risk Factors for Functional Constipation in Children. Journal of Pedicatric Gastroenterology and Nutrition, 39, 460-461.

     3.    Misra, S., Lee, A., & Gensel, K. (2006). Chronic constipation in overweight children. JPEN J Parenter.Enteral Nutr., 30, 81-84.

     4.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

MOHANAM,S.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Adachi, Y., Chandrasekar, N., Kin, Y., Lakka, S. S., Mohanam, S., Yanamandra, N. et al. (2002). Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene, 21, 87-95.

     3.    Chandrasekar, N., Jasti, S. L., Alfred-Yung, W. K., Ali-Osman, F., Dinh, D. H., Olivero, W. C. et al. (2000). Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin.Exp.Metastasis, 18, 337-342.

     4.    Chandrasekar, N., Mohanam, S., Gujrati, M., Olivero, W. C., Dinh, D. H., & Rao, J. S. (2003). Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene, 22, 392-400.

     5.    Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Glial Cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin.Cancer Res., 9, 2342-2349.

     6.    Jadhav, U., Chigurupati, S., Lakka, S. S., & Mohanam, S. (2004). Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. International Journal of Oncology, 25, 1407-1414.

     7.    Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20, 6938-6945.

     8.    Lakka, S. S., Konduri, S. D., Mohanam, S., Nicolson, G. L., & Rao, J. S. (2000). In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clinical & Experimental Metastasis, 18, 239-244.

     9.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Kin, Y., Fuller, G. N. et al. (2001). Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin.Cancer Res., 7, 2519-2526.

   10.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Lakka, S. S., Kin, Y. et al. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 20, 3665-3673.

   11.    Mohanam, S., Chandrasekar, N., Yanamandra, N., Siddique, K., Mirza, F., Dinh, D. H. et al. (2002). Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene, 21, 7824-7829.

   12.    Mohanam, S. & Rao, J. S. (2004). Role of urokinase-type plasminogen activator receptor in human glioma invasion. CONTEMPORARY CANCER RESEARCH, 237-247.

   13.    Rao, C. N., Lakka, S. S., Kin, Y., Konduri, S. D., Fuller, G. N., Mohanam, S. et al. (2001). Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clinical Cancer Research, 7, 570-576.

   14.    Yanamandra, N., Konduri, S. D., Mohanam, S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2000). Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clin.Exp.Metastasis, 18, 611-615.

   15.    Yanamandra, N., Gumidyala, K. V., Waldron, K. G., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene, 23, 2224-2230.

MORGAN,A.M.


     1.    Adesman, A. R. & Morgan, A. M. (1999). Management of stimulant medications in children with attention- deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 945-963, vii-viii.

     2.    Hanigan, W. C., Morgan, A. M., Stahlberg, L. K., & Hiller, J. L. (1990). Tentorial hemorrhage associated with vacuum extraction. Pediatrics, 85, 534-539.

     3.    Hanigan, W. C., Morgan, A. M., Anderson, R. J., Bradle, P., Cohen, H. S., Cusack, T. J. et al. (1991). Incidence and neurodevelopmental outcome of periventricular hemorrhage and hydrocephalus in a regional population of very low birth weight infants. Neurosurgery, 29, 701-706.

     4.    Hanigan, W. C., Morgan, A. M., Shaaban, A., & Bradle, P. (1991). Surgical treatment and long-term neurodevelopmental outcome for infants with idiopathic aqueductal stenosis. Childs.Nerv.Syst., 7, 386-390.

     5.    Hokanson, J. S. & Morgan, A. M. (1999). Adults with tetralogy of Fallot: long-term follow-up. Cardiology in Review, 7, 149-155.

     6.    Morgan, A. M. & Aldag, J. C. (1996). Early identification of cerebral palsy using a profile of abnormal motor patterns [see comments]. Pediatrics, 98, 692-697.

     7.    Morgan, A. M. (1999). Diagnosis of attention-deficit/hyperactivity disorder in the office. Pediatr.Clin.North Am., 46, 871-84, vi.

     8.    Morgan, A. M. (1999). Attention-deficit/hyperactivity disorder - Preface. Pediatric Clinics of North America, 46, XI-XII.

MUELLER,D.K.


     1.    Hoy, F. B. Y., Mueller, D. K., Geiss, D. M., Munns, J. R., Bond, L. M., Linett, C. E. et al. (2000). Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? The Annals of Thoracic Surgery, 70, 1259-1263.

     2.    Mueller, D. K., Whitten, P. E., Tillis, W. P., Bond, L. M., & Munns, J. R. (2002). Delayed closure of persistent postpneumonectomy bronchopleural fistula. Chest, 121, 1703-1704.

     3.    Mueller, D. K., Becker, J., Schell, S. K., Karamchandani, K. M., Munns, J. R., & Jaquet, B. (2004). An alternative method of neck flexion after tracheal resection. The Annals of Thoracic Surgery, 78, 720-721.

     4.    Tisol, W. B., Mueller, D. K., Hoy, F. B. Y., Gomez, R. C., Clemson, B. S., & Hussain, S. M. (2001). Ventricular assist device use with mechanical heart valves: an outcome series and literature review. The Annals of Thoracic Surgery, 72, 2051-2054.

MUNNS,J.R.


     1.    Hoy, F. B. Y., Mueller, D. K., Geiss, D. M., Munns, J. R., Bond, L. M., Linett, C. E. et al. (2000). Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? The Annals of Thoracic Surgery, 70, 1259-1263.

     2.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     3.    Mueller, D. K., Whitten, P. E., Tillis, W. P., Bond, L. M., & Munns, J. R. (2002). Delayed closure of persistent postpneumonectomy bronchopleural fistula. Chest, 121, 1703-1704.

     4.    Mueller, D. K., Becker, J., Schell, S. K., Karamchandani, K. M., Munns, J. R., & Jaquet, B. (2004). An alternative method of neck flexion after tracheal resection. The Annals of Thoracic Surgery, 78, 720-721.

NATTIER,B.


     1.    Whitty, L. A., Crawford, D. L., Woodland, J. H., Patel, J. C., Nattier, B., & Thomas, C. R., Jr. (2005). Metastatic breast cancer presenting as linitis plastica of the stomach. Gastric Cancer, 8, 193-197.

NAYAK,A.S.


     1.    Berger, W. E., Nayak, A. S., & Staudinger, H. W. (2005). Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis. Annals of Pharmacotherapy, 39, 1984-1989.

     2.    Meltzer, E. O., Prenner, B. M., & Nayak, A. S. (2000). Efficacy and tolerability of once-daily 5mg desloratadine, an H-1-receptor antagonist, in patients with seasonal allergic rhinitis - Assessment during the spring and fall allergy seasons. Desloratadine Study Grp, 21, 25-32.

     3.    Milgrom, H., Berger, W. E., Nayak, A. S., Gupta, N., Pollard, S., McAlary, M. et al. (2001). Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics, 108, E36.

     4.    Nayak, A. S. & Schenkel, E. (2001). Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy, 56, 1077-1080.

     5.    Nayak, A. S., Lanier, R., Weinstein, S., Stampone, P., & Welch, M. H. (2002). Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma - A 12-week, randomized, double-blind, placebo-controlled study. Chest, 122, 1956-1965.

     6.    Nayak, A. S. (2002). A common pathway: asthma and allergic rhinitis. Allergy Asthma Proceedings, 23, 359-365.

     7.    Nayak, A. S. (2003). The asthma and allergic rhinitis link. Allergy Asthma Proc., 24, 395-402.

     8.    Nayak, A. S. (2004). A review of montelukast in the treatment of asthma and allergic rhinitis. Expert.Opin.Pharmacother., 5, 679-686.

     9.    Philip, G., Nayak, A. S., Berger, W. E., Leynadier, F., Vrijens, F., Dass, S. B. et al. (2004). The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Current medical research and opinion, 20, 1549-1558.

   10.    Philip, G., Nayak, A. S., Berger, W. E., Leynadier, F., Vrijens, F., Dass, S. B. et al. (2005). The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Allergologie, 28, 343.

NIXON,J.B.


     1.    Nixon, J. B., Burdick, J. S., & Mirza, A. H. (1995). Premalignant changes in ulcerative colitis. Seminars in Surgical Oncology, 11, 386-393.

NOVOTNY,N.


     1.    Daniels, C. L., Lindborg, L. A., Rusch, S., Frederick, R., Aldag, J. C., & Novotny, N. (2000). Influence of Physician Training Level on Patients with Low-risk Pneumonia in the ED. Academic Emergency Medicine 7[5], 453.
Ref Type: Abstract

     2.    Lindborg, L. A., Rusch, S., Daniels, C. L., Frederick, R. C., Novotny, N., & Aldag, J. C. (2000). Characteristics influencing discharge disposition for low risk community acquired pneumonia patients from the emergency department. Academic Emergency Medicine 7[5], 580.
Ref Type: Abstract

OLIVERO,W.C.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Adachi, Y., Chandrasekar, N., Kin, Y., Lakka, S. S., Mohanam, S., Yanamandra, N. et al. (2002). Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene, 21, 87-95.

     3.    Chandrasekar, N., Jasti, S. L., Alfred-Yung, W. K., Ali-Osman, F., Dinh, D. H., Olivero, W. C. et al. (2000). Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin.Exp.Metastasis, 18, 337-342.

     4.    Chandrasekar, N., Mohanam, S., Gujrati, M., Olivero, W. C., Dinh, D. H., & Rao, J. S. (2003). Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene, 22, 392-400.

     5.    Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Glial Cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin.Cancer Res., 9, 2342-2349.

     6.    Crawford, T. S., Olivero, W. C., & Hanigan, W. C. (2000). The Prognosis of Children with Hydrocephalus and Congenital Heart Disease. Pediatr.Neurosurg., 33, 12-15.

     7.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C. et al. (2003). Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene, 22, 5967-5975.

     8.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res., 64, 4069-4077.

     9.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23, 8486-8496.

   10.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). Inhibition of glioma cell invasion, angiogenesis, and tumor growth in both in vivo and in vitro models by downregulation of uPAR, uPA, and MMP-9 by using small interfering hairpin RNA (siRNA) driven by a CMV promoter. Neuro-oncology, 6, 309-310.

   11.    Gondi, C. S., Kandhukuri, N., Kondraganti, S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2006). Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int.J Oncol., 28, 633-639.

   12.    Kondraganti, S., Gondi, C. S., McCutcheon, I., Dinh, D. H., Gujrati, M., Rao, J. S. et al. (2006). RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int.J.Oncol., 28, 1353-1360.

   13.    Kondraganti, S., Gondi, C. S., Gujrati, M., McCutcheon, I., Dinh, D. H., Rao, J. S. et al. (2006). Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int.J.Oncol., 29, 25-32.

   14.    Konduri, S. D., Lakka, S. S., Tasiou, A., Yanamandra, N., Gondi, C. S., Dinh, D. H. et al. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology, 19, 519-524.

   15.    Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20, 6938-6945.

   16.    Konduri, S. D., Osman, F. A., Rao, C. N., Srinivas, H., Yanamandra, N., Tasiou, A. et al. (2002). Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas. Oncogene, 21, 921-928.

   17.    Konduri, S. D., Yanamandra, N., Siddique, K., Joseph, A., Dinh, D. H., Olivero, W. C. et al. (2002). Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 21, 8705-8712.

   18.    Konduri, S. D., Srivenugopal, K. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells. Oncogene, 22 , 4509-4516.

   19.    Kraus, R. R., Hanigan, W. C., Kattah, J. C., & Olivero, W. C. (2003). Changes in visual acuity associated with shunt failure. Childs.Nerv.Syst., 19, 226-231.

   20.    Krishnamoorthy, B., Darnay, B., Aggarwal, B., Dinh, D. H., Kouraklis, G., Olivero, W. C. et al. (2001). Glioma cells deficient in urokinase plasminogen activator receptor expression are susceptible to tumor necrosis factor-a-related apoptosis-inducing ligand-induced apoptosis. Clin.Cancer Res., 7, 4195-4201.

   21.    Kurth, S. M., Kurylo, M. F., Xu, M. Y., Patton, K. J., Mcvey, K. M., Rodde, M. et al. (2005). A paradigm for investigating memory localization using fMRI. Epilepsia, 46, 263.

   22.    Lakka, S. S., Rajagopal, R., Rajan, M. K., Mohan, P. M., Adachi, Y., Dinh, D. H. et al. (2001). Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research, 7, 1087-1093.

   23.    Lakka, S. S., Rajan, M. K., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L. et al. (2002). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene, 21, 8011-8019.

   24.    Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23, 4681-4689.

   25.    Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H. et al. (2005). Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. Journal of Biological Chemistry.

   26.    Lin, J., Olivero, W. C., & McCluney, K. W. (1999). Acute hydrocephalus following lateral C1-2 puncture - Case illustration. J.Neurosurg., 90, S277.

   27.    Lin, J., Nauta, H. J. W., & Olivero, W. C. (2001). Anatomical relationships between Sylvian fissure and the sphenoid ridge. Neurological Research, 23, 645-646.

   28.    Lin, J., Morris, M., Olivero, W. C., Boop, F., & Sanford, R. A. (2003). Computational and experimental study of proximal flow in ventricular catheters. Technical note. J Neurosurg., 99, 426-431.

   29.    Medlock, M. D., Olivero, W. C., Hanigan, W. C., Wright, R. M., & Winek, S. J. (1992). Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery, 31, 870-6; discussion 876.

   30.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Kin, Y., Fuller, G. N. et al. (2001). Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin.Cancer Res., 7, 2519-2526.

   31.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Lakka, S. S., Kin, Y. et al. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 20, 3665-3673.

   32.    Mohanam, S., Chandrasekar, N., Yanamandra, N., Siddique, K., Mirza, F., Dinh, D. H. et al. (2002). Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene, 21, 7824-7829.

   33.    Olivero, W. C. & Asner, N. G. (1992). Occlusion of the sagittal sinus in craniectomized rabbits. Childs.Nerv.Syst., 8, 307-309.

   34.    Olivero, W. C. & Dinh, D. H. (1992). Chiari I malformation with traumatic syringomyelia and spontaneous resolution: case report and literature review. Neurosurgery, 30, 758-760.

   35.    Olivero, W. C., Hanigan, W. C., & McCluney, K. W. (1993). Angiographic demonstration of a spinal epidural arteriovenous malformation. Case report. J.Neurosurg., 79, 119-120.

   36.    Olivero, W. C. (1993). A unique presentation of nontraumatic atlantoaxial instability: a case report. Childs.Nerv.Syst., 9, 117-118.

   37.    Olivero, W. C., Lister, J. R., & Elwood, P. W. (1995). The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J.Neurosurg., 83, 222-224.

   38.    Olivero, W. C., Dulebohn, S. C., & Lister, J. R. (1995). The use of PET in evaluating patients with primary brain tumours: is it useful? J.Neurol.Neurosurg.Psychiatry, 58, 250-252.

   39.    Olivero, W. C. (1996). Radiculopathy versus referred pain in diskography. American Journal of Neuroradiology, 17, 1195-1197.

   40.    Olivero, W. C. (1996). Growth of meningiomas - response. J.Neurosurg., 84, 150.

   41.    Olivero, W. C., Deshmukh, P., & Gujrati, M. (1999). Bilateral enhancing thalamic lesions in a 10 year old boy: case report. J Neurol Neurosurg Psychiatry, 66, 633-635.

   42.    Olivero, W. C. (1999). Pathogenesis of Syringomyelia. American Journal of Neuroradiology, 20, 2024-2025.

   43.    Olivero, W. C., Deshmukh, P., & Gujrati, M. (2000). Radiation-induced cavernous angioma mimicking metastatic disease. British Journal of Neurosurgery, 14, 575-578.

   44.    Olivero, W. C. (2000). Neurosurgical Trauma and Cervical Spine Injuries. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 224-226).

   45.    Olivero, W. C. & Dulebohn, S. C. (2002). Results of halter cervical traction for the treatment of cervical radiculopathy: retrospective review of 81 patients. Neurosurg Focus., 12, ECP1.

   46.    Powell, F. C., Hanigan, W. C., & Olivero, W. C. (1993). A risk/benefit analysis of spinal manipulation therapy for relief of lumbar or cervical pain [see comments]. Neurosurgery, 33, 73-8; discussion 78-9.

   47.    Rao, J. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., & Gujrati, M. (2006). RNAi-mediated downregulation of proteases and uPAR in xenograft glioma cells inhibits invasion angiogenesis and tumor growth. Journal of Neurochemistry, 96, 72.

   48.    Rust, M. S. & Olivero, W. C. (1999). Far-lateral disc herniations: the results of conservative management. Journal of Spinal Disorders, 12, 138-140.

   49.    Siddique, K., Yanamandra, N., Gujrati, M., Dinh, D. H., Rao, J. S., & Olivero, W. C. (2003). Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. Int.J.Oncol., 22, 289-294.

   50.    Tasiou, A., Konduri, S. D., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2001). A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Int.J.Oncol., 19, 591-597.

   51.    Wang, H., Olivero, W. C., Lanzino, G., Elkins, W., Rose, J. A., Honings, D. et al. (2004). Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg., 100, 272-277.

   52.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent: a brief historical overview. Acta Neurochir.(Wien.)., ..

   53.    Wang, H., Wang, D., Lanzino, G., Elkins, W., & Olivero, W. C. (2006). Differential interhemispheric cooling and ICP compartmentalization in a patient with left ICA occlusion. Acta Neurochir.(Wien.)., ..

   54.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent. Acta Neurochirurgica, 148, 565-570.

   55.    Xu, M. Y., Kurylo, M. F., Kurth, S. M., Mcvey, K. M., Patton, K. J., Rodde, M. et al. (2005). Functional MRI presugical memory function assessment in intractable epilepsy. Epilepsia, 46, 48.

   56.    Yanamandra, N., Konduri, S. D., Mohanam, S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2000). Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clin.Exp.Metastasis, 18, 611-615.

   57.    Yanamandra, N., Berhow, M. A., Konduri, S. D., Dinh, D. H., Olivero, W. C., Nicolson, G. L. et al. (2003). Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells. Clinical & Experimental Metastasis, 20, 375-383.

   58.    Yanamandra, N., Kondraganti, S., Srinivasula, S. M., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells. Oncogene, ..

   59.    Yanamandra, N., Gumidyala, K. V., Waldron, K. G., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene, 23, 2224-2230.

   60.    Yanamandra, N., Kondraganti, S., Gondi, C. S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2005). Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer, 115, 998-1005.

OLSSON,P.J.


     1.    Hjelle, J. T., Waters, D. C., Golinska, B. T., Steidley, K. R., Burmeister, V., Caughey, R. C. et al. (1990). Autosomal recessive polycystic kidney disease: characterization of human peritoneal and cystic kidney cells in vitro. Am.J.Kidney Dis., 15, 123-136.

     2.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1992). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 8, 30-32.

     3.    Hjelle, J. T., Welch, M. H., Pavlina, T. M., Webb, L. E., Mockler, D. F., Miller, M. A. et al. (1993). Choline levels in human peritoneal dialysate. Adv.Perit.Dial., 9, 299-302.

PALAGALLO,G.L.


     1.    Hanigan, W. C., Powell, F. C., Palagallo, G. L., & Miller, T. C. (1995). Lobar hemorrhages in full-term neonates. Childs.Nerv.Syst., 11, 276-280.

     2.    Mclean, J. M., Palagallo, G. L., Henderson, J. P., & Kimm, J. A. (1995). Myelopathy associated with fibrocartilaginous emboli (FE): review and two suspected cases. Surg.Neurol., 44, 228-235.

PALMER,R.E.


     1.    Palmer, R. E. (1994). Sports injuries of the hand. Instr.Course.Lect., 43, 25-30.

     2.    Palmer, R. E. (1998). Joint injuries of the hand in athletes. Clinics in Sports Medicine, 17, 513-531.

PARISI,A.


     1.    Sandlow, L. J., Fulkerson, P., & Parisi, A. (2001). University of Illinois College of Medicine at Chicago, Rockford, Peoria, and Urbana-Champaign. Academic Medicine, 75, s99-103.

PATEL,G.N.


     1.    Patel, G. N., Braastad, F. E., & DeBord, J. R. (2000). Cystic adventitial disease of the popliteal artery: An illustrative case and literature review. Vascular Surgery, 34, 259-263.

PAULSEN,J.K.


     1.    Joo, J. B., DeBord, J. R., Montgomery, C. E., Munns, J. R., Marshall, J. S., Paulsen, J. K. et al. (2001). Perioperative factors as predictors of operative mortality and morbidity in pneumonectomy. American Surgeon, 67, 318-321.

     2.    Reitter, D. R., Paulsen, J. K., DeBord, J. R., & Estes, N. C. (2000). Five-year experience with the "four-before" laparoscopic ventral hernia repair. The American Surgeon, 66, 465-468; discussion 468-9.

PEARL,R.H.


     1.    Abrahams, N. A., Colby, T. V., Pearl, R. H., Chipps, B. E., Juris, A. L., & Leslie, K. O. (2002). Pulmonary hemangiomas of infancy and childhood: Report of two cases and review of the literature. Pediatric.& Developmental.Pathology., 5, 283-292.

     2.    Densmore, J. C., Pierce, B. R., Winek, R. R., Mitchell, D. S., & Pearl, R. H. (2000). Case report of a newborn with a posterior thoracic midline congenital hemangiopericytoma of the back. J Pediatr.Surg., 35, 1120-1122.

     3.    Diefenbach, K. & Pearl, R. H. (2000). Shock. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 5-8). Hanley & Belfus.

     4.    Glick, R. P., Pearl, R. H., Irish, M. S., & Caty, M. G. (2000). Pediatric Surgery Secrets : Questions you will be asked. Philadelphia: Hanley & Belfus, Inc.

     5.    Hackam, D. J., Kreller, M., & Pearl, R. H. (1999). Snow-related recreational injuries in children: Assessment of morbidity and management strategies. J.Pediatr.Surg., 34, 65-68.

     6.    Hackam, D. J. & Pearl, R. H. (2000). Disorders of Colonic Motility. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 152-155).

     7.    Hackam, D. J., Mazzioti, M. V., Pearl, R. H., Mazziotti, G. M., Winthrop, A. L., & Langer, J. C. (2004). Mechanisms of pediatric trauma deaths in Canada and the United States: The role of firearms. Journal of Trauma-Injury Infection and Critical Care, 56, 1286-1290.

     8.    Johnson, C. A., Azarow, K. S., & Pearl, R. H. (2000). Trauma - General Approach. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 221-223).

     9.    Joo, J. B. & Pearl, R. H. (2000). Spleen. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 175-178).

   10.    McDonald, J. M., Azarow, K. S., & Pearl, R. H. (2000). Gastroesophageal Reflux Disease. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 36-39).

   11.    McGuigan, R. M., Mullenix, P. S., Vegunta, R. K., Pearl, R. H., Sawin, R., & Azarow, K. S. (2006). Splanchnic perfusion pressure: a better predictor of safe primary closure than intraabdominal pressure in neonatal gastroschisis. Journal of pediatric surgery, 41, 901-904.

   12.    Pearl, R. H., Irish, M. S., Caty, M. G., & Glick, P. (1998). The approach to common abdominal diagnoses in infants and children Part II. Pediatric Clinics of North America, 45, 1287-+.

   13.    Pearl, R. H. (2000). Snow-related recreational injuries in children: Assessment of morbidity and mangagement strategies - author's response. J.Pediatr.Surg., 35, 1410.

   14.    Pearl, R. H. (2000). Malrotation and Midgut Bolbulus. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 123-126).

   15.    Pearl, R. H. (2000). Abdominal Trauma. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 230-233).

   16.    Tisol, W. B. & Pearl, R. H. (2000). Meckel's Diverticulum. In Pediatric Surgery Secrets (pp. 142-143).

   17.    Torres, A., DiLiberti, J. H., Pearl, R. H., Wohrley, J. D., Raff, G. W., Bysani, G. K. et al. (2002). Noncardiac surgery in children with hypoplastic left heart syndrome. J Pediatr.Surg., 37, 1399-1403.

   18.    Vegunta, R. K., Ali, A., Wallace, L. J., Switzer, D. M., & Pearl, R. H. (2004). Laparoscopic appendectomy in children: technically feasible and safe in all stages of acute appendicitis. Am Surg., 70, 198-201.

   19.    Vegunta, R. K., Loethen, P., Wallace, L. J., Albert, V. L., & Pearl, R. H. (2005). Differences in the outcome of surgically placed long-term central venous catheters in neonates: neck vs groin placement. Journal of pediatric surgery, 40, 47-51.

   20.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

   21.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

PFLEDERER,B.R.


     1.    Pflederer, B. R., Torrey, C., Priester-Coary, A., Lau, A. H., & Daugirdas, J. T. (1995). Estimating equilibrated KT/V from an intradialytic sample - effects of access and cardiopulmonary recirculations. Kidney International, 48, 832-837.

PULUKURI,S.M.


     1.    Pulukuri, S. M. & Rao, J. S. (2005). Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. International Journal of Oncology, 26, 863-871.

     2.    Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol.Chem., 280, 36529-36540.

     3.    Pulukuri, S. M. & Rao, J. S. (2006). CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene., %19;..

PYLE,J.W.


     1.    Pyle, J. W., Ash, J. L., Hussain, S. M., Reid, N., & Anderson, R. C. (2005). Sternal resection and reconstruction after renal cell carcinoma metastatic to the sternum. The Journal of thoracic and cardiovascular surgery, 129, 1177-1178.

RAO,J.S.


     1.    Adachi, Y., Lakka, S. S., Chandrasekar, N., Yanamandra, N., Gondi, C. S., Mohanam, S. et al. (2001). Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J.Biol.Chem., 276, 47171-47177.

     2.    Adachi, Y., Chandrasekar, N., Kin, Y., Lakka, S. S., Mohanam, S., Yanamandra, N. et al. (2002). Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene, 21, 87-95.

     3.    Chandrasekar, N., Jasti, S. L., Alfred-Yung, W. K., Ali-Osman, F., Dinh, D. H., Olivero, W. C. et al. (2000). Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin.Exp.Metastasis, 18, 337-342.

     4.    Chandrasekar, N., Mohanam, S., Gujrati, M., Olivero, W. C., Dinh, D. H., & Rao, J. S. (2003). Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene, 22, 392-400.

     5.    Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Glial Cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin.Cancer Res., 9, 2342-2349.

     6.    Chetty, C., Bhoopathi, P., Joseph, P., Chittivelu, S., Rao, J. S., & Lakka, S. (2006). Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. mol.cancer ther., 5, 2289-2299.

     7.    Dasari, V. R., Spomar, D. G., Li, L., Cady, C., Gujrati, M., Rao, J. S. et al. (2006). Human cord blood stem cells exhibit neural phenotypes and ameliorate caspase-3 pathway proteins after traumatic SCI in rats. Journal of Neurochemistry, 96, 52.

     8.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C. et al. (2003). Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene, 22, 5967-5975.

     9.    Gondi, C. S., Lakka, S. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res., 64, 4069-4077.

   10.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23, 8486-8496.

   11.    Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). Inhibition of glioma cell invasion, angiogenesis, and tumor growth in both in vivo and in vitro models by downregulation of uPAR, uPA, and MMP-9 by using small interfering hairpin RNA (siRNA) driven by a CMV promoter. Neuro-oncology, 6, 309-310.

   12.    Gondi, C. S., Kandhukuri, N., Kondraganti, S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2006). Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int.J Oncol., 28, 633-639.

   13.    Gruss, C. J., Satyamoorthy, K., Berking, C., Lininger, J., Nesbit, M., Schaider, H. et al. (2003). Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J.Invest Dermatol., 120, 683-692.

   14.    Hormigo, A., Gu, B., Karimi, S., Riedel, E., Panageas, K. S., Edgar, M. A. et al. (2006). YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas. Clin.Cancer Res., 12, 5698-5704.

   15.    Kargiotis, O., Rao, J. S., & Kyritsis, A. P. (2006). Mechanisms of angiogenesis in gliomas. Journal of neuro-oncology, 78, 281-293.

   16.    Kondraganti, S., Gondi, C. S., McCutcheon, I., Dinh, D. H., Gujrati, M., Rao, J. S. et al. (2006). RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int.J.Oncol., 28, 1353-1360.

   17.    Kondraganti, S., Gondi, C. S., Gujrati, M., McCutcheon, I., Dinh, D. H., Rao, J. S. et al. (2006). Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int.J.Oncol., 29, 25-32.

   18.    Konduri, S. D., Tasiou, A., Chandrasekar, N., Nicolson, G. L., & Rao, J. S. (2000). Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion. Clinical & Experimental Metastasis, 18, 303-308.

   19.    Konduri, S. D., Lakka, S. S., Tasiou, A., Yanamandra, N., Gondi, C. S., Dinh, D. H. et al. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology, 19, 519-524.

   20.    Konduri, S. D., Rao, C. N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene, 20, 6938-6945.

   21.    Konduri, S. D., Osman, F. A., Rao, C. N., Srinivas, H., Yanamandra, N., Tasiou, A. et al. (2002). Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas. Oncogene, 21, 921-928.

   22.    Konduri, S. D., Yanamandra, N., Siddique, K., Joseph, A., Dinh, D. H., Olivero, W. C. et al. (2002). Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 21, 8705-8712.

   23.    Konduri, S. D., Srivenugopal, K. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2003). Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells. Oncogene, 22 , 4509-4516.

   24.    Krishnamoorthy, B., Darnay, B., Aggarwal, B., Dinh, D. H., Kouraklis, G., Olivero, W. C. et al. (2001). Glioma cells deficient in urokinase plasminogen activator receptor expression are susceptible to tumor necrosis factor-a-related apoptosis-inducing ligand-induced apoptosis. Clin.Cancer Res., 7, 4195-4201.

   25.    Lakka, S. S., Konduri, S. D., Mohanam, S., Nicolson, G. L., & Rao, J. S. (2000). In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clinical & Experimental Metastasis, 18, 239-244.

   26.    Lakka, S. S., Jasti, S. L., Kyritsis, A. P., Yung, W. K. A., Ali-Osman, F., Nicolson, G. L. et al. (2000). Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clinical & Experimental Metastasis, 18, 245-252.

   27.    Lakka, S. S., Rajagopal, R., Rajan, M. K., Mohan, P. M., Adachi, Y., Dinh, D. H. et al. (2001). Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research, 7, 1087-1093.

   28.    Lakka, S. S., Rajan, M. K., Gondi, C. S., Yanamandra, N., Chandrasekar, N., Jasti, S. L. et al. (2002). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene, 21, 8011-8019.

   29.    Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M. et al. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23, 4681-4689.

   30.    Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H. et al. (2005). Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. Journal of Biological Chemistry.

   31.    Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005). Proteases and glioma angiogenesis. Brain Pathology, 15, 327-341.

   32.    Mitlianga, P. G., Sioka, C., Vartholomatos, G., Goussia, A., Polyzoidis, K., Rao, J. S. et al. (2006). P53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect. Oncology Reports, 15, 149-153.

   33.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Kin, Y., Fuller, G. N. et al. (2001). Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin.Cancer Res., 7, 2519-2526.

   34.    Mohanam, S., Jasti, S. L., Kondraganti, S., Chandrasekar, N., Lakka, S. S., Kin, Y. et al. (2001). Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 20, 3665-3673.

   35.    Mohanam, S., Chandrasekar, N., Yanamandra, N., Siddique, K., Mirza, F., Dinh, D. H. et al. (2002). Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene, 21, 7824-7829.

   36.    Mohanam, S. & Rao, J. S. (2004). Role of urokinase-type plasminogen activator receptor in human glioma invasion. CONTEMPORARY CANCER RESEARCH, 237-247.

   37.    Muralikrishna, P. S., Gondi, C. S., Lakka, S. S., Julta, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival and tumorigenicity in vivo. Journal of Biological Chemistry.

   38.    Nirmala, C., Rao, J. S., Ruifrok, A. C., Langford, L. A., & Obeyesekere, M. (2001). Growth characteristics of glioblastoma spheroids. International.Journal of Oncology., 19, 1109-1115.

   39.    Pulukuri, S. M. & Rao, J. S. (2005). Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. International Journal of Oncology, 26, 863-871.

   40.    Pulukuri, S. M., Gondi, C. S., Lakka, S. S., Jutla, A., Estes, N. C., Gujrati, M. et al. (2005). RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol.Chem., 280, 36529-36540.

   41.    Pulukuri, S. M. & Rao, J. S. (2006). CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene., %19;..

   42.    Rao, C. N., Lakka, S. S., Kin, Y., Konduri, S. D., Fuller, G. N., Mohanam, S. et al. (2001). Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clinical Cancer Research, 7, 570-576.

   43.    Rao, J. S. (2003). Molecular mechanisms of glioma invasiveness: the role of proteases. Nat.Rev.Cancer, 3, 489-501.

   44.    Rao, J. S., Gondi, C. S., Chetty, C., Chittivelu, S., Joseph, P. A., & Lakka, S. S. (2005). Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. mol.cancer ther., 4, 1399-1408.

   45.    Rao, J. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., & Gujrati, M. (2006). RNAi-mediated downregulation of proteases and uPAR in xenograft glioma cells inhibits invasion angiogenesis and tumor growth. Journal of Neurochemistry, 96, 72.

   46.    Siddique, K., Yanamandra, N., Gujrati, M., Dinh, D. H., Rao, J. S., & Olivero, W. C. (2003). Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. Int.J.Oncol., 22, 289-294.

   47.    Subramanian, R., Gondi, C. S., Lakka, S. S., Jutla, A., & Rao, J. S. (2006). siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int.J Oncol., 28, 831-839.

   48.    Tasiou, A., Konduri, S. D., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2001). A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Int.J.Oncol., 19, 591-597.

   49.    Yanamandra, N., Konduri, S. D., Mohanam, S., Dinh, D. H., Olivero, W. C., Gujrati, M. et al. (2000). Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clin.Exp.Metastasis, 18, 611-615.

   50.    Yanamandra, N., Berhow, M. A., Konduri, S. D., Dinh, D. H., Olivero, W. C., Nicolson, G. L. et al. (2003). Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells. Clinical & Experimental Metastasis, 20, 375-383.

   51.    Yanamandra, N., Kondraganti, S., Srinivasula, S. M., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells. Oncogene, ..

   52.    Yanamandra, N., Gumidyala, K. V., Waldron, K. G., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2004). Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene, 23, 2224-2230.

   53.    Yanamandra, N., Kondraganti, S., Gondi, C. S., Gujrati, M., Olivero, W. C., Dinh, D. H. et al. (2005). Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer, 115, 998-1005.

RASO,M.


     1.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

RAWLINGS,K.K.


     1.    Yunus, M. B., Khan, M. A., Rawlings, K. K., Green, J. R., Olson, J. M., & Shah, S. (1999). Genetic linkage analysis of multicase families with fibromyalgia syndrome. Journal of Rheumatology, 26, 408-412.

REID,C.A.


     1.    Reid, C. A. (2000). Genitourinary Trauma. In P.Glick & R. H. Pearl (Eds.), Pediatric Surgery Secrets (pp. 234-237).

RENFROE,Y.


     1.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

ROSSI,T.R.


     1.    Estes, N. C., Conlee, L. S., bord-Smith, A., Smith, E., Whittaker, L. D., Jr., & Rossi, T. R. (2004). The value of using naive observers to assess resident ACGME competencies. Current surgery, 61, 629-635.

     2.    Marshall, J. S., Srivastava, A., Gupta, S. K., Rossi, T. R., & DeBord, J. R. (2003). Roux-en-Y gastric bypass leak complications. Archives of Surgery, 138, 520-523.

     3.    Rossi, T. R., Dynda, D. I., Estes, N. C., & Marshall, J. S. (2005). Stricture dilation 1820after laparoscopic Roux-en-Y gastric bypass. American Journal of Surgery, 189, 357-360.

ROWE,L.P.


     1.    Baker, T. R., Paterson, B. G., & Rowe, L. P. (2005). Judicial complaint resolution models for higher education: an administrator's reference guide. Horsham,PA.: LRP Publications.

     2.    Birkel, L., Bollin, R., Doyle, P., Hickey, T., Long, H., & Rowe, L. P. (2003). Mental health services in the Peoria Area : Research report prepared for the Peoria, IL Area Chamber of Commerce Community Leadership School.

     3.    Rowe, L. P. (2003). The View from Harvard Square? 3.
Ref Type: Generic

     4.    Rowe, L. P. (2004). Academic integrity begins with students' beliefs. Campus Safety and Student Development, 5, 61-64-49-50 (editorial).

     5.    Rowe, L. P. (2004). Framing Education with Justice: A Model for Implementing Judicial Sanctions. Campus Safety and Student Development, 5, 3-6.

     6.    Rowe, L. P. (2004). Doctor-patient communication provides clues to effective communication in the campus conduct process. Campus Safety and Student Development, 6.

     7.    Rowe, L. P. (2005). What judicial officers need to know about the HIPAA Privacy Rule. NASPA Journal, 42.

     8.    Rowe, L. P. (2005). What judicial officers need to know about the HIPAA Privacy Rule (reprinted). Campus Safety and Student Development, 7.

     9.    Rowe, L. P. (2005). Eight suicide prevention tips. Campus Safety and Student Development, 7.

   10.    Rowe, L. P. (2005). "HELP" in interpreting FERPA may be coming to a legislature near you. Chronicle of Campus Conduct, 1.

   11.    Rowe, L. P. (2005). FIRE's Guide to Free Speech on Campus is useful if flawed. Campus Safety and Student Development, 6.

   12.    Rowe, L. P. (2005). Trust is important but fragile in discipline programs. Campus Safety and Student Development, 6.

   13.    Rowe, L. P. (2006). Understanding the college student brain. Campus Safety and Student Development, 7.

   14.    Rowe, L. P. (2006). Understanding the college student brain (reprint). Chronicle of Campus Conduct, 2.

   15.    Rowe, L. P. (2006). When the other judicial system can't be ignored: what to do when students face criminal charges. Campus Safety and Student Development, 5.

   16.    Rowe, L. P. (2006). Best practice or bandwagon? Knowing the difference can preserve institution's distintiveness. Campus Safety and Student Development.

   17.    Sokolow, B. A. & Rowe, L. P. (2005). Mission impossible: can colleges protect and promote freedom of expression while protecting and promoting civility and freedom from harassment? Campus Safety and Student Development, 6.

RUSCH,S.


     1.    Daniels, C. L., Lindborg, L. A., Rusch, S., Frederick, R., Aldag, J. C., & Novotny, N. (2000). Influence of Physician Training Level on Patients with Low-risk Pneumonia in the ED. Academic Emergency Medicine 7[5], 453.
Ref Type: Abstract

     2.    Lindborg, L. A., Rusch, S., Daniels, C. L., Frederick, R. C., Novotny, N., & Aldag, J. C. (2000). Characteristics influencing discharge disposition for low risk community acquired pneumonia patients from the emergency department. Academic Emergency Medicine 7[5], 580.
Ref Type: Abstract

SAUDER,S.E.


     1.    Wise, J. E., Kolb, E. L., & Sauder, S. E. (1992). Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care, 15, 826-830.

SAVING,K.L.


     1.    Davoren, A., Saving, K. L., McFarland, J. G., Aster, R. H., & Curtis, B. R. (2004). Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies. Transfusion, 44, 1041-1046.

     2.    Hocker, J. R. & Saving, K. L. (1995). Fatal aortic thrombosis in a neonate during infusion of epsilon- aminocaproic acid. J.Pediatr.Surg., 30, 1490-1492.

     3.    Joseph, M. A., Adams, D., Maragos, J., & Saving, K. L. (1996). Flow cytometry of neonatal platelet RNA. J.Pediatr.Hematol.Oncol., 18, 277-281.

     4.    Mankin, P. E., Maragos, J., Akhand, M., & Saving, K. L. (2000). Impaired platelet--dense granule release in neonates. J.Pediatr.Hematol.Oncol., 22, 143-147.

     5.    Saving, K. L., McLaren, R. A., & Miller, T. C. (1990). Responsibility expands to extended family members. American Journal of Obstetrics & Gynecology, 163, 1369-1370.

     6.    Saving, K. L., Aldag, J. C., Jennings, D. E., Caughey, R. C., Regan, M., & Powers, W. (1991). Electron microscopic characterization of neonatal platelet ultrastructure: effects of sampling techniques. Thromb.Res., 61, 65-80.

     7.    Saving, K. L., Jennings, D. E., Aldag, J. C., & Caughey, R. C. (1994). Platelet ultrastructure of high-risk premature infants. Thromb.Res., 73, 371-384.

     8.    Saving, K. L., Mankin, P. E., Maragos, J., Adams, D., & Caughey, R. C. (2001). Association of whole blood aggregation response with immunogold-labeled glycoproteins in adult and neonatal platelets. Thrombosis Research, 101, 73-81.

     9.    Saving, K. L., Mankin, P. E., & Gorman, M. J. (2002). Differences in adhesion receptor expression between immature and older platelets and red blood cells of neonates and adults. J.Pediatr.Hematol.Oncol., 24, 120-124.

   10.    Saving, K. L. & Mankin, P. E. (2003). CD62 expression during thrombus formation. Journal of Pediatric Hematology/Oncology, 25, 266-269.

SCHAEFER,T.J.


     1.    Schaefer, T. J. & Wolford, R. W. (2005). Disorders of potassium. Emergency medicine clinics of North America, 23, 723-747.

SCHEIBEL,L.W.


     1.    Gomez-Flores, R., Calderon, C. L., Scheibel, L. W., Tamez-Guerra, P., Rodriguez-Padilla, C., Tamez-Guerra, R. et al. (2000). Immunoenhancing properties of plantago major leaf extract. Phytother.Res., 14, 617-622.

     2.    Graumlich, J. F., Blough, L. S., McLaughlin, R. G., Milbrandt, J. C., Calderon, C. L., Agha, S. Y. et al. (2003). Healing Pressure Ulcers with Collagen or Hydrocolloid: A Randomized, Controlled Trial. Journal of the American Geriatrics Society, 51, 147-153.

     3.    Husain, M. A. & Scheibel, L. W. (1997). Anthelmintic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (5th ed., pp. 649-658). Philidelphia: Lippincott Williams & Wilkins.

     4.    Husain, M. A. & Scheibel, L. W. (2004). Anthelmintic Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 621-629). Philidelphia: Lippincott Williams & Wilkins.

     5.    Scheibel, L. W. & Van Dyke, K. (1997). Antiprotozoal Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (5th ed., pp. 633-648). Philidelphia: Lippincott Williams & Wilkins.

     6.    Scheibel, L. W. (2004). Antiprotozoal Drugs. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 606-620). Philidelphia: Lippincott Williams & Wilkins.

     7.    Song, G. H., Andre, R. G., Scheibel, L. W., Wirtz, R. A., Strickman, D. A., Cheriathundam, E. et al. (1995). Plasmodium berghei: sensitivity of chloroquine-resistant and chloroquine-sensitive strains to irradiation and the effect of irradiated malaria parasites on cytochrome P450-dependent monooxygenases. Research Communications in Molecular Pathology and Pharmacology, 90, 75-86.

     8.    Wang, X. D., Kiang, J. G., Scheibel, L. W., & Smallridge, R. C. (1999). Phospholipase C Activation by Na+/Ca2+ Exchange is Essential for Monensin-Induced Ca2+ Influx and Arachidonic Acid Release in FRTL-5 Thyroid Cells. Journal of Investigative Medicine, 47, 388-396.

SCHNEIDER,D.J.


     1.    Hasselman, T., Schneider, D. J., Madan, N., & Jacobs, M. (2005). Reversal of fenestration flow during ventricular systole in Fontan patients in junctional or ventricular paced rhythm. Pediatr Cardiol., 26, 638-641.

     2.    Plunkett, M. D., Schneider, D. J., Shah, J. J., Bash, S. E., Bond, L. M., & Geiss, D. M. (1998). Homograft replacement of mitral valve in children. The Annals of Thoracic Surgery, 66, 849-852.

     3.    Schneider, D. J. & Moore, J. W. (2001). Transcatheter Treatment of IVC Channel Obstruction and Baffle Leak after Mustard Procedure for d-Transposition of the Great Arteries Using Amplatzer ASD Device and Multiple. J.Invasive.Cardiol., 13, 306-309.

SHAH,J.J.


     1.    Agarwal, S., Deshpande, G., Agarwal, D., Dave, A., & Shah, J. J. (2005). Sudden Cardiac Arrest in a Neonate with Congenital Adrenal Hyperplasia. Pediatric cardiology.

     2.    Osborn, P., Gross, T. L., Shah, J. J., & Ma, L. (2000). Prenatal diagnosis of fetal heart failure in twin reversed arterial perfusion syndrome. Prenat.Diagn., 20, 615-617.

     3.    Plunkett, M. D., Schneider, D. J., Shah, J. J., Bash, S. E., Bond, L. M., & Geiss, D. M. (1998). Homograft replacement of mitral valve in children. The Annals of Thoracic Surgery, 66, 849-852.

     4.    Raff, G. W., Geiss, D. M., Shah, J. J., & Bond, L. M. (2002). Repair of transposition of the great arteries with total anomalous pulmonary venous return. The Annals of Thoracic Surgery, 73, 655-657.

SLOFFER,C.A.


     1.    Catapano, D., Sloffer, C. A., Frank, G., Pasquini, E., D'Angelo, V. A., & Lanzino, G. (2006). Comparison between the microscope and endoscope in the direct endonasal extended transsphenoidal approach: anatomical study. J Neurosurg., 104, 419-425.

     2.    Hanigan, W. C. & Sloffer, C. A. (2004). Nelson's wound: treatment of spinal cord injury in 19th and early 20th century military conflicts. Neurosurg.Focus., 16, E4.

     3.    Sloffer, C. A., Augspurger, L., Wagenbach, A., & Lanzino, G. (2005). Antimicrobial-impregnated external ventricular catheters: does the very low infection rate observed in clinical trials apply to daily clinical practice? Neurosurgery, 56, 1041-1044.

     4.    Sloffer, C. A. & Lanzino, G. (2006). Historical vignette. Dominique Anel: father of the Hunterian ligation? J Neurosurg., 104, 626-629.

SMITH,E.


     1.    Estes, N. C., Conlee, L. S., bord-Smith, A., Smith, E., Whittaker, L. D., Jr., & Rossi, T. R. (2004). The value of using naive observers to assess resident ACGME competencies. Current surgery, 61, 629-635.

SMITH,K.


     1.    Aaland, M. O. & Smith, K. (1996). Delayed diagnosis in a rural trauma center. Surgery, 120, 774-779.

SMITH,T.


     1.    Kaufmann, R. C., Smith, T., Bochantin, T., Khardori, R., Evans, M. S., & Steahly, L. (1999). Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Obstetrics & Gynecology, 93, 734-737.

SMOUSE,H.B.


     1.    Brady, T. M., Swischuk, J. L., Castaneda, F., Smouse, H. B., & Fox, P. F. (2000). Central venous thrombolysis/PTA/stenting. Seminars in Interventional Radiology, 17, 121-138.

     2.    Brady, T. M., Castaneda, F., Swischuk, J. L., & Smouse, H. B. (2001). Re: The Legs for Life (R) screening for peripheral vascular disease: Compliance with physician recommendations in moderate- and high-risk assessed patients. Journal of Vascular & Interventional Radiology, 12, 774.

     3.    Castaneda, F., Smouse, H. B., Swischuk, J. L., Wyffels, P. L., Patel, J. C., & Li, R. Z. (2000). Pharmacomechanical thrombolysis with use of the brush catheter in canine thrombosed femoropopliteal arterial PTFE bypass grafts. J.Vasc.Interv.Radiol, 11, 503-508.

     4.    Castaneda, F., Li, R. Z., Smouse, H. B., Fox, P. F., Brady, T. M., & Swischuk, J. L. (2000). Current status of endoluminal grafting of the thoracic aorta. Seminars in Interventional Radiology, 17, 193-200.

     5.    Castaneda, F., Li, R. Z., Young, K., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2002). Catheter-directed Thrombolysis in Deep Venous Thrombosis with Use of Reteplase: Immediate Results and Complications from a Pilot Study. J.Vasc.Interv.Radiol., 13, 577-580.

     6.    Castaneda, F., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2003). Gelatin Sponge Closure Device versus Manual Compression after Peripheral Arterial Catheterization Procedures. J Vasc.Interv.Radiol, 14, 1517-1523.

     7.    Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Smouse, H. B. (2000). Embolization techniques in trauma of the chest. Seminars in Interventional Radiology, 17, 161-169.

     8.    Smouse, H. B., Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Pham, M. T. (2000). Intravascular foreign body removal. Seminars in Interventional Radiology, 17, 201-212.

     9.    Smouse, H. B., Nikanorov, A., & LaFlash, D. (2004). Changes in major peripheral arteries during joint movement before and after Stent placement in the cadaver model. American Journal of Cardiology, 94, 26E.

   10.    Smouse, H. B., Ragheb, A. O., & Patel, S. G. (2004). Safety and performance of a new, retrievable vena cava filter at 30 and 60 days in the ovine inferior vena cava. American Journal of Cardiology, 94, 166E.

   11.    Smouse, H. B. (2006). A modified technique to minimize filter tilting during deployment of the gunther tulip filter: in vitro study. J.Vasc.Interv.Radiol., 17, 1365.

   12.    Swischuk, J. L., Castaneda, F., Smouse, H. B., Fox, P. F., & Brady, T. M. (2000). Embolization of pulmonary arteriovenous malformations. Seminars in Interventional Radiology, 17, 171-183.

   13.    Swischuk, J. L., Fox, P. F., Young, K., Hussain, S. M., Smouse, H. B., Castaneda, F. et al. (2001). Transcatheter Intraarterial Infusion of rt-PA for Acute Lower Limb Ischemia: Results and Complications. J.Vasc.Interv.Radiol., 12, 423-430.

SOMARAJU,V.


     1.    Miller-Hjelle, M. A., Somaraju, V., & Hjelle, J. T. (2004). Synthetic Organic Antimicrobials: Sulfonamides, Trimethoprim,Nitrofurans, Quinolones, Methenamine. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 515-525). Philidelphia: Lippincott Williams & Wilkins.

     2.    Somaraju, V., Smith, L. G., & Smith, S. M. (2001). Infectious Complications in Asplenic Hosts. Infectious Disease Clinics of North America, 15, 551-565.

     3.    Somaraju, V. (2004). Drugs Used in Tuberculosis and Leprosy. In C.R.Craig & R. E. Stitzel (Eds.), Modern Pharmacology with Clinical Applications (6th ed., pp. 557-566). Philidelphia: Lippincott Williams & Wilkins.

SPOMAR,D.G.


     1.    Dasari, V. R., Spomar, D. G., Li, L., Cady, C., Gujrati, M., Rao, J. S. et al. (2006). Human cord blood stem cells exhibit neural phenotypes and ameliorate caspase-3 pathway proteins after traumatic SCI in rats. Journal of Neurochemistry, 96, 52.

STANISTIC,T.H.


     1.    Stanistic, T. H. (1996). New data from abroad about intravesical therapy of bladder cancer--how does it play in Peoria? Journal of Urology, 155, 1239-1240.

STONER,G.D.


     1.    Stoner, G. D. (2005). Hyperosmolar hyperglycemic state. American Family Physician, 71, 1723-1730.

SWINGLER,J.L.


     1.    Swingler, J. L. (2001). Other bacterial infections: listeria, Lyme disease, granuloma inguinale and chancroid. In H.M.Winn & J. C. Hobbins (Eds.), Clinical Maternal-Fetal Medicine (pp. 213-219). New York: Parthenon Publishing Group.

SWISCHUK,J.L.


     1.    Brady, T. M., Swischuk, J. L., Castaneda, F., Smouse, H. B., & Fox, P. F. (2000). Central venous thrombolysis/PTA/stenting. Seminars in Interventional Radiology, 17, 121-138.

     2.    Brady, T. M., Castaneda, F., Swischuk, J. L., & Smouse, H. B. (2001). Re: The Legs for Life (R) screening for peripheral vascular disease: Compliance with physician recommendations in moderate- and high-risk assessed patients. Journal of Vascular & Interventional Radiology, 12, 774.

     3.    Castaneda, F., Wyffels, P. L., Patel, J. C., Swischuk, J. L., Li, R. Z., Cole, B. A. et al. (1998). New thrombolytic brush catheter in thrombosed polytetrafluoroethylene dialysis grafts: preclinical animal study. J.Vasc.Interv.Radiol., 9, 793-798.

     4.    Castaneda, F., Smouse, H. B., Swischuk, J. L., Wyffels, P. L., Patel, J. C., & Li, R. Z. (2000). Pharmacomechanical thrombolysis with use of the brush catheter in canine thrombosed femoropopliteal arterial PTFE bypass grafts. J.Vasc.Interv.Radiol, 11, 503-508.

     5.    Castaneda, F., Li, R. Z., Smouse, H. B., Fox, P. F., Brady, T. M., & Swischuk, J. L. (2000). Current status of endoluminal grafting of the thoracic aorta. Seminars in Interventional Radiology, 17, 193-200.

     6.    Castaneda, F., Li, R. Z., Patel, J. C., DeBord, J. R., & Swischuk, J. L. (2001). Comparison of three mechanical thrombus removal devices in thrombosed canine iliac arteries. Radiology, 219, 153-156.

     7.    Castaneda, F., Li, R. Z., Young, K., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2002). Catheter-directed Thrombolysis in Deep Venous Thrombosis with Use of Reteplase: Immediate Results and Complications from a Pilot Study. J.Vasc.Interv.Radiol., 13, 577-580.

     8.    Castaneda, F., Goodwin, S. C., Swischuk, J. L., Wong, G. C., Bonilla, S. M., Wang, M. J. et al. (2002). Treatment of pelvic arteriovenous malformations with ethylene vinyl alcohol copolymer (onyx). J.Vasc.Interv.Radiol., 13, 513-516.

     9.    Castaneda, F., Swischuk, J. L., Smouse, H. B., & Brady, T. M. (2003). Gelatin Sponge Closure Device versus Manual Compression after Peripheral Arterial Catheterization Procedures. J Vasc.Interv.Radiol, 14, 1517-1523.

   10.    Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Smouse, H. B. (2000). Embolization techniques in trauma of the chest. Seminars in Interventional Radiology, 17, 161-169.

   11.    Ouriel, K., Castaneda, F., McNamara, T., Swischuk, J. L., Tepe, G., Smith, J. J. et al. (2004). Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: Results from the RELAX trial. Journal of Vascular and Interventional Radiology, 15, 229-238.

   12.    Smouse, H. B., Fox, P. F., Brady, T. M., Swischuk, J. L., Castaneda, F., & Pham, M. T. (2000). Intravascular foreign body removal. Seminars in Interventional Radiology, 17, 201-212.

   13.    Swischuk, J. L., Castaneda, F., Patel, J. C., Li, R. Z., Brady, T. M., Fraser, K. et al. (1998). Percutaneous transthoracic needle biopsy of the lung: review of 612 lesions. Journal of Vascular & Interventional Radiology, 9, 347-352.

   14.    Swischuk, J. L. (1998). Percutaneous transthoracic needle biopsy - a difference in definitions and calculation of diagnostic yield - Dr. Swischuck responds. Journal of Vascular & Interventional Radiology, 9, 851-852.

   15.    Swischuk, J. L., Castaneda, F., Smouse, H. B., Fox, P. F., & Brady, T. M. (2000). Embolization of pulmonary arteriovenous malformations. Seminars in Interventional Radiology, 17, 171-183.

   16.    Swischuk, J. L., Fox, P. F., Young, K., Hussain, S. M., Smouse, H. B., Castaneda, F. et al. (2001). Transcatheter Intraarterial Infusion of rt-PA for Acute Lower Limb Ischemia: Results and Complications. J.Vasc.Interv.Radiol., 12, 423-430.

   17.    Wang, H., Swischuk, J. L., Fraser, K., Alvernia, J., & Lanzino, G. (2005). Transaxillary carotid stenting: technical case report. Neurosurgery, 56, E441.

TALKAD,A.


     1.    Wiese, K. M., Talkad, A., Mathews, M., & Wang, D. (2006). Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke., 37, 2168-2169.

TALKAD,A.V.


     1.    Talkad, A. V., Kattah, J. C., Xu, M. Y., Orth, E. H., & Chang, J. Y. (2004). Prolactinoma presenting as painful postganglionic Horner syndrome. Neurology, 62, 1440-1441.

     2.    Talkad, A. V., Mathews, M., Honings, D., Jahnel, J., & Wang, D. (2005). Reversal of warfarin-induced anticoagulation with factor VIIa prior to rt-PA in acute stroke. Neurology, 64, 1480-1481.

TARANTINO,M.D.


     1.    Ewenstein, B. M., Valentino, L. A., Journeycake, J. M., Tarantino, M. D., Shapiro, A. D., Blanchette, V. S. et al. (2004). Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia, 10, 629-648.

     2.    Hanigan, W. C., Fraser, K., Tarantino, M. D., & Wang, H. (2005). Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report. Journal of neurosurgery, 102, 426-430.

     3.    Lin, J., Hanigan, W. C., Tarantino, M. D., & Wang, J. (2003). The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J.Neurosurg., 98, 737-740.

     4.    McMinn, J. R., Cohen, S., Moore, J., Lilly, S., Parkhurst, J., Tarantino, M. D. et al. (2003). Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. American Journal of Hematology, 73, 135-140.

     5.    Pratt, E. L., Tarantino, M. D., Wagner, D., Hirsch Pescovitz, O., Bowyer, S., & Shapiro, A. D. (2005). Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura. American Journal of Hematology, 79, 175-179.

     6.    Tarantino, M. D. (2001). On the conservative management of acute immune thrombocytopenia in children. J.Pediatr., 138, 787-788.

     7.    Tarantino, M. D. (2002). Acute immune (idiopathic) thrombocytopenic purpura in childhood. Blood Rev., 16, 19-21.

     8.    Tarantino, M. D., Lail, A., Donfield, S. M., Lynn, H., Peddle, L., Hunsberger, S. et al. (2003). Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia., 9, 588-592.

     9.    Tarantino, M. D., Abshire, T., Shapiro, A. D., Collins, P. W., Rogy, S., Retzios, A. D. et al. (2004). Global clinical evaluation of an rFVIII prepared using a plasma/albumin-free method, ADVATE rAHF-PFM. Pediatric research, 55, 286A.

   10.    Tarantino, M. D., Young, G., Bertolone, S., Kalinyak, K. A., Shafer, F. E., Kulkarni, R. et al. (2004). High-dose anti-D immune globulin raises the platelet count in newly diagnosed childhood ITP more rapidly than standard-dose anti-D and higher than IVIg. Pediatric research, 55, XLIII.

   11.    Tarantino, M. D. & Aledort, L. M. (2004). Advances in clotting factor treatment for congenital hemorrhagic disorders. Clin Adv Hematol Oncol., 2, 363-368.

   12.    Tarantino, M. D. & Buchanan, G. R. (2004). The pros and cons of drug therapy for immune thrombocytopenic purpura in children. Hematology/oncology clinics of North America, 18, 1301-1314.

   13.    Tarantino, M. D., Collins, P. W., Hay, C. R., Shapiro, A. D., Gruppo, R. A., Berntorp, E. et al. (2004). Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia, 10, 428-437.

   14.    Tarantino, M. D., Young, G., Bertolone, S. J., Kalinyak, K. A., Shafer, F. E., Kulkarni, R. et al. (2006). Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J.Pediatr., 148, 489-494.

   15.    Tarantino, M. D. (2006). Recent advances in the treatment of childhood immune thrombocytopenic purpura. Semin.Hematol., 43, S11-S17.

   16.    Tarantino, M. D. (2006). The treatment of immune thrombocytopenic purpura in children. Curr.Hematol.Rep., 5, 89-94.

   17.    Young, G., Manco-Johnson, M. J., Gill, J. C., Dimichele, D. M., Tarantino, M. D., Abshire, T. et al. (2003). Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. Journal of Thrombosis and Haemostasis, 1, 958-962.

TILLIS,W.P.


     1.    Mueller, D. K., Whitten, P. E., Tillis, W. P., Bond, L. M., & Munns, J. R. (2002). Delayed closure of persistent postpneumonectomy bronchopleural fistula. Chest, 121, 1703-1704.

TORRES,A.


     1.    Devabhaktuni, V. G., Torres, A., Wilson, S., & Yeh, M. P. (1999). Effect of nitric oxide, perfluorocarbon, and heliox on minute volume measurement and ventilator volumes delivered. Critical Care Medicine, 27, 1603-1607.

     2.    Fiser, R. T., Torres, A., Butch, A. W., & Valentine, J. L. (1998). Ionized magnesium concentrations in critically ill children. Critical Care Medicine, 26, 2048-2052.

     3.    Raff, G. W., Gray, B. M., Torres, A., & Hasselman, T. (2004). Aortitis in a Child with Abiotrophia defectiva Endocarditis. The Pediatric Infectious Disease Journal, 23, 574-576.

     4.    Sedaghat-Yazdi, F., Torres, A., Fortuna, R., & Geiss, D. M. (2005). Pulse oximeter performance affected by probe position in cyanotic critically ill infants. Critical Care Medicine, 33, A62.

     5.    Torres, A. & Wiggins, P. (2000). Nutrition in the pediatric intensive care unit patient. In (pp. 311-331).

     6.    Torres, A., DiLiberti, J. H., Pearl, R. H., Wohrley, J. D., Raff, G. W., Bysani, G. K. et al. (2002). Noncardiac surgery in children with hypoplastic left heart syndrome. J Pediatr.Surg., 37, 1399-1403.

     7.    Torres, A., Skender, K. M., Wohrley, J. D., Aldag, J. C., Raff, G. W., Bysani, G. K. et al. (2004). Pulse oximetry in children with congenital heart disease: effects of cardiopulmonary bypass and cyanosis. Journal of intensive care medicine, 19, 229-234.

     8.    Torres, A., Haque, A., & Fortuna, R. (2005). Dexmedetomidine is safe and effective in children after cardiac surgery. Critical Care Medicine, 33, A177.

     9.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

   10.    Webster, P. A., King, S. E., & Torres, A. (1998). An in vitro validation of a commercially available metabolic cart using pediatric ventilator volumes. Pediatric Pulmonology, 26, 405-411.

TOTH,P.P.


     1.    Davidson, M. H. & Toth, P. P. (2004). Combination therapy in the management of complex dyslipidemias. Curr.Opin.Lipidol., 15, 423-431.

     2.    Davidson, M. H. & Toth, P. P. (2004). Comparative effects of lipid-lowering therapies. Progress in cardiovascular diseases, 47, 73-104.

     3.    Toth, P. P. (2004). High-density lipoprotein and cardiovascular risk. Circulation, 109, 1809-1812.

     4.    Toth, P. P. & Davidson, M. H. (2004). Therapeutic interventions targeted at the augmentation of reverse cholesterol transport. Curr.Opin.Cardiol., 19, 374-379.

     5.    Toth, P. P. & Urtis, J. (2004). Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clinical therapeutics, 26, 1355-1367.

     6.    Toth, P. P. (2005). Cardiology patient page. The "good cholesterol": high-density lipoprotein. Circulation, 111, e89-e91.

     7.    Toth, P. P. (2005). The "good cholesterol" - High-density lipoprotein. Circulation, 111, E89-E91.

     8.    Toth, P. P. (2005). High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am.J Cardiol., 96, 50-58.

     9.    Toth, P. P. & Davidson, M. H. (2005). Cholesterol absorption blockade with ezetimibe. Curr.Drug Targets.Cardiovasc.Haematol.Disord., 5, 455-462.

TRACHTENBARG,D.E.


     1.    Trachtenbarg, D. E. (1990). Treatment of osteoporosis. What is the role of calcium? Postgrad.Med., 87, 263-6, 269-70.

     2.    Trachtenbarg, D. E. (1994). Tension headaches. Relieving pain without creating dependence. Postgrad.Med., 95, 44-6, 49-52, 55-6.

     3.    Trachtenbarg, D. E. & Miller, T. C. (1995). Office care of the small, premature infant. Prim.Care, 22, 1-21.

     4.    Trachtenbarg, D. E. (1996). Getting the lead out: when is treatment necessary? Postgrad.Med., 99, 201-2, 207-18.

     5.    Trachtenbarg, D. E. & Golemon, T. B. (1998). Office care of the premature infant: Part II. Common medical and surgical problems. Am.Fam.Physician., 57, 2383-90, 2400-2.

     6.    Trachtenbarg, D. E. & Golemon, T. B. (1998). Care of the premature infant: Part I. Monitoring growth and development. Am.Fam.Physician., 57, 2123-2130.

     7.    Trachtenbarg, D. E. (1998). Ten errors to avoid in managing type 2 diabetes - getting back to the basics. Postgrad.Med., 104, 35 ff.

     8.    Trachtenbarg, D. E. (2000). Pediatric emergencies: Preparedness and prevention. American Family Physician, 61, 3237-3238.

     9.    Trachtenbarg, D. E. (2002). Headache. In Conn's Current Therapy 2002 (pp. 903-911). W.B.Saunders Company.

   10.    Trachtenbarg, D. E. (2005). Diabetic ketoacidosis. American Family Physician, 71, 1705-1714.

   11.    Trachtenbarg, D. E. (2006). Press 1 to promote health behavior with interactive voice response. American Journal of Managed Care, 12, 305.

TRACY,P.T.


     1.    Kraus, R. R., Tracy, P. T., & Hanigan, W. C. (2003). Intracranial hemorrhage following blunt injury to a shunt valve. Childs Nerv.Syst., 20, 68-70.

     2.    Sabo, R. A., Tracy, P. T., & Weinger, J. M. (1996). A series of 60 juxtafacet cysts: clinical presentation, the role of spinal instability, and treatment. J.Neurosurg., 85, 560-565.

     3.    Tracy, P. T. & Hanigan, W. C. (1990). Spinal dysraphism: use of magnetic resonance imaging in evaluation. Clin.Pediatr.(Phila)., 29, 228-233.

     4.    Wang, H., Lanzino, G., Fraser, K., Tracy, P. T., & Wang, D. (2003). Urgent endovascular treatment of acute symptomatic occlusion of the cervical internal carotid artery. J Neurosurg., 99, 972-977.

TUDOR,G.


     1.    Glover, C. L., III, Benink, E., Tudor, G., Aldag, J. C., & Smith, M. (2000). Outcome analysis of chest pain patients discharged from the ED--a pilot study. Am.J.Emerg.Med., 18, 779-783.

     2.    Woodland, J. H., Tudor, G., & Getz, M. A. (2003). Investigation of the Use of Core Practical Objectives for Standardizing the Experiences of Fourth Year Medical Students during an Emergency Medicine Clerkship. Academic Emergency Medicine, 10, 503.

VEGUNTA,R.K.


     1.    Drenckpohl, D., Hocker, J. R., Shareef, M., Vegunta, R. K., & Colgan, C. (2005). Adding dietary green beans resolves the diarrhea associated with bowel surgery in neonates: a case study. Nutr.Clin.Pract., 20, 674-677.

     2.    McGuigan, R. M., Mullenix, P. S., Vegunta, R. K., Pearl, R. H., Sawin, R., & Azarow, K. S. (2006). Splanchnic perfusion pressure: a better predictor of safe primary closure than intraabdominal pressure in neonatal gastroschisis. Journal of pediatric surgery, 41, 901-904.

     3.    Vegunta, R. K., Ali, A., Wallace, L. J., Switzer, D. M., & Pearl, R. H. (2004). Laparoscopic appendectomy in children: technically feasible and safe in all stages of acute appendicitis. Am Surg., 70, 198-201.

     4.    Vegunta, R. K., Loethen, P., Wallace, L. J., Albert, V. L., & Pearl, R. H. (2005). Differences in the outcome of surgically placed long-term central venous catheters in neonates: neck vs groin placement. Journal of pediatric surgery, 40, 47-51.

     5.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

     6.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

WALLACE,D.R.


     1.    Campagna, D. P. & Wallace, D. R. (2001). Poststreptococcal glomerulonephritis presenting as impending airway obstruction. Annals of Emergency Medicine, 38, 450-452.

WALLACE,L.J.


     1.    Vegunta, R. K., Ali, A., Wallace, L. J., Switzer, D. M., & Pearl, R. H. (2004). Laparoscopic appendectomy in children: technically feasible and safe in all stages of acute appendicitis. Am Surg., 70, 198-201.

     2.    Vegunta, R. K., Loethen, P., Wallace, L. J., Albert, V. L., & Pearl, R. H. (2005). Differences in the outcome of surgically placed long-term central venous catheters in neonates: neck vs groin placement. Journal of pediatric surgery, 40, 47-51.

     3.    Vegunta, R. K., Wallace, L. J., Leonardi, M. R., Gross, T. L., Renfroe, Y., Marshall, J. S. et al. (2005). Perinatal management of gastroschisis: analysis of a newly established clinical pathway. Journal of pediatric surgery, 40, 528-534.

     4.    Vegunta, R. K., Raso, M., Pollock, J., Misra, S., Wallace, L. J., Torres, A. et al. (2005). Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery, 138, 726-731.

WANG,D.Z.


     1.    Al Kawi, A., Wang, D. Z., Kishore, K., & Kattah, J. C. (2004). A Case of Ischemic Cerebral Infarction Associated with Acute Posterior Multifocal Placoid Pigment Epitheliopathy, CNS Vasculitis, Vitamin B(12) Deficiency and Homocysteinemia. Cerebrovascular diseases (Basel, Switzerland), 18, 338-339.

     2.    LaMonte, M. P., Nash, M. L., Wang, D. Z., Woolfenden, A. R., Schultz, J., Hursting, M. J. et al. (2004). Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study. Stroke, 35, 1677-1682.

     3.    Wang, D. Z., Rose, J. A., & Milbrandt, J. C. (1998). OSF Stroke Network: Exploring the Way of Community Stroke Care. Stroke Interventionist, I, 11-13.

     4.    Wang, D. Z., Rose, J. A., Honings, D., & Milbrandt, J. C. (2000). tPA: A rural network experience - Response. Stroke, 31, 1457-1458.

     5.    Wang, D. Z., Rose, J. A., Honings, D., Garwacki, D. J., & Milbrandt, J. C. (2000). Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke, 31, 77-81.

     6.    Wang, D. Z. (2001). It Is Time to Implement Stroke Practice Improvement Programs and Prevent the Racial Disparity in Stroke Care - Editorial Comment. Stroke, 32, 1067-1068.

     7.    Wang, D. Z. (2001). IV tPA, much underutilized, does not increase stroke mortality. Stroke, 32, 1840.

     8.    Wang, D. Z. (2001). Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers - The influence of ethnicity - Editorial Comment. Stroke, 32, 1067-1068.

     9.    Wang, D. Z., Wang, H., Fraser, K., & Lanzino, G. (2004). Treatment Options for Unruptured Cerebral Aneurysm. Curr Treat Options Neuro, 6, 451-458.

WANG,H.


     1.    Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2004). Subacute spinal subdural hematoma after spontaneous resolution of cranial subdural hematoma: causal relationship or coincidence? Case report. J Neurosurg., 100, 372-374.

     2.    Cai, Y. L., Spelle, L., Wang, H., Piotin, M., Mounayer, C., Vanzin, J. R. et al. (2005). Endovascular treatment of intracranial aneurysms in the elderly: Single-center experience in 63 consecutive patients. Neurosurgery, 57, 1096-1102.

     3.    Diao, C. G., Zhu, L., & Wang, H. (2003). Cooling and rewarming for brain ischemia or injury: Theoretical analysis. Annals of Biomedical Engineering, 31, 346-353.

     4.    Hanigan, W. C., Fraser, K., Tarantino, M. D., & Wang, H. (2005). Tumefaction of the dural sinuses associated with a coagulopathy following treatment of hydrocephalus in a perinate: case report. Journal of neurosurgery, 102, 426-430.

     5.    Perrini, P., Bortolotti, C., Wang, H., Fraser, K., & Lanzino, G. (2005). Thrombosed giant intracavernous aneurysm with subsequent spontaneous ipsilateral carotid artery occlusion. Acta Neurochirurgica, 147, 215-216.

     6.    Wang, D. Z., Wang, H., Fraser, K., & Lanzino, G. (2004). Treatment Options for Unruptured Cerebral Aneurysm. Curr Treat Options Neuro, 6, 451-458.

     7.    Wang, H., Lanzino, G., Kraus, R. R., & Fraser, K. (2003). Provocative test occlusion or the Matas test: who was Rudolph Matas? J.Neurosurg., 98, 926-928.

     8.    Wang, H., Lanzino, G., Fraser, K., Tracy, P. T., & Wang, D. (2003). Urgent endovascular treatment of acute symptomatic occlusion of the cervical internal carotid artery. J Neurosurg., 99, 972-977.

     9.    Wang, H., Olivero, W. C., Lanzino, G., Elkins, W., Rose, J. A., Honings, D. et al. (2004). Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg., 100, 272-277.

   10.    Wang, H., Fraser, K., Bortolotti, C., & Lanzino, G. (2005). Emergent endovascular treatment with direct carotid puncture for exsanguinating Carotid Blowout Syndrome. Neurocritical Care, 2, 176-178.

   11.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery, 57, E398.

   12.    Wang, H., Fraser, K., Wang, D., & Lanzino, G. (2005). The evolution of endovascular therapy for neurosurgical disease. Neurosurgery clinics of North America, 16, 223-229.

   13.    Wang, H., Swischuk, J. L., Fraser, K., Alvernia, J., & Lanzino, G. (2005). Transaxillary carotid stenting: technical case report. Neurosurgery, 56, E441.

   14.    Wang, H., Fraser, K., Wang, D., Alvernia, J., & Lanzino, G. (2005). Successful intra-arterial basilar artery thrombolysis in a patient with bilateral vertebral artery occlusion: technical case report. Neurosurgery., 57, E398.

   15.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent: a brief historical overview. Acta Neurochir.(Wien.)., ..

   16.    Wang, H., Wang, D., Lanzino, G., Elkins, W., & Olivero, W. C. (2006). Differential interhemispheric cooling and ICP compartmentalization in a patient with left ICA occlusion. Acta Neurochir.(Wien.)., ..

   17.    Wang, H., Olivero, W. C., Wang, D., & Lanzino, G. (2006). Cold as a therapeutic agent. Acta Neurochirurgica, 148, 565-570.

WARD,M.


     1.    Harbick, S., Frederick, R., Ward, M., & Cummings, A. J. (2000). Unusual cause of chest pain in a 60-year-old woman. Ann.Emerg.Med., 35, 382-390.

WATNE,A.L.


     1.    Miller, B., Montgomery, C. E., Watne, A. L., Johnson, D., Bailey, T. S., & Kowalski, R. (1991). Lymphoepithelioma-like carcinoma of the lung. J.Surg.Oncol., 48, 62-68.

     2.    Sohrabi, A. K., Phillips, J., & Watne, A. L. (1991). Gynecological malignancies, brain tumors, and familial adenomatous polyposis. J.Surg.Oncol., 47, 203-205.

     3.    Watne, A. L., Starke, J., McQuitty, D., & Sohrabi, A. K. (1991). Follicular carcinoma of the thyroid. Semin.Surg.Oncol., 7, 87-91.

WEBER,R.J.


     1.    Brinkman, W. J., Hall, D. M., Suo, J. L., & Weber, R. J. (1998). Centrally-mediated opioid-induced immunosuppression. Elucidation of sympathetic nervous system involvement. Adv.Exp.Med.Biol., 437, 43-49.

     2.    Caballero-Hernandez, D., Weber, R. J., Hicks, M. E., Tamez-Guerra, R., Rodriguez-Padilla, C., Tamez-Guerra, P. et al. (2005). Potentiation of rat lymphocyte proliferation by novel non-peptidic synthetic opioids. International immunopharmacology, 5, 1271-1278.

     3.    Carr, D. J. J., Rogers, T. J., & Weber, R. J. (1996). Ther relevance of opioid receptors on immunocompetence and immune meostasis. Proceedings of the Society for Experimental Biology & Medicine, 213, 248-257.

     4.    Carr, D. J. J. & Weber, R. J. (2001). Opioidergic Modulation of the Immune System. In R.Ader, D. L. Felton, & N. Cohen (Eds.), Psychoneuroimmunology (3 ed., pp. 405-414). Academic Press.

     5.    Dombrink-Kurtzman, M. A., Gomez-Flores, R., & Weber, R. J. (2000). Activation of rat splenic macrophage and lymphocyte functions by fumonisin B(1). Immunopharmacology, 49, 401-409.

     6.    Ewing, S. E., Weber, R. J., Zauner, A., & Plunkett, R. J. (1992). Recovery in hemiparkinsonian rats following intrastriatal implantation of activated leukocytes. Brain Research, 576, 42-48.

     7.    Gomez-Flores, R. & Weber, R. J. (1998). Immunomodulation of macrophage functions by opioids. Adv.Exp.Med.Biol., 437, 13-19.

     8.    Gomez-Flores, R., Suo, J. L., & Weber, R. J. (1999). Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav.Immun., 13, 212-224.

     9.    Gomez-Flores, R. & Weber, R. J. (1999). Inhibition of interleukin-2 production and downregulation of IL- 2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J.Interferon.Cytokine.Res., 19, 625-630.

   10.    Gomez-Flores, R. & Weber, R. J. (2000). Opioids, Opioid Receptors, and the Immune System. In N.P.Plotnikoff, R. E. Faith, A. J. Murgo, & R. A. Good (Eds.), Cytokines: Stress and Immunity (pp. 281-314).

   11.    Gomez-Flores, R. & Weber, R. J. (2000). Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology, 48, 145-156.

   12.    Gomez-Flores, R., Calderon, C. L., Scheibel, L. W., Tamez-Guerra, P., Rodriguez-Padilla, C., Tamez-Guerra, R. et al. (2000). Immunoenhancing properties of plantago major leaf extract. Phytother.Res., 14, 617-622.

   13.    Gomez-Flores, R., Rice, K. C., Zhang, X. Y., & Weber, R. J. (2001). Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the delta-opioid agonist SNC 80. Life Sci., 68, 2675-2684.

   14.    Hall, D. M., Suo, J. L., & Weber, R. J. (1998). Opioid mediated effects on the immune system: sympathetic nervous system involvement. J.Neuroimmunol., 83, 29-35.

   15.    Hicks, M. E., Gomez-Flores, R., Wang, C. G., Mosberg, H. I., & Weber, R. J. (2001). Differential effects of the novel non-peptidic opioid 4-tyrosylamido-6-benzyl-1,2,3,4 tetrahydroquinoline (CGPM-9) on in vitro rat t lymphocyte and macrophage functions. Life Sci., 68, 2685-2694.

   16.    Kurtz, B. S., Lehman, J., Garlick, P., Amberg, J., Mishra, P. K., Dailey, J. W. et al. (2001). Penetrance and expressivity of genes involved in the development of epilepsy in the genetically epilepsy-prone rat (GEPR). Journal of Neurogenetics, 15, 233-244.

   17.    Liang-Suo, J., Gomez-Flores, R., & Weber, R. J. (2002). Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486). Life Sci., 71, 2595-2602.

   18.    Lockwood, L. L., Silvert, L. H., Fleshner, M. R., Mcneal, C., Watkins, L. R., Laudenslager, M. L. et al. (1996). Morphine-induced alterations in antibody levels - receptor and immune mechanisms. Journal of Pharmacology & Experimental Therapeutics, 278, 689-696.

   19.    Nowak, J. E., Gomez-Flores, R., Calderon, S. N., Rice, K. C., & Weber, R. J. (1998). Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80. J.Pharmacol.Exp.Ther., 286, 931-937.

   20.    Pert, A. & Weber, R. J. (2004). Electrical stimulation of the mesencephalic periaqueductal gray matter in rats alters NK cell function. Journal of neuroimmunology, 154, 132.

   21.    Riley, M. E., Ananthan, S., & Weber, R. J. (1998). Novel non-peptidic opioid compounds with immunopotentiating effects. Adv.Exp.Med.Biol., 437, 183-187.

   22.    Suo, J. L. & Weber, R. J. (1998). Immunomodulation mediated by microinjection of morphine into the periaqueductal gray matter of the mesencephalon. Adv.Exp.Med.Biol., 437, 177-182.

   23.    Weber, R. J. & Pert, A. (1989). The periaqueductal gray matter mediates opiate-induced immunosuppression. Science, 245, 188-190.

   24.    Weber, R. J. & Lysle, D. T. (1994). Special issue on stress, opiods, and immune function - editorial comment. Brain, Behavior, & Immunity, 8, 171.

   25.    Weber, R. J. (1996). Opiod regulation of immune function in vivo and in vitro. J.Neuroimmunol., 69, 38-39.

   26.    Weber, R. J. (2003). Chemotaxis of Human and Rat Leukocytes by the Delta-Selective Non-Peptidic Opioid SNC 80. Revista Latinoamericana de Microbiología, 45, 16-23.

   27.    Weber, R. J. & Gomez-Flores, R. (2004). Delta Opioids and Immune Function. In K.Chang, F. Porreca, & J. Woods (Eds.), The Delta Receptor (pp. 383-399). New York, N.Y.: Marcel Dekker, Inc.

   28.    Weber, R. J., Gomez-Flores, R., Smith, J. E., & Martin, T. J. (2004). Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse. J Neuroimmunol., 147, 134-137.

   29.    Weber, R. J. & Pert, A. (2006). Immune system : Neural control. In G.Adelman & B. H. Smith (Eds.), Elsevier's Encyclopedia of Neuroscience (2nd ed., pp. 943-946). Amsterdam,Lausanne,New York, Oxford...: Elsevier.

   30.    Williams, W., Rice, K. C., & Weber, R. J. (1991). Nonpeptide opioids: in vivo effects on the immune system. NIDA Res Monogr., 105, 404-407.

WEINGER,J.M.


     1.    Sabo, R. A., Tracy, P. T., & Weinger, J. M. (1996). A series of 60 juxtafacet cysts: clinical presentation, the role of spinal instability, and treatment. J.Neurosurg., 85, 560-565.

WHITTAKER,L.D.,JR.


     1.    Estes, N. C., Conlee, L. S., bord-Smith, A., Smith, E., Whittaker, L. D., Jr., & Rossi, T. R. (2004). The value of using naive observers to assess resident ACGME competencies. Current surgery, 61, 629-635.

     2.    Whittaker, L. D., Jr., Estes, N. C., Ash, J. L., & Meyer, L. E. (2006). The value of resident teaching to improve student perceptions of surgery clerkships and surgical career choices. Am.J Surg., 191, 320-324.

     3.    Whittaker, L. D., Jr. (2006). Concepts Evolving in Surgical Training by Simulation. FOCUS on Surgical Education, 23, 16-21.

WILKINS,W.R.


     1.    Lanier, D. & Wilkins, W. R. (1994). Ready reference via the internet. RQ, 33, 359-368.

     2.    Masi, A. T. & Wilkins, W. R. (1996). Does male/female sex ration in ankylosing spondylitis change with age. Journal of Rheumatology, 23, 947-948.

     3.    Vishwanatham, R., Wilkins, W. R., & Jevec, T. (1997). The Internet as a medium for online instruction. College and Research Libraries, 58, 433-444.

WINEK,R.R.


     1.    Densmore, J. C., Pierce, B. R., Winek, R. R., Mitchell, D. S., & Pearl, R. H. (2000). Case report of a newborn with a posterior thoracic midline congenital hemangiopericytoma of the back. J Pediatr.Surg., 35, 1120-1122.

     2.    Winter, P. F., Lapke, J. M., & Winek, R. R. (1996). Subcutaneous cavernous hemangioma visualized on an indium-111- octreotide scan. J.Nucl.Med., 37, 1516-1517.

WINEK,S.J.


     1.    Medlock, M. D., Olivero, W. C., Hanigan, W. C., Wright, R. M., & Winek, S. J. (1992). Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery, 31, 870-6; discussion 876.

     2.    Medlock, M. D., Cruse, R. S., Winek, S. J., Geiss, D. M., Horndasch, R. L., Schultz, D. L. et al. (1993). A 10-year experience with postpump chorea. Ann.Neurol., 34, 820-826.

WIPFLER,E.J.,III


     1.    Cassidy, E. S., Adkins, C. R., Rayl, J. H., & Wipfler, E. J., III (2001). Evaluation of warmed intravenous fluids in the prehospital setting. Air Med.J., 20, 25-26.

WISE,J.E.


     1.    Wise, J. E., Kolb, E. L., & Sauder, S. E. (1992). Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care, 15, 826-830.

YAN,Q.S.


     1.    Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L., & Jobe, P. C. (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 260, 533-540.

     2.    Dailey, J. W., Seo, D. O., Yan, Q. S., Ko, K. H., Jo, M., & Jobe, P. C. (1994). The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study [published erratum appears in Neurosci Lett 1994 Oct 24;180(2):294]. Neurosci.Lett., 178, 179-183.

     3.    Dailey, J. W., Yan, Q. S., Adams-Curtis, L. E., Ryu, J. R., Ko, K. H., Mishra, P. K. et al. (1996). Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci., 58, 259-266.

     4.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+. Eur.J.Pharmacol., 328, 153-162.

     5.    Dailey, J. W., Reith, M. E., Yan, Q. S., Li, M. Y., & Jobe, P. C. (1997). Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. Neurosci.Lett., 227, 13-16.

     6.    Feng, M. J., Yan, S. E., & Yan, Q. S. (2005). Effects of prenatal alcohol exposure on brain-derived neurotrophic factor and its receptor tyrosine kinase B in offspring. Brain Research, 1042, 125-132.

     7.    Feng, M. J., Yan, S. E., & Yan, Q. S. (2006). Cocaine exposure at a sublethal concentration downregulates CREB functions in cultured neuroblastoma cells. Brain Research, ..

     8.    Lasley, S. M. & Yan, Q. S. (1994). Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats. Neurosci.Lett., 175, 145-148.

     9.    Li, M. Y., Yan, Q. S., Coffey, L. L., & Reith, M. E. (1996). Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J.Neurochem., 66, 559-568.

   10.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The paradoxical effect of NMDA receptor stimulation on electrical activity of the sensorimotor cortex in freely behaving rats: analysis by combined EEG-intracerebral microdialysis. Synapse, 12, 87-98.

   11.    Ludvig, N., Mishra, P. K., Yan, Q. S., Lasley, S. M., Burger, R. L., & Jobe, P. C. (1992). The combined EEG-intracerebral microdialysis technique: a new tool for neuropharmacological studies on freely behaving animals. J.Neurosci.Methods, 43, 129-137.

   12.    Mishra, P. K., Yan, Q. S., Burger, R. L., Dailey, J. W., & Jobe, P. C. (1994). Microdialysis for the Study of Seizure Regulation. In.

   13.    Reith, M. E., Li, M. Y., & Yan, Q. S. (1997). Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl), 134, 309-317.

   14.    Yan, Q. S., Mishra, P. K., Burger, R. L., Bettendorf, A. F., Jobe, P. C., & Dailey, J. W. (1992). Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J.Pharmacol.Exp.Ther., 261, 652-659.

   15.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Research, 610, 24-31.

   16.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1993). Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res., 14, 229-236.

   17.    Yan, Q. S., Jobe, P. C., Cheong, J. H., Ko, K. H., & Dailey, J. W. (1994). Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch.Pharmacol., 350, 149-152.

   18.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1994). Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur.J.Pharmacol., 252, 105-112.

   19.    Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1995). Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br.J.Pharmacol., 115, 1314-1318.

   20.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1996). Focal ethanol elevates extracellular dopamine and serotonin concentrations in the rat ventral tegmental area. Eur.J.Pharmacol., 301, 49-57.

   21.    Yan, Q. S., Reith, M. E., Jobe, P. C., & Dailey, J. W. (1997). Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research, 765, 149-158.

   22.    Yan, Q. S., Reith, M. E., Yan, S. G., & Jobe, P. C. (1998). Effect of systemic ethanol on basal and stimulated glutamate releases in the nucleus accumbens of freely moving Sprague-Dawley rats: a microdialysis study. Neurosci.Lett., 258, 29-32.

   23.    Yan, Q. S., Dailey, J. W., Steenbergen, J. L., & Jobe, P. C. (1998). Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study. Brain Research, 780, 199-209.

   24.    Yan, Q. S. (1999). Extracellular dopamine and serotonin after ethanol monitored with 5-minute microdialysis. Alcohol, 19, 1-7.

   25.    Yan, Q. S. (1999). Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis. Eur.J.Pharmacol., 385, 7-13.

   26.    Yan, Q. S. (2000). Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Research Bulletin, 51, 75-81.

   27.    Yan, Q. S., Reith, M. E., & Yan, S. E. (2000). Enhanced accumbal dopamine release following 5-HT2A receptor stimulation in rats pretreated with intermittent cocaine. Brain Research, 863, 254-258.

   28.    Yan, Q. S. & Yan, S. E. (2001). Activation of 5-HT1B/(1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur.J.Pharmacol., 418, 55-64.

   29.    Yan, Q. S. & Yan, S. E. (2001). Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices. J.Neurochem., 79, 914-922.

   30.    Yan, Q. S. (2002). Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure. Brain Research, 929, 59-69.

   31.    Yan, Q. S. (2003). Involvement of non-exocytotic mechanisms in ethanol-induced in vivo dopamine release: comparisons with cocaine. Eur.J Pharmacol., 477, 37-44.

   32.    Yan, Q. S., Zheng, S. Z., & Yan, S. E. (2004). Prenatal cocaine exposure decreases brain-derived neurotrophic factor proteins in the rat brain. Brain Research, 1009, 228-233.

   33.    Yan, Q. S. (2004). Involvement of 5-HT-1B receptors in effects of ethanol on mesolimbic dopamine neurotransmission: A microdialysis study. Alcoholism-Clinical and Experimental Research, 28, 11A.

   34.    Yan, Q. S., Zheng, S. Z., & Yan, S. E. (2004). Involvement of 5-HT(1B) receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Research, 1021, 82-91.

   35.    Yan, Q. S., Feng, M. J., & Yan, S. E. (2005). Different expression of brain-derived neurotrophic factor in the nucleus accumbens of alcohol-preferring (P) and -nonpreferring (NP) rats. Brain Research, 1035, 215-218.

   36.    Yan, Q. S., Zheng, S. Z., Feng, M. J., & Yan, S. E. (2005). Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission. Brain Research, 1060, 126-137.

YAN,S.E.


     1.    Feng, M. J., Yan, S. E., & Yan, Q. S. (2005). Effects of prenatal alcohol exposure on brain-derived neurotrophic factor and its receptor tyrosine kinase B in offspring. Brain Research, 1042, 125-132.

     2.    Feng, M. J., Yan, S. E., & Yan, Q. S. (2006). Cocaine exposure at a sublethal concentration downregulates CREB functions in cultured neuroblastoma cells. Brain Research, ..

     3.    Yan, Q. S., Reith, M. E., & Yan, S. E. (2000). Enhanced accumbal dopamine release following 5-HT2A receptor stimulation in rats pretreated with intermittent cocaine. Brain Research, 863, 254-258.

     4.    Yan, Q. S. & Yan, S. E. (2001). Activation of 5-HT1B/(1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur.J.Pharmacol., 418, 55-64.

     5.    Yan, Q. S. & Yan, S. E. (2001). Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices. J.Neurochem., 79, 914-922.

     6.    Yan, Q. S., Zheng, S. Z., & Yan, S. E. (2004). Prenatal cocaine exposure decreases brain-derived neurotrophic factor proteins in the rat brain. Brain Research, 1009, 228-233.

     7.    Yan, Q. S., Zheng, S. Z., & Yan, S. E. (2004). Involvement of 5-HT(1B) receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Research, 1021, 82-91.

     8.    Yan, Q. S., Feng, M. J., & Yan, S. E. (2005). Different expression of brain-derived neurotrophic factor in the nucleus accumbens of alcohol-preferring (P) and -nonpreferring (NP) rats. Brain Research, 1035, 215-218.

     9.    Yan, Q. S., Zheng, S. Z., Feng, M. J., & Yan, S. E. (2005). Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission. Brain Research, 1060, 126-137.

YOUNG,C.S.


     1.    Smith, S. M., Young, C. S., & Bishop, A. F. (1996). Adenocarcinoma of a foregut cyst: detection with positron emission tomography. Am.J.Roentgenol., 167, 1153-1154.

     2.    Utech, C. I., Young, C. S., & Winter, P. F. (1996). Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur.J.Nucl.Med., 23, 1588-1593.

     3.    Yunus, M. B., Young, C. S., Saeed, S. A., Mountz, J. M., & Aldag, J. C. (2004). Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis and Rheumatism, 51, 513-518.

YUNUS,M.B.


     1.    Choudhury, A. K., Yunus, M. B., Haq, S. A., Alam, M. N., Sebrina, F., & Aldag, J. C. (2001). Clinical features of fibromyalgia syndrome in a Bangladeshi population. Journal of Musculoskeletal Pain, 9, 25-33.

     2.    Inanici, F., Yunus, M. B., & Aldag, J. C. (1999). Clinical features and psychologic factors in regional soft tissue pain: Comparison with fibromyalgia syndrome. Journal of Musculoskeletal Pain, 7, 293-301.

     3.    Inanici, F. & Yunus, M. B. (2001). Fibromyalgia Syndrome: Diagnosis and Management. JCOM, 8, 55-67.

     4.    Inanici, F. & Yunus, M. B. (2001). Management of fibromyalgia syndrome. In Myofascial Pain and Fibromyalgia Syndromes: A Clinical Guide to Diagnosis and Management (pp. 379-398). New York: Churchill Livingstone.

     5.    Inanici, F. & Yunus, M. B. (2004). History of fibromyalgia: past to present. Current pain and headache reports, 8, 369-378.

     6.    Kalyan-Raman, U. P., Kalyan-Raman, K., Yunus, M. B., & Masi, A. T. (1984). Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol., 11, 808-813.

     7.    Reddy, S. S., Yunus, M. B., Inanici, F., & Aldag, J. C. (2000). Tender point injections are beneficial in fibromyalgia syndrome: A descriptive, open study. Journal of Musculoskeletal Pain, 8, 7-18.

     8.    Usman, A. R. & Yunus, M. B. (1996). Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate [see comments]. J.Rheumatol., 23, 1095-1097.

     9.    Usman, A. R. & Yunus, M. B. (1997). Malignancy in patients with rheumatoid arthritis treated with methotrexate - reply. Journal of Rheumatology, 24, 806-807.

   10.    Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L. et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee [see comments]. Arthritis Rheum., 33, 160-172.

   11.    Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L. et al. (1997). A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis & Rheumatism, 40, 1560-1570.

   12.    Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L. et al. (1997). Health status and disease severity in fibromyalgia - results of a six-center longitudinal study. Arthritis & Rheumatism, 40, 1571-1579.

   13.    Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L. et al. (1997). Work and disability status of persons with fibromyalgia. Journal of Rheumatology, 24, 1171-1178.

   14.    Yunus, M. B., Radford, C. M., Masi, A. T., Zimmerman, T. J., Calabro, J. J., & Miller, K. A. (1984). Aortic regurgitation in scleroderma. J Rheumatol., 11, 384-386.

   15.    Yunus, M. B., Morgan, R. J., Barclay, A. M., Shah, I. K., & Masi, A. T. (1985). Organic brain syndrome in rheumatoid arthritis after corticosteroid withdrawal. J Rheumatol., 12, 636-637.

   16.    Yunus, M. B., Denko, C. W., & Masi, A. T. (1986). Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. J Rheumatol., 13, 183-186.

   17.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol.Suppl, 19:62-71., 62-71.

   18.    Yunus, M. B., Berg, B. C., & Masi, A. T. (1989). Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: a blinded study. J Rheumatol., 16, 1466-1468.

   19.    Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol., 16, 527-532.

   20.    Yunus, M. B., Kalyan-Raman, U. P., Masi, A. T., & Aldag, J. C. (1989). Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol., 16, 97-101.

   21.    Yunus, M. B., Ahles, T. A., Aldag, J. C., & Masi, A. T. (1991). Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum., 34, 15-21.

   22.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 95-97.

   23.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J.Rheumatol., 19, 90-94.

   24.    Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T., & Jobe, P. C. (1992). Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. The Journal of Rheumatology, 19, 95-97.

   25.    Yunus, M. B., Hussey, F. X., & Aldag, J. C. (1993). Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J.Rheumatol., 20, 1557-1560.

   26.    Yunus, M. B. (1994). Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres.Clin.Rheumatol., 8, 811-837.

   27.    Yunus, M. B. (1995). Fibromyalgia syndrome. Cranio-The Journal of Craniomandibular Practice, 13, 198-202.

   28.    Yunus, M. B., Aldag, J. C., Dailey, J. W., & Jobe, P. C. (1995). Interrelationships of biochemical parameters in Classification of Fibromyalgia Syndrome and Health Normal Controls. Journal of Musculoskeletal Pain, 3, 15-24.

   29.    Yunus, M. B. & Arslan, S. (1995). Fibromyalgia syndrome: can it be treated? Consultant, 44, 289-292.

   30.    Yunus, M. B. (1996). Fibromyalgia syndrome: is there any effective therapy?...two- part series. Consultant, 36, 1279-1285.

   31.    Yunus, M. B. (1996). Fibromyalgia syndrome: blueprint for a reliable diagnosis...two- part series. Consultant, 36, 1260-1272.

   32.    Yunus, M. B. & Aldag, J. C. (1996). Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ, 312, 1339.

   33.    Yunus, M. B. (1998). Genetic factors in fibromyalgia syndrome. Zeitschrift fur Rheumatologie, 57, 61-62.

   34.    Yunus, M. B., Bennett, R. M., Romano, T. J., & Russell, I. J. (1998). Fibromyalgia consensus report - additional comments. Jcr-Journal of Clinical Rheumatology, 4, 289-290.

   35.    Yunus, M. B., Bennett, R. M., Romano, T. J., & Russell, I. J. (1998). Fibromyalgia - the plot thickens - response. Jcr-Journal of Clinical Rheumatology, 4, 291-292.

   36.    Yunus, M. B., Khan, M. A., Rawlings, K. K., Green, J. R., Olson, J. M., & Shah, S. (1999). Genetic linkage analysis of multicase families with fibromyalgia syndrome. Journal of Rheumatology, 26, 408-412.

   37.    Yunus, M. B., Inanici, F., Aldag, J. C., & Mangold, R. F. (2000). Fibromyalgia in men: Comparison of clinical features with women. Journal of Rheumatology, 27, 485-490.

   38.    Yunus, M. B. (2000). Central Sensitivity Syndromes : A Unified Concept for Fibromyalgia and other similar maladies. JIRA 8[1], 27-33.
Ref Type: Journal (Full)

   39.    Yunus, M. B. (2001). The role of gender in fibromyalgia syndrome. Curr.Rheumatol.Rep., 3, 128-134.

   40.    Yunus, M. B. & Inanici, F. (2001). Clinical charactistics and biopathophysiological mechanisms of fibromyalgia. In P.E.Baldry, M. B. Yunus, F. Inanici, & B. Hazelman (Eds.), Myofascial Pain and Fibromyalgia Syndromes (pp. 351-377).

   41.    Yunus, M. B. (2001). Genetic Aspects of Fibromyalgia Syndrome. J rheum med rehab, 11, 143-145.

   42.    Yunus, M. B. (2002). Gender differences in fibromyalgia and other related syndromes. J.Gend.Specif.Med., 5, 42-47.

   43.    Yunus, M. B., Arslan, S., & Aldag, J. C. (2002). Relationship between body mass index and fibromyalgia features. Scand.J.Rheumatol., 31, 27-31.

   44.    Yunus, M. B., Arslan, S., & Aldag, J. C. (2002). Relationship between fibromyalgia features and smoking. Scand.J.Rheumatol., 31, 301-305.

   45.    Yunus, M. B. (2003). Research in Fibromyalgia and Myofacial Pain Syndromes: Current Status, Problems and Future Directions. Journal of Musculoskeletal Pain, 1, 23-41.

   46.    Yunus, M. B. (2004). Suffering, science and sabotage. Journal of Musculoskeletal Pain, 12, 3-18.

   47.    Yunus, M. B. & Arslan, S. (2004). Fibromyalgia syndrome: can it be treated? Consultant, 44, 289-292.

   48.    Yunus, M. B., Celiker, R., & Aldag, J. C. (2004). Fibromyalgia in men: Comparison of psychological features with women. Journal of Rheumatology, 31, 2464-2467.

   49.    Yunus, M. B., Young, C. S., Saeed, S. A., Mountz, J. M., & Aldag, J. C. (2004). Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis and Rheumatism, 51, 513-518.

    50.    Yunus, M., Plattner, P. F., Masi, A. T., Shah, I. K., Lindahl, L. S., & Conner, D. E. (1982). Ulnar deviation of the fingers in gout simulating rheumatoid arthritis. J Rheumatol., 9, 619-623.

   51.    Zakzook, S. I., Yunus, M. B., & Mulconrey, D. S. (2002). Hyperviscosity syndrome in rheumatoid arthritis with Felty's syndrome: case report and review of the literature. Clin.Rheumatol., 21, 82-85.

ZALLEK,S.


     1.    Lee, R. K., Bartel, S., Murphy, C., & Zallek, S. (2006). The Epworth Sleepiness Scale predicts dozing off at the wheel and at work; Sleep disordered breathing does not. Sleep, 29, A200.

ZALLEK,S.N.


     1.    Hanigan, W. C. & Zallek, S. N. (2004). Headaches, shunts, and obstructive sleep apnea: report of two cases. Neurosurgery, 54, 764-768.

     2.    Murphy, C., Valerio, T. D., & Zallek, S. N. (2006). Trichotillomania: An NREM sleep parasomnia? Neurology, 66, 1276.

     3.    Valerio, T. D. & Zallek, S. N. (2004). Clinical practice among non-sleep specialist physicians when sleep apnea is suspected. Sleep, 27, 188.

     4.    Valerio, T. D. & Zallek, S. N. (2004). Treatment choices for obstructive sleep apnea among non-sleep specialist physicians. Sleep, 27, 374-375.

     5.    Zallek, S. N. (2004). Prior education and interest in continuing medical education in sleep medicine among practicing physicians. Sleep, 27, 375.

     6.    Zallek, S. N. (2004). Comfort levels of non-sleep specialist physicians in diagnosis and treatment of sleep apnea and insomnia. Sleep, 27, 377.